"SYMBOL","COMPANY NAME","SUBJECT","DETAILS","BROADCAST DATE/TIME","RECEIPT","DISSEMINATION","DIFFERENCE","ATTACHMENT"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Clarification on reported news article'.","17-Feb-2024 18:30:03","2024-02-17 18:30:03","17-Feb-2024 19:00:34","00:30:31","https://nsearchives.nseindia.com/corporate/DRREDDY_17022024183003_SE_intimation_clarification_news_article_17022024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss/Duplicate-Share Certificate-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Loss of share certificates","17-Feb-2024 15:23:49","2024-02-17 15:23:49","17-Feb-2024 18:50:21","03:26:32","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_17022024152349_LOSS_OF_SHARE_1057586_17022024032348_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","16-Feb-2024 16:01:04","2024-02-16 16:01:04","16-Feb-2024 16:01:15","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_16022024160104_StockExchangeIntimation_newspaperadvertisement_signed.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Postal Ballot. Further, the company has informed the Exchange regarding voting results.","14-Feb-2024 19:47:57","2024-02-14 19:47:57","14-Feb-2024 19:48:02","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_14022024194757_StockExchangeintimation_resultsofPB_14022024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015   Update on the USFDA inspection at the Company s R&D centre (Integrated Product Development Organisation or IPDO) in Bachupally, Hyderabad'.","12-Feb-2024 14:58:38","2024-02-12 14:58:38","12-Feb-2024 14:58:43","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_12022024145838_SE_intimationdated12022024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015   Update on the USFDA cGMP inspection at the Company s formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad USFDA cGMP inspection at the Company s formulations manufacturing facility (FTO-3) in Bachupally, Hyderabad'.","10-Feb-2024 11:47:47","2024-02-10 11:47:47","10-Feb-2024 11:47:53","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_10022024114747_SE_intimationdated10022024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss/Duplicate-Share Certificate-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Loss of share certificates","07-Feb-2024 18:27:42","2024-02-07 18:27:42","07-Feb-2024 18:27:47","00:00:05","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_07022024182742_LOSS_OF_SHARE_1047339_07022024062741_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","07-Feb-2024 14:36:32","2024-02-07 14:36:32","07-Feb-2024 14:36:39","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_07022024143632_07022024_SEintimation_lossofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript","05-Feb-2024 18:17:01","2024-02-05 18:17:01","05-Feb-2024 18:17:07","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_05022024181701_SEIntimation_Transcriptofearningcallrecordings.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","02-Feb-2024 14:52:21","2024-02-02 14:52:21","02-Feb-2024 14:52:34","00:00:13","https://nsearchives.nseindia.com/corporate/DRREDDY_02022024145221_Intimation02022024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss/Duplicate-Share Certificate-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation","31-Jan-2024 17:44:26","2024-01-31 17:44:26","31-Jan-2024 17:44:33","00:00:07","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_31012024174426_LOSS_OF_SHARE_1040512_31012024054425_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Initmation on filing of Form 6k for the quarter ended December 31, 2023'.","31-Jan-2024 17:39:58","2024-01-31 17:39:58","31-Jan-2024 17:40:09","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_31012024173958_SEIntimation_6Kfiling.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","31-Jan-2024 17:23:40","2024-01-31 17:23:40","31-Jan-2024 17:23:46","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_31012024172340_SEintimation31012024_newspaperpublication.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Letter of Confirmation in lieu of share certificate(s) reported lost/ misplaced","31-Jan-2024 11:30:17","2024-01-31 11:30:17","31-Jan-2024 11:30:29","00:00:12","https://nsearchives.nseindia.com/corporate/DRREDDY_31012024113017_SE_intimation_duplicate_issue_31012024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording","31-Jan-2024 08:49:12","2024-01-31 08:49:12","31-Jan-2024 08:49:18","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_31012024084912_SEIntimation_Earningscallrecordings.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 30, 2024.","30-Jan-2024 16:11:59","2024-01-30 16:11:59","30-Jan-2024 16:12:06","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_30012024161159_SEintimation_30012024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting   Unaudited Financial Results for the quarter and nine months ended December 31, 2023","30-Jan-2024 16:08:48","2024-01-30 16:08:48","30-Jan-2024 16:08:54","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_30012024160848_SEintimation_30012024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","30-Jan-2024 16:06:06","2024-01-30 16:06:06","30-Jan-2024 16:06:12","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_30012024160606_SE_intimation_Reg30.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2023.","30-Jan-2024 15:58:53","2024-01-30 15:58:53","30-Jan-2024 15:58:57","00:00:04","https://nsearchives.nseindia.com/corporate/SEintimation_30012024_30012024155853.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Grant of stock options to the eligible employee(s) under the Employees Stock Option Schemes of the Company'.","29-Jan-2024 15:55:39","2024-01-29 15:55:39","29-Jan-2024 15:55:48","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_29012024155539_SEintimation_ESOPgrants_29012024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","19-Jan-2024 17:43:12","2024-01-19 17:43:12","19-Jan-2024 17:43:24","00:00:12","https://nsearchives.nseindia.com/corporate/DRREDDY_19012024174312_SEintiamtionearningscallnotification.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy s Laboratories eyes mega brand in UK - The Financial Express.  The response from the Company is attached.","18-Jan-2024 18:47:01","2024-01-18 18:47:01","18-Jan-2024 18:47:08","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_18012024184701_NSE_Clarification_News_Item_18012024_final.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy s Laboratories eyes mega brand in UK - The Financial Express.  The response from the Company is awaited.","17-Jan-2024 18:56:12","2024-01-17 18:56:12","17-Jan-2024 18:56:20","00:00:08","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding Postal Ballot Notice - Advertisement","17-Jan-2024 17:07:02","2024-01-17 17:07:02","17-Jan-2024 17:07:08","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_17012024170702_StockExchangeIntimation_newspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Clarification on reported news item'.","16-Jan-2024 22:37:47","2024-01-16 22:37:47","16-Jan-2024 22:37:51","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_16012024223747_SE_Intimation_News_Item_16012024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding ''Disclosure under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015","16-Jan-2024 18:57:07","2024-01-16 18:57:07","16-Jan-2024 18:57:11","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_16012024185707_SE_intimation_GST_Penalty.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Notice Of Shareholders Meetings-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot","16-Jan-2024 16:12:57","2024-01-16 16:12:57","16-Jan-2024 16:13:04","00:00:07","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_16012024161257_NOTICE_OF_SHAREHOLDERS_MEETINGS_1022927_16012024041257_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot","15-Jan-2024 16:44:12","2024-01-15 16:44:12","15-Jan-2024 16:44:19","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_15012024164413_IntimationPB15012024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","12-Jan-2024 14:54:58","2024-01-12 14:54:58","12-Jan-2024 14:55:04","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_12012024145458_StockExchangeIntimation_newspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","11-Jan-2024 10:44:25","2024-01-11 10:44:25","11-Jan-2024 10:44:31","00:00:06","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_11012024104425_CIM_16139_1015347_11012024104424_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss/Duplicate-Share Certificate-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation","10-Jan-2024 19:25:47","2024-01-10 19:25:47","10-Jan-2024 19:25:53","00:00:06","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_10012024192547_LOSS_OF_SHARE_1015119_10012024072547_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss/Duplicate-Share Certificate-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Loss of share certificates","10-Jan-2024 19:22:09","2024-01-10 19:22:09","10-Jan-2024 19:22:13","00:00:04","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_10012024192209_LOSS_OF_SHARE_1015111_10012024072209_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Letter of confirmation in lieu of Duplicate Share Certificates","10-Jan-2024 19:17:39","2024-01-10 19:17:39","10-Jan-2024 19:17:44","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_10012024191739_SE_intimation_duplicate_issue_10012024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Management","Dr. Reddy's Laboratories Limited has informed the Exchange about Change in Senior Management Personnel","10-Jan-2024 17:16:13","2024-01-10 17:16:13","10-Jan-2024 17:16:20","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_10012024171613_Intimation10012024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","10-Jan-2024 11:50:51","2024-01-10 11:50:51","10-Jan-2024 11:50:57","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_10012024115051_10012024SEintimation_lossofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy's recalls 8,000 bottles of generic drug in US over packaging error.  The response from the Company is awaited.","08-Jan-2024 19:55:26","2024-01-08 19:55:26","08-Jan-2024 19:55:33","00:00:07","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","05-Jan-2024 19:42:39","2024-01-05 19:42:39","05-Jan-2024 19:42:45","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_05012024194239_SE_intimation_GST_Penalty.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","04-Jan-2024 17:25:44","2024-01-04 17:25:44","04-Jan-2024 17:25:51","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_04012024172544_SEintimationCertificateunder74_5_.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 03, 2024, titled ""ￂﾬￂﾬDr. Reddy's announces the acquisition of MenoLabsￂﾮ, a leading women s health and dietary supplements portfolio of brands"".","03-Jan-2024 14:22:41","2024-01-03 14:22:41","03-Jan-2024 14:22:46","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_03012024142241_PressRelease03012024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","31-Dec-2023 11:32:46","2023-12-31 11:32:46","31-Dec-2023 22:20:27","10:47:41","https://nsearchives.nseindia.com/corporate/DRREDDY_31122023113246_Intimation30122023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","31-Dec-2023 11:29:47","2023-12-31 11:29:47","31-Dec-2023 22:20:00","10:50:13","https://nsearchives.nseindia.com/corporate/DRREDDY_31122023112947_Intimation31122023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss/Duplicate-Share Certificate-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Loss of share certificates","29-Dec-2023 19:27:55","2023-12-29 19:27:55","29-Dec-2023 19:28:03","00:00:08","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_29122023192756_LOSS_OF_SHARE_1005224_29122023072755_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","29-Dec-2023 19:05:53","2023-12-29 19:05:53","29-Dec-2023 19:06:01","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_29122023190553_29122023SEintimation_lossofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","29-Dec-2023 17:48:52","2023-12-29 17:48:52","29-Dec-2023 17:48:58","00:00:06","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_29122023174852_CIM_15569_1004944_29122023054852_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Director(s)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.","29-Dec-2023 17:38:01","2023-12-29 17:38:01","29-Dec-2023 17:38:06","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_29122023173801_SE_intimation_Reg30_change_in_director_Dec29_2023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Acquisition","Dr. Reddy's Laboratories Limited has informed the Exchange about Acquisition of securities by a wholly-owned step-down subsidiary company","29-Dec-2023 15:48:47","2023-12-29 15:48:47","29-Dec-2023 15:48:52","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_29122023154847_SEintimation29122023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss/Duplicate-Share Certificate-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Loss of share certificates","26-Dec-2023 17:44:42","2023-12-26 17:44:42","26-Dec-2023 17:44:49","00:00:07","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_26122023174442_LOSS_OF_SHARE_1001895_26122023054441_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","23-Dec-2023 18:17:58","2023-12-23 18:17:58","23-Dec-2023 18:18:04","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_23122023181759_StockExchangeIntimation_newspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","22-Dec-2023 14:44:46","2023-12-22 14:44:46","22-Dec-2023 14:44:57","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_22122023144446_22122023SEintimationlossofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Board Meeting Intimation","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 30-Jan-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2023 .","21-Dec-2023 16:18:44","2023-12-21 16:18:44","21-Dec-2023 16:18:56","00:00:12","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_21122023161844_PRIOR_INTIMATION_15329_999931_21122023041843_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","21-Dec-2023 11:22:33","2023-12-21 11:22:33","21-Dec-2023 11:22:41","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_21122023112234_BoardMeetingNoticeIntimation_21122023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 14, 2023, titled ""Dr. Reddy s becomes first Indian pharma company to debut on the Dow Jones Sustainability World Index"".","14-Dec-2023 15:51:43","2023-12-14 15:51:43","14-Dec-2023 15:51:50","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_14122023155143_SEintimation14122023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss/Duplicate-Share Certificate-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation","12-Dec-2023 11:49:16","2023-12-12 11:49:16","12-Dec-2023 11:49:22","00:00:06","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_12122023114916_LOSS_OF_SHARE_995675_12122023114915_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Clarification on reported news article'.","12-Dec-2023 10:18:14","2023-12-12 10:18:14","12-Dec-2023 10:18:20","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_12122023101814_SEIntimaitonNewsItemDec122023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Alteration Of Capital and Fund Raising-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Allotment of Securities","11-Dec-2023 14:40:35","2023-12-11 14:40:35","11-Dec-2023 14:40:41","00:00:06","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_11122023144035_ALTERATION_OF_CAPITAL_AND_FUND_RAISING_995352_11122023024034_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Letter of confirmation in lieu of share certificate(s) lost/misplaced","11-Dec-2023 14:36:04","2023-12-11 14:36:04","11-Dec-2023 14:36:10","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_11122023143604_SEintimationofissueofdupSC_111223.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 9181 securities pursuant to ESOP/ESPS at its meeting held on December 09, 2023","09-Dec-2023 18:15:27","2023-12-09 18:15:27","09-Dec-2023 18:15:33","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_09122023181527_SEintimation_ESOP_final.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation' regarding completion of USFDA inspection","08-Dec-2023 21:55:06","2023-12-08 21:55:06","08-Dec-2023 21:55:13","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_08122023215506_SE_intimation_Reg30_08122023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","08-Dec-2023 16:26:31","2023-12-08 16:26:31","08-Dec-2023 16:26:37","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_08122023162631_08122023_SEintimation_lossofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned US regulators inspect Dr Reddy's, other Indian pharma majors: Report.  The response from the Company is awaited.","06-Dec-2023 18:00:39","2023-12-06 18:00:39","06-Dec-2023 18:00:47","00:00:08","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 06, 2023, titled ""Press Release"".","06-Dec-2023 17:35:35","2023-12-06 17:35:35","06-Dec-2023 17:35:42","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_06122023173535_Intimation06122023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","01-Dec-2023 16:09:30","2023-12-01 16:09:30","01-Dec-2023 16:09:35","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_01122023160930_Intimation01122023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet on 04/12/2023-05/12/2023","28-Nov-2023 16:58:03","2023-11-28 16:58:03","28-Nov-2023 16:58:10","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_28112023165803_Intimation28112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","24-Nov-2023 14:40:08","2023-11-24 14:40:08","24-Nov-2023 14:40:21","00:00:13","https://nsearchives.nseindia.com/corporate/DRREDDY_24112023144009_StockExchangeIntimationnewspaperadvertisement_final.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Acquisition-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Acquisition","22-Nov-2023 10:25:11","2023-11-22 10:25:11","22-Nov-2023 10:25:17","00:00:06","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_22112023102511_REG30_Restructuring_990542_22112023102511_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Alteration Of Capital and Fund Raising-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Allotment of Securities","21-Nov-2023 17:03:35","2023-11-21 17:03:35","21-Nov-2023 17:03:40","00:00:05","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_21112023170335_ALTERATION_OF_CAPITAL_AND_FUND_RAISING_990395_21112023050334_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 3362 securities pursuant to ESOP/ESPS at its meeting held on November 21, 2023","21-Nov-2023 16:40:39","2023-11-21 16:40:39","21-Nov-2023 16:40:46","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_21112023164039_SEintimation_ESOP_final_21112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","20-Nov-2023 15:42:37","2023-11-20 15:42:37","20-Nov-2023 15:42:42","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_20112023154237_Intimation20112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Analyst/Investor Meet","17-Nov-2023 18:06:44","2023-11-17 18:06:44","17-Nov-2023 18:06:55","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_17112023180644_Intimation17112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Postal Ballot. Further, the company has informed the Exchange regarding voting results.","16-Nov-2023 15:56:53","2023-11-16 15:56:53","16-Nov-2023 15:57:01","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_16112023155653_StockExchangeintimationresultsofPB16112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 16, 2023, titled ""Press Release/Media Release"".","16-Nov-2023 14:00:13","2023-11-16 14:00:13","16-Nov-2023 14:00:55","00:00:42","https://nsearchives.nseindia.com/corporate/DRREDDY_16112023140013_PressRelease16112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Acquisition","Dr. Reddy's Laboratories Limited has informed the Exchange about Acquisition of securities of O2 Renewable Energy IX Private Limited","10-Nov-2023 19:02:49","2023-11-10 19:02:49","10-Nov-2023 19:02:57","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_10112023190249_SEIntimation10112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 '.","09-Nov-2023 19:41:22","2023-11-09 19:41:22","09-Nov-2023 19:41:29","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_09112023194122_SEIntimationunderReg3009112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Alteration Of Capital and Fund Raising-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Allotment of Securities","09-Nov-2023 17:39:42","2023-11-09 17:39:42","09-Nov-2023 17:40:02","00:00:20","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_09112023173942_ALTERATION_OF_CAPITAL_AND_FUND_RAISING_983251_09112023053941_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","07-Nov-2023 15:23:37","2023-11-07 15:23:37","07-Nov-2023 15:23:43","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_07112023152338_SeintimationlossofSC06112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 12090 securities pursuant to ESOP/ESPS at its meeting held on November 06, 2023","07-Nov-2023 10:43:21","2023-11-07 10:43:21","07-Nov-2023 10:43:27","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_07112023104321_StockExchangeintimation07112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation on Intimation on filing of Form 6-K for the quarter ended September 30, 2023'.","02-Nov-2023 17:20:13","2023-11-02 17:20:13","02-Nov-2023 17:20:23","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_02112023172013_SEIntimation6Kfiling02112023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript","01-Nov-2023 14:42:28","2023-11-01 14:42:28","01-Nov-2023 14:42:35","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_01112023144228_SEIntimationTranscriptofearningcallrecordings.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","28-Oct-2023 16:55:10","2023-10-28 16:55:10","28-Oct-2023 16:55:20","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_28102023165510_Copyofnewspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording","28-Oct-2023 09:22:09","2023-10-28 09:22:09","28-Oct-2023 09:22:16","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_28102023092209_SEIntimationEarningscallrecordings.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 '.","28-Oct-2023 06:48:24","2023-10-28 06:48:24","28-Oct-2023 06:48:31","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_28102023064824_SEintimationunderReg30_28102023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 27, 2023, titled ""Press Release"".","27-Oct-2023 15:33:39","2023-10-27 15:33:39","27-Oct-2023 15:33:45","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_27102023153339_OutcomeofBM27102023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding  Outcome of Board Meeting   Unaudited Financial Results for the quarter and half-year ended September 30, 2023","27-Oct-2023 15:26:38","2023-10-27 15:26:38","27-Oct-2023 15:27:31","00:00:53","https://nsearchives.nseindia.com/corporate/DRREDDY_27102023152638_OutcomeofBM27102023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2023.","27-Oct-2023 15:24:07","2023-10-27 15:24:07","27-Oct-2023 15:24:14","00:00:07","https://nsearchives.nseindia.com/corporate/OutcomeofBM27102023_27102023152407.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 7346  Options.","26-Oct-2023 17:13:32","2023-10-26 17:13:32","26-Oct-2023 17:13:37","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_26102023171332_SEintimationgrantofstockoptions.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Notice Of Shareholders Meetings-XBRL","Dr. Reddy's Laboratories Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot","19-Oct-2023 15:27:44","2023-10-19 15:27:44","19-Oct-2023 15:27:59","00:00:15","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_19102023152744_NOTICE_OF_SHAREHOLDERS_MEETINGS_960129_19102023032743_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","18-Oct-2023 17:52:57","2023-10-18 17:52:57","18-Oct-2023 17:53:04","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_18102023175257_SEIntimationnewspaperadvertisement181023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot","16-Oct-2023 15:01:10","2023-10-16 15:01:10","16-Oct-2023 15:01:17","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_16102023150110_SE_Intimation_Postal_Ballot_Notice_16102023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","16-Oct-2023 14:31:22","2023-10-16 14:31:22","16-Oct-2023 14:31:29","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_16102023143122_EarningscallsnotificationforQ2FY2024161023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 '.","12-Oct-2023 18:46:25","2023-10-12 18:46:25","12-Oct-2023 18:46:31","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_12102023184625_Intimation12102023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","11-Oct-2023 14:04:56","2023-10-11 14:04:56","11-Oct-2023 14:05:03","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_11102023140456_SEintimationlossofdupSC11102023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 '.","09-Oct-2023 19:55:28","2023-10-09 19:55:28","09-Oct-2023 19:55:33","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_09102023195528_Intimation09102023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","06-Oct-2023 18:10:51","2023-10-06 18:10:51","06-Oct-2023 18:10:59","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_06102023181051_SEintimationreg74_5_300923.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about : Issue of Letter of Confirmation in lieu of share certificate(s) reported lost/misplaced","05-Oct-2023 17:07:41","2023-10-05 17:07:41","05-Oct-2023 17:07:47","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_05102023170741_StockExchangeIntimation_IssueofDupSC05102023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Acquisition","Dr. Reddy's Laboratories Limited has informed the Exchange about incorporation of a step down wholly-owned subsidiary","28-Sep-2023 19:04:21","2023-09-28 19:04:21","28-Sep-2023 19:04:26","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_28092023190421_DRL_Regulation30_28092023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Acquisition","Dr. Reddy's Laboratories Limited has informed the Exchange about Incorporation of a Wholly owned subsidiary","28-Sep-2023 14:40:28","2023-09-28 14:40:28","28-Sep-2023 14:40:37","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_28092023144028_SEintimationReg30.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","26-Sep-2023 17:54:34","2023-09-26 17:54:34","26-Sep-2023 17:54:38","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_26092023175434_SEIntimationlossofSC260923.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Board Meeting Intimation","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 27-Oct-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2023 .","22-Sep-2023 19:34:28","2023-09-22 19:34:28","22-Sep-2023 19:34:36","00:00:08","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_22092023193428_PRIOR_INTIMATION_10673_933433_22092023073427_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Letter of Confirmation in lieu of share certificate(s) reported lost/misplaced","20-Sep-2023 17:55:11","2023-09-20 17:55:11","20-Sep-2023 17:55:15","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_20092023175511_StockExchangeIntimation_IssueofDupSC20092023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","20-Sep-2023 16:16:20","2023-09-20 16:16:20","20-Sep-2023 16:16:24","00:00:04","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_20092023161620_CIM_10579_932369_20092023041620_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Appointment of  Dr. Alpna Hansraj Seth  as Non- Executive Director of the company w.e.f. September 19, 2023.","19-Sep-2023 19:58:28","2023-09-19 19:58:28","19-Sep-2023 19:58:32","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_19092023195828_SE_intimation_Reg30_Sept2023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issuance of Letter of confirmation in lieu of Duplicate Share certificate(s)","19-Sep-2023 17:03:21","2023-09-19 17:03:21","19-Sep-2023 17:03:24","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_19092023170321_SEinitmationissueofDupSC_19092023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","19-Sep-2023 15:46:50","2023-09-19 15:46:50","19-Sep-2023 15:46:56","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_19092023154650_SEIntimation_DRL_Regulation30_19092023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Clarification/ information on reported news item'.","16-Sep-2023 17:21:39","2023-09-16 17:21:39","16-Sep-2023 17:21:43","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_16092023172139_SE_Intimation_News_Item_16092023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","13-Sep-2023 17:20:51","2023-09-13 17:20:51","13-Sep-2023 17:21:16","00:00:25","https://nsearchives.nseindia.com/corporate/DRREDDY_13092023172051_SEintimationforpapera.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","07-Sep-2023 15:02:27","2023-09-07 15:02:27","07-Sep-2023 15:02:33","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_07092023150227_Intimation07092023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Alteration Of Capital and Fund Raising-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Allotment of Securities","06-Sep-2023 11:24:55","2023-09-06 11:24:55","06-Sep-2023 11:25:00","00:00:05","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_06092023112455_ALTERATION_OF_CAPITAL_AND_FUND_RAISING_927463_06092023112455_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 13283 securities pursuant to ESOP/ESPS at its meeting held on September 05, 2023","05-Sep-2023 22:26:56","2023-09-05 22:26:56","05-Sep-2023 22:27:02","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_05092023222656_SE_intimation_ESOP_allotment_05092023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Clarification/Information on news item'.","05-Sep-2023 08:53:36","2023-09-05 08:53:36","05-Sep-2023 08:53:39","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_05092023085336_SE_clarification.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","01-Sep-2023 17:13:28","2023-09-01 17:13:28","01-Sep-2023 17:13:33","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_01092023171328_SEintimationlossofDupSC01092023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","30-Aug-2023 12:15:05","2023-08-30 12:15:05","30-Aug-2023 12:15:16","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_30082023121505_SEintimationlossofDupSC30082023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Cancellation of Certificate of Registration( CoR ) by Reserve Bank of India of M/s Imperial Credit Private Limited ( Wholly Owned Subsidiary )'.","29-Aug-2023 15:26:20","2023-08-29 15:26:20","29-Aug-2023 15:26:25","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_29082023152620_SEIntimationSurrenderofCoR29082023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","29-Aug-2023 14:52:48","2023-08-29 14:52:48","29-Aug-2023 14:52:52","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_29082023145248_StockExchangeIntimationnewspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Alteration Of Capital and Fund Raising-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Allotment of Securities","24-Aug-2023 18:46:38","2023-08-24 18:46:38","24-Aug-2023 18:46:43","00:00:05","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_24082023184638_ALTERATION_OF_CAPITAL_AND_FUND_RAISING_922553_24082023064637_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 12322 securities pursuant to ESOP/ESPS at its meeting held on August 24, 2023","24-Aug-2023 18:29:15","2023-08-24 18:29:15","24-Aug-2023 18:29:18","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_24082023182915_SEintimationESOPfinal.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","24-Aug-2023 14:49:21","2023-08-24 14:49:21","24-Aug-2023 14:49:26","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_24082023144921_Intimation24082023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","17-Aug-2023 17:35:40","2023-08-17 17:35:40","17-Aug-2023 17:35:52","00:00:12","https://nsearchives.nseindia.com/corporate/DRREDDY_17082023173540_SEintimationlossofsharecertificate170823.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30 of the SEBI LODR 2015'.","14-Aug-2023 22:24:55","2023-08-14 22:24:55","14-Aug-2023 22:25:29","00:00:34","https://nsearchives.nseindia.com/corporate/DRREDDY_14082023222455_DRL_Reguation30_14082023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 10, 2023, titled ""Dr. Reddy's Laboratories announces its launch of Saxagliptin and Metformin Hydrochloride Extended-Release Tablets in the U.S"".","10-Aug-2023 12:52:12","2023-08-10 12:52:12","10-Aug-2023 12:52:22","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_10082023125212_PressRelease10082023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Alteration Of Capital and Fund Raising-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Allotment of Securities","07-Aug-2023 11:46:49","2023-08-07 11:46:49","07-Aug-2023 11:46:59","00:00:10","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_07082023114649_ALTERATION_OF_CAPITAL_AND_FUND_RAISING_909741_07082023114649_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","04-Aug-2023 15:35:31","2023-08-04 15:35:31","04-Aug-2023 15:35:47","00:00:16","https://nsearchives.nseindia.com/corporate/DRREDDY_04082023153531_04082023FDAintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","04-Aug-2023 14:37:02","2023-08-04 14:37:02","04-Aug-2023 14:37:17","00:00:15","https://nsearchives.nseindia.com/corporate/DRREDDY_04082023143702_SEintimationlossofDupSC04082023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","04-Aug-2023 14:35:52","2023-08-04 14:35:52","04-Aug-2023 14:36:06","00:00:14","https://nsearchives.nseindia.com/corporate/DRREDDY_04082023143552_04082023SEintimationlossofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 201234 securities pursuant to ESOP/ESPS at its meeting held on August 03, 2023","03-Aug-2023 22:34:12","2023-08-03 22:34:12","03-Aug-2023 22:34:28","00:00:16","https://nsearchives.nseindia.com/corporate/DRREDDY_03082023223412_SEintimationESOPfinal.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 '.","02-Aug-2023 16:35:32","2023-08-02 16:35:32","02-Aug-2023 16:35:45","00:00:13","https://nsearchives.nseindia.com/corporate/DRREDDY_02082023163532_AnnuncementunderReg3002082023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Earnings call for Q1 FY24","31-Jul-2023 18:32:36","2023-07-31 18:32:36","31-Jul-2023 18:32:49","00:00:13","https://nsearchives.nseindia.com/corporate/DRREDDY_31072023183236_SEIntimationTranscriptofEarningscall.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 27, 2023. Further, the company has informed the Exchange regarding voting results along with copy of scrutinizers report .","28-Jul-2023 18:44:37","2023-07-28 18:44:37","28-Jul-2023 18:44:54","00:00:17","https://nsearchives.nseindia.com/corporate/DRREDDY_28072023184437_Outcome39thAGM.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","28-Jul-2023 17:20:33","2023-07-28 17:20:33","28-Jul-2023 17:20:50","00:00:17","https://nsearchives.nseindia.com/corporate/DRREDDY_28072023172033_SEinimationlossofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding filing of Form 6k for Q1 FY24'.","27-Jul-2023 19:56:54","2023-07-27 19:56:54","27-Jul-2023 19:57:00","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_27072023195654_SEIntimation6Kfiling.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","27-Jul-2023 19:43:48","2023-07-27 19:43:48","27-Jul-2023 19:43:55","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_27072023194348_SEintimationpublicationofnewspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","27-Jul-2023 13:07:22","2023-07-27 13:07:22","27-Jul-2023 13:07:46","00:00:24","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_27072023130722_CIM_7799_901287_27072023010721_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording","26-Jul-2023 23:50:01","2023-07-26 23:50:01","26-Jul-2023 23:50:10","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_26072023235001_SEIntimationEarningscallrecordings.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Letter of confirmation/Share Certificates","26-Jul-2023 16:31:09","2023-07-26 16:31:09","26-Jul-2023 16:32:00","00:00:51","https://nsearchives.nseindia.com/corporate/DRREDDY_26072023163109_SEintimationonissueofdupscletterofconfirmation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Retirement","Dr. Reddy's Laboratories Limited has informed the Exchange about retirement of Mr. Sridar Iyengar (DIN:00278512), Independent Director of the Company","26-Jul-2023 16:06:41","2023-07-26 16:06:41","26-Jul-2023 16:06:49","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_26072023160641_Reg30announcement26072023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 26, 2023, titled ""Results-Press Release"".","26-Jul-2023 16:04:10","2023-07-26 16:04:10","26-Jul-2023 16:04:25","00:00:15","https://nsearchives.nseindia.com/corporate/DRREDDY_26072023160410_Resultoutcom26072023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2023.","26-Jul-2023 16:02:19","2023-07-26 16:02:19","26-Jul-2023 16:02:24","00:00:05","https://nsearchives.nseindia.com/corporate/Resultoutcom26072023_26072023160219.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)'.","26-Jul-2023 15:59:34","2023-07-26 15:59:34","26-Jul-2023 15:59:44","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_26072023155934_Reg30announcement26072023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding  Outcome of Board Meeting Unaudited Financial Results for the quarter ended June 30, 2023","26-Jul-2023 15:55:54","2023-07-26 15:55:54","26-Jul-2023 15:56:09","00:00:15","https://nsearchives.nseindia.com/corporate/DRREDDY_26072023155554_Resultoutcom26072023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Alteration Of Capital and Fund Raising-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Allotment of Securities","25-Jul-2023 19:08:00","2023-07-25 19:08:00","25-Jul-2023 19:08:09","00:00:09","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_25072023190800_ALTERATION_OF_CAPITAL_AND_FUND_RAISING_900044_25072023070759_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 2424 securities pursuant to ESOP/ESPS at its meeting held on July 25, 2023","25-Jul-2023 18:09:20","2023-07-25 18:09:20","25-Jul-2023 18:09:35","00:00:15","https://nsearchives.nseindia.com/corporate/DRREDDY_25072023180920_SEESOPintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding update on acqusition'.","20-Jul-2023 23:38:23","2023-07-20 23:38:23","20-Jul-2023 23:38:30","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_20072023233823_20072023ABCDintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding completion of USFDA inspection  '.","19-Jul-2023 18:08:15","2023-07-19 18:08:15","19-Jul-2023 18:08:31","00:00:16","https://nsearchives.nseindia.com/corporate/DRREDDY_19072023180815_19072023FDAintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","17-Jul-2023 18:35:09","2023-07-17 18:35:09","17-Jul-2023 18:35:17","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_17072023183509_Earningscallnotification17072023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Security Subscription and Shareholders  Agreement executed by Dr. Reddy s Laboratories Limited with TEQ Green Power XI Private Limited and its affiliates'.","15-Jul-2023 17:00:38","2023-07-15 17:00:38","15-Jul-2023 17:00:51","00:00:13","https://nsearchives.nseindia.com/corporate/DRREDDY_15072023170038_15072023IntimationISTS.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 12, 2023, titled ""Dr. Reddy s proposed rituximab biosimilar application accepted for review by USFDA, EMA and MHRA"".","12-Jul-2023 18:32:36","2023-07-12 18:32:36","12-Jul-2023 18:32:45","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_12072023183236_PressRelease12072023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication for notice of AGM and e-voting instructions","05-Jul-2023 17:48:57","2023-07-05 17:48:57","05-Jul-2023 17:49:03","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_05072023174857_SEintimationnewspaperad.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","04-Jul-2023 14:47:57","2023-07-04 14:47:57","04-Jul-2023 14:48:06","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_04072023144757_SEStockExchnageintimationnewspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","04-Jul-2023 14:43:29","2023-07-04 14:43:29","04-Jul-2023 14:43:39","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_04072023144329_04072023SEintimationlossofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","03-Jul-2023 18:40:53","2023-07-03 18:40:53","03-Jul-2023 18:41:02","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_03072023184053_SEinitmationcertiifcateunderreg74_5_.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","K Satish Reddy and G V Prasad has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.","28-Jun-2023 15:23:32","2023-06-28 15:23:32","28-Jun-2023 15:23:38","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_28062023152332_Disclosure19.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 23, 2023, titled ""Dr. Reddy s enters the trade generics business in India"".","23-Jun-2023 14:35:22","2023-06-23 14:35:22","23-Jun-2023 14:35:33","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_23062023143522_PressRelease23062023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Alteration Of Capital and Fund Raising-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Allotment of Securities","23-Jun-2023 10:57:31","2023-06-23 10:57:31","23-Jun-2023 10:57:34","00:00:03","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_23062023105731_ALTERATION_OF_CAPITAL_AND_FUND_RAISING_868637_23062023105730_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","22-Jun-2023 17:55:03","2023-06-22 17:55:03","22-Jun-2023 17:55:15","00:00:12","https://nsearchives.nseindia.com/corporate/DRREDDY_22062023175503_22062023SEintimationlossofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 10959 securities pursuant to ESOP/ESPS at its meeting held on Jun 22, 2023","22-Jun-2023 17:50:18","2023-06-22 17:50:18","22-Jun-2023 17:50:22","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_22062023175018_SEintimationESOPfinal.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Board Meeting Intimation","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 26-Jul-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 .","21-Jun-2023 17:04:21","2023-06-21 17:04:21","21-Jun-2023 17:04:24","00:00:03","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_21062023170421_PRIOR_INTIMATION_6364_867822_21062023050421_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","21-Jun-2023 15:22:34","2023-06-21 15:22:34","21-Jun-2023 15:22:40","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_21062023152234_BmIntimation21062023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","19-Jun-2023 22:54:58","2023-06-19 22:54:58","19-Jun-2023 22:55:00","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_19062023225458_STXIntimationTDS_communication_on_Dividend_income_to_Shareholders.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","19-Jun-2023 10:57:24","2023-06-19 10:57:24","19-Jun-2023 10:57:29","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_19062023105724_Intimation16062023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","16-Jun-2023 14:46:52","2023-06-16 14:46:52","16-Jun-2023 14:46:55","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_16062023144652_SEintimationlossofsharecertificate15062023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 14, 2023, titled ""Dr. Reddy s Laboratories Limited announces filing of Annual Report on Form 20-F"".","14-Jun-2023 15:55:39","2023-06-14 15:55:39","14-Jun-2023 15:55:50","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_14062023155539_PressRelease14062023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","12-Jun-2023 18:51:25","2023-06-12 18:51:25","12-Jun-2023 18:51:29","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_12062023185125_Intimation12062023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","08-Jun-2023 15:00:18","2023-06-08 15:00:18","08-Jun-2023 15:00:21","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_08062023150018_SEintimationpublicationofnewspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Alteration Of Capital and Fund Raising-XBRL","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of Securities","06-Jun-2023 14:25:34","2023-06-06 14:25:34","06-Jun-2023 14:25:38","00:00:04","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_06062023142534_ALTERATION_OF_CAPITAL_AND_FUND_RAISING_862686_06062023022534_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 05, 2023, titled ""Dr. Reddy s successfully completes Phase I study (IV route) of DRL_TC, a proposed biosimilar of tocilizumab"".","05-Jun-2023 09:01:46","2023-06-05 09:01:46","05-Jun-2023 09:01:50","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_05062023090146_PressRelease05062023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 16666  Shares.","03-Jun-2023 22:17:33","2023-06-03 22:17:33","03-Jun-2023 22:18:12","00:00:39","https://nsearchives.nseindia.com/corporate/DRREDDY_03062023221733_SEintimation03062023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","31-May-2023 17:24:21","2023-05-31 17:24:21","31-May-2023 17:24:25","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_31052023172421_Intimation31052023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Annual Secretarial Compliance Report","Annual Secretarial Compliance Report for the year ended March 31, 2023","26-May-2023 18:41:08","2023-05-26 18:41:08","26-May-2023 18:41:12","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_26052023184108_SEIntimationSecretarialcompliancereport.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","25-May-2023 15:14:48","2023-05-25 15:14:48","25-May-2023 15:15:04","00:00:16","https://nsearchives.nseindia.com/corporate/DRREDDY_25052023151448_SEintimationlossofsharecertificate25052023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","22-May-2023 14:33:11","2023-05-22 14:33:11","22-May-2023 14:33:29","00:00:18","https://nsearchives.nseindia.com/corporate/DRREDDY_22052023143311_Intimation22052023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","19-May-2023 15:33:26","2023-05-19 15:33:26","19-May-2023 15:33:35","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_19052023153326_19052023SEIntimationLossofShareCertificates_1_.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript","15-May-2023 16:25:57","2023-05-15 16:25:57","15-May-2023 16:26:01","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_15052023162557_SEIntimationTranscriptofEarningscall.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'intimation regarding completion of US FDA audit of FTO SEZ PU2'.","12-May-2023 22:37:24","2023-05-12 22:37:24","12-May-2023 22:37:27","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_12052023223725_SEIntimationFTOSEZPU2.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","11-May-2023 19:23:42","2023-05-11 19:23:42","11-May-2023 19:24:05","00:00:23","https://nsearchives.nseindia.com/corporate/DRREDDY_11052023192342_SEintimationpublicationofnewspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent","11-May-2023 13:13:39","2023-05-11 13:13:39","11-May-2023 13:13:44","00:00:05","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_11052023131340_CIM_4065_840558_11052023011339_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting-XBRL","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange regarding Outcome of Board Meeting held on 10-May-2023 for Dividend","11-May-2023 13:09:36","2023-05-11 13:09:36","11-May-2023 13:09:40","00:00:04","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_11052023130936_OUTCOME_840556_11052023010935_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording","11-May-2023 09:07:58","2023-05-11 09:07:58","11-May-2023 09:08:00","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_11052023090758_SEIntimationEarningscallrecordings.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transactions","Dr. Reddy's Laboratories Limited has informed the Exchange about related Party Transactions for H2 FY23","10-May-2023 20:47:22","2023-05-10 20:47:22","10-May-2023 20:47:28","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_10052023204722_SEintimationRPT.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 12-Jul-2023 to 14-Jul-2023 for the purpose of Dividend.","10-May-2023 18:31:46","2023-05-10 18:31:46","10-May-2023 18:31:50","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_10052023183146_Reg30.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Director(s)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.","10-May-2023 18:20:11","2023-05-10 18:20:11","10-May-2023 18:20:15","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_10052023182011_Reg30.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 10, 2023, titled ""Press Release - Audited Financial Results of FY23"".","10-May-2023 17:33:10","2023-05-10 17:33:10","10-May-2023 17:33:16","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_10052023173310_Pressrelease.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2023.","10-May-2023 17:14:12","2023-05-10 17:14:12","10-May-2023 17:14:15","00:00:03","https://nsearchives.nseindia.com/corporate/Outcome10052023_10052023171412.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 10, 2023, recommended Final Dividend of 40 per equity share.","10-May-2023 17:11:48","2023-05-10 17:11:48","10-May-2023 17:11:55","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_10052023171148_Outcome10052023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 238623  Options.","09-May-2023 21:24:54","2023-05-09 21:24:54","09-May-2023 21:24:58","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_09052023212454_SEIntimationESOP09052023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation on USFDA audit at CTO 1 unit'.","05-May-2023 15:09:21","2023-05-05 15:09:21","05-May-2023 15:09:24","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_05052023150921_SEIntimationCTO1.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 05, 2023, titled ""Dr. Reddy's Laboratories announces the launch of Regadenoson Injection 0.4 mg/5 mL in the U.S"".","05-May-2023 15:05:13","2023-05-05 15:05:13","05-May-2023 15:05:21","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_05052023150513_PressRelease05052023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","28-Apr-2023 17:55:29","2023-04-28 17:55:29","28-Apr-2023 17:55:36","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_28042023175529_SEintimationlossofdupsc.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","22-Apr-2023 18:56:05","2023-04-22 18:56:05","22-Apr-2023 18:56:09","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_22042023185605_22042023EarningsCallNotificationQ4FY23.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 21, 2023, titled ""Dr. Reddy's Laboratories announces the launch of Treprostinil Injection in the U.S"".","21-Apr-2023 11:24:06","2023-04-21 11:24:06","21-Apr-2023 11:24:15","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_21042023112406_Pressrelease21042023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","19-Apr-2023 18:09:22","2023-04-19 18:09:22","19-Apr-2023 18:09:29","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_19042023180922_SEintimationlossofSC19042023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","17-Apr-2023 18:26:51","2023-04-17 18:26:51","17-Apr-2023 18:26:55","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_17042023182651_CertiifcateunderReg74_5_forsubmission.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of share certificate/letter of confirmation.","11-Apr-2023 17:54:58","2023-04-11 17:54:58","11-Apr-2023 17:55:01","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_11042023175458_StockExchangeintimationofIssueofDupSharecertificate11042023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Update on Press Release dated February 27, 2023'.","07-Apr-2023 11:54:51","2023-04-07 11:54:51","07-Apr-2023 11:54:56","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_07042023115451_SEIntimationmaynetransactioncompletion.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","23-Mar-2023 21:24:21","2023-03-23 21:24:21","23-Mar-2023 21:24:25","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_23032023212421_SEintimationImperialrelated23032023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Board Meeting Intimation","DR. REDDY'S LABORATORIES LIMITED has informed the Exchange about Board Meeting to be held on 10-May-2023 to consider financial statements for the period ended March 2023, Financial results/Dividend.","23-Mar-2023 21:11:30","2023-03-23 21:11:30","23-Mar-2023 21:11:34","00:00:04","https://nsearchives.nseindia.com/corporate/xbrl/DRREDDY_23032023211130_PRIOR_INTIMATION_2351_804758_23032023091129_WEB.xml"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","23-Mar-2023 20:38:31","2023-03-23 20:38:31","23-Mar-2023 20:38:34","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_23032023203831_BoardMeetingNoticeIntimation23032023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 1022 securities pursuant to ESOP/ESPS at its meeting held on March 20, 2023","21-Mar-2023 11:28:15","2023-03-21 11:28:15","21-Mar-2023 11:28:22","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_21032023112815_SEintimationESOPfinal.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","17-Mar-2023 17:10:25","2023-03-17 17:10:25","17-Mar-2023 17:10:27","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_17032023171025_SEIntimationLossofDuplicateSC17032023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 16, 2023, titled ""Dr. Reddy s divests certain non-core brands in dermatology in India to Eris Lifesciences to focus on strengthening core"".","16-Mar-2023 15:35:27","2023-03-16 15:35:27","16-Mar-2023 15:35:30","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_16032023153527_PressRelease16032023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 1873 securities pursuant to ESOP/ESPS at its meeting held on March 11, 2023","12-Mar-2023 09:08:03","2023-03-12 09:08:03","12-Mar-2023 09:08:45","00:00:42","https://nsearchives.nseindia.com/corporate/DRREDDY_12032023090803_SEintimationESOPfinal.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","28-Feb-2023 10:07:26","2023-02-28 10:07:26","28-Feb-2023 10:07:33","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_28022023100726_Intimation28022023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 27, 2023, titled ""Dr. Reddy's Laboratories announces agreement to acquire Mayne Pharma s U.S. generic prescription product portfolio."".","27-Feb-2023 09:27:59","2023-02-27 09:27:59","27-Feb-2023 09:28:04","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_27022023092759_PR27022023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 1342  Shares.","16-Feb-2023 14:52:05","2023-02-16 14:52:05","16-Feb-2023 14:52:22","00:00:17","https://nsearchives.nseindia.com/corporate/DRREDDY_16022023145205_SEintimationESOP16022023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 08, 2023, titled ""Dr. Reddy s included in Bloomberg Gender-Equality Index for the 6th year in a row and S&P Global s Sustainability Yearbook for the 3rd year"".","08-Feb-2023 17:30:01","2023-02-08 17:30:01","08-Feb-2023 17:30:43","00:00:42","https://nsearchives.nseindia.com/corporate/DRREDDY_08022023173000_PressRelease08022023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","03-Feb-2023 18:37:18","2023-02-03 18:37:18","03-Feb-2023 18:37:22","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_03022023183718_Intimation03022023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript","30-Jan-2023 16:49:24","2023-01-30 16:49:24","30-Jan-2023 16:49:30","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_30012023164924_SEIntimation_TranscriptofEarningscall.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 27, 2023, titled ""Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05% in the U.S. Market."".","27-Jan-2023 11:50:50","2023-01-27 11:50:50","27-Jan-2023 11:50:53","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_27012023115050_PressRelease27012023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","26-Jan-2023 23:00:45","2023-01-26 23:00:45","26-Jan-2023 23:00:49","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_26012023230045_SEintimationpublicationofnewspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Form 6-K for the quarter ended December 31, 2022, filed with United States Securitiesand Exchange Commission'.","26-Jan-2023 11:15:47","2023-01-26 11:15:47","26-Jan-2023 11:15:51","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_26012023111547_SEIntimation_6Kfiling.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording","26-Jan-2023 11:11:59","2023-01-26 11:11:59","26-Jan-2023 11:12:01","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_26012023111159_SEIntimation_Earningscallrecording.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Duplicate Share certificates","25-Jan-2023 21:50:25","2023-01-25 21:50:25","25-Jan-2023 21:50:29","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_25012023215025_StockExchangeIntimationissueofDuplicateSharecertificate.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Outcome of Board Meeting   Unaudited Financial Results for the quarter and nine months ended December 31, 2022","25-Jan-2023 16:17:11","2023-01-25 16:17:11","25-Jan-2023 16:17:14","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_25012023161710_Outcome25012023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2022.","25-Jan-2023 16:09:21","2023-01-25 16:09:21","25-Jan-2023 16:09:26","00:00:05","https://nsearchives.nseindia.com/corporate/Outcome25012023_25012023160921.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 3234  Options.","25-Jan-2023 13:41:53","2023-01-25 13:41:53","25-Jan-2023 13:41:58","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_25012023134153_SE_intimation_ESOP_grant.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 20, 2023, titled ""Dr. Reddy s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe"".","20-Jan-2023 09:14:40","2023-01-20 09:14:40","20-Jan-2023 09:14:45","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_20012023091440_PressRelease20012023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Certificate under SEBI (Depositories and Participants) Regulations, 2018","Dr. Reddy's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018","14-Jan-2023 13:49:50","2023-01-14 13:49:50","14-Jan-2023 13:49:54","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_14012023134950_intimation74_5_.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 13, 2023, titled ""Dr. Reddy s launches in-house palbociclib (PRIMCYVￂﾮ) to widen access to high-quality breast cancer drug"".","13-Jan-2023 16:44:27","2023-01-13 16:44:27","13-Jan-2023 16:44:33","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_13012023164427_PressRelease1302023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","12-Jan-2023 15:11:11","2023-01-12 15:11:11","12-Jan-2023 15:11:18","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_12012023151111_Earningscallintimation12012023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Resignation","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Resignation of Mr Allan Oberman as Independent Director of the company w.e.f. January 06, 2023.","06-Jan-2023 19:24:28","2023-01-06 19:24:28","06-Jan-2023 19:24:30","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_06012023192428_Intimation_Allan.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of meet","06-Jan-2023 17:00:58","2023-01-06 17:00:58","06-Jan-2023 17:01:02","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_06012023170058_Intimation06012023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015'.","29-Dec-2022 08:44:46","2022-12-29 08:44:46","29-Dec-2022 08:44:50","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_29122022084446_Intimation29122022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","27-Dec-2022 18:33:38","2022-12-27 18:33:38","27-Dec-2022 18:33:41","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_27122022183338_boardmeetingintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","26-Dec-2022 22:55:26","2022-12-26 22:55:26","26-Dec-2022 22:55:28","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_26122022225525_StockExchangeIntimationnewspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Completion of transaction by Dr. Reddy's Research and Development B. V. (DRRDBV)'.","23-Dec-2022 16:39:46","2022-12-23 16:39:46","23-Dec-2022 16:39:51","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_23122022163946_SE_Intimation_Leiden_transaction_completion.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 19, 2022, titled ""Dr. Reddy s successfully completes Phase 1 study ofDRL_TC, a proposed biosimilar of tocilizumab"".","19-Dec-2022 12:12:07","2022-12-19 12:12:07","19-Dec-2022 12:12:21","00:00:14","https://nsearchives.nseindia.com/corporate/DRREDDY_19122022121207_PressRelease19122022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Dr. Reddy's Research and Development B. V., a subsidiary , has entered into an Asset Purchase Agreement for sale of its certain assets and liabilities including transfer of employees at site situated at Leiden, The Netherlands'.","17-Dec-2022 10:35:14","2022-12-17 10:35:14","17-Dec-2022 10:35:19","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_17122022103514_SE_Intimation_Leiden.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESPS/SBEB Scheme","Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of Equity Shares on exercise of Stock Options under ESOPs","16-Dec-2022 12:24:03","2022-12-16 12:24:03","16-Dec-2022 12:24:07","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_16122022122403_SEIntimationESOPallotment16122022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 16-Dec-2022 titled Aurigene Oncology Limited,, a wholly owned subsidiary of the Company, reports results of AUR101 in Phase II Study in Patients with moderate to severe psoriasis","16-Dec-2022 11:31:06","2022-12-16 11:31:06","16-Dec-2022 11:31:10","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_16122022113106_PressRelease16122022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","12-Dec-2022 22:09:09","2022-12-12 22:09:09","12-Dec-2022 22:09:14","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_12122022220909_StockExchangeIntimation_IssueofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","06-Dec-2022 23:41:39","2022-12-06 23:41:39","06-Dec-2022 23:41:41","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_06122022234139_Intimation06122022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Sustainability Report for FY2022.","24-Nov-2022 15:35:37","2022-11-24 15:35:37","24-Nov-2022 15:35:39","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_24112022153536_IntimationSR24112022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","23-Nov-2022 15:15:09","2022-11-23 15:15:09","23-Nov-2022 15:15:15","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_23112022151509_SEIntimation_Lossofsharecertificates_23.11.2022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015","22-Nov-2022 14:07:33","2022-11-22 14:07:33","22-Nov-2022 14:07:39","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_22112022140733_Intimation22112022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements","17-Nov-2022 22:05:39","2022-11-17 22:05:39","17-Nov-2022 22:05:43","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_17112022220539_StockExchangeIntimation_PaperpublicationforlossofDuplicateSharecertificate.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","16-Nov-2022 23:12:21","2022-11-16 23:12:21","16-Nov-2022 23:12:28","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_16112022231221_Intimation16112022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transaction","Dr. Reddy's Laboratories Limited has informed the Exchange about related party transaction for the period ended September 2022","11-Nov-2022 18:23:06","2022-11-11 18:23:06","11-Nov-2022 18:23:08","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_11112022182306_RPTH1FY23report.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Transcript of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call ","03-Nov-2022 18:26:30","2022-11-03 18:26:30","03-Nov-2022 18:26:34","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_03112022182630_SEIntimation_TranscriptofEarningscall.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","01-Nov-2022 17:21:54","2022-11-01 17:21:54","01-Nov-2022 17:21:58","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_01112022172154_Intimation01112022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about the copy of Newspaper Advertisement for Q2 FY23 financial results","31-Oct-2022 10:41:48","2022-10-31 10:41:48","31-Oct-2022 10:41:52","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_31102022104148_SEintimationpublicationofnewspaperadvertisement.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Retirement","Dr. Reddy's Laboratories Limited  has informed the Exchange about retirement of Prasad Menon as Independent Director of the company from close of business hours on 29-Oct-2022","29-Oct-2022 21:05:30","2022-10-29 21:05:30","29-Oct-2022 21:05:32","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_29102022210530_SEIntimation_PrasadMenon.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Form 6-K for Q2 FY23 filed with US SEC ","29-Oct-2022 19:30:24","2022-10-29 19:30:24","29-Oct-2022 19:30:28","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_29102022193024_SEIntimation_6Kfiling.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Recording of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Recording of Analysts/Institutional Investor Meet/Con. Call","29-Oct-2022 13:35:45","2022-10-29 13:35:45","29-Oct-2022 13:35:50","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_29102022133545_SEIntimationEarningscallrecording.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","28-Oct-2022 17:58:42","2022-10-28 17:58:42","28-Oct-2022 21:25:58","03:27:16","https://nsearchives.nseindia.com/corporate/DRREDDY_28102022175842_StockExchangeIntimation_IssueofDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited  has informed the Exchange about the Outcome of Board Meeting ￢ﾀﾓ Unaudited Financial Results for the quarter and half-year ended September 30, 2022","28-Oct-2022 16:23:52","2022-10-28 16:23:52","28-Oct-2022 21:26:06","05:02:14","https://nsearchives.nseindia.com/corporate/DRREDDY_28102022162351_Outcome.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESPS/SBEB Scheme","Dr. Reddy's Laboratories Limited has informed the Exchange about ESOP/ESPS/SBEB Scheme","28-Oct-2022 14:05:36","2022-10-28 14:05:36","28-Oct-2022 21:26:57","07:21:21","https://nsearchives.nseindia.com/corporate/DRREDDY_28102022140536_SEintimation_ESOP.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot","Dr. Reddy's Laboratories Limited has informed the Exchange about Voting results and  Scrutinizer report of Postal Ballot","21-Oct-2022 23:23:24","2022-10-21 23:23:24","21-Oct-2022 23:23:27","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_21102022232324_PBOutcome21102022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","13-Oct-2022 11:47:24","2022-10-13 11:47:24","13-Oct-2022 11:47:26","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_13102022114724_Earningscallnotification13102022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements","12-Oct-2022 17:38:09","2022-10-12 17:38:09","12-Oct-2022 17:38:15","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_12102022173809_StockExchangeIntimation_newspaperadvertisement_12.10.2022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 11-Oct-2022 titled World Economic Forum recognises Dr. Reddy￢ﾀﾙs Hyderabad factory as part of its Global Lighthouse Network","11-Oct-2022 11:39:54","2022-10-11 11:39:54","11-Oct-2022 11:39:58","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_11102022113954_PressRelease11102022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESPS/SBEB Scheme","Dr. Reddy's Laboratories Limited has informed the Exchange about ESOP/ESPS/SBEB Scheme","07-Oct-2022 11:20:57","2022-10-07 11:20:57","07-Oct-2022 11:21:02","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_07102022112057_SE_intimation_Allotment_7October2022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESPS/SBEB Scheme","Dr. Reddy's Laboratories Limited has informed the Exchange about ESOP/ESPS/SBEB Scheme","30-Sep-2022 17:13:24","2022-09-30 17:13:24","30-Sep-2022 17:13:28","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_30092022171324_SEintimation_allotmentofoptions_Sep29_2022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Closure of trading window","Dr. Reddy's Laboratories Limited has informed the Exchange that the trading window for dealing in securities of the Company will be closed from Friday, September 30, 2022, to Sunday, October 30, 2022 (both days inclusive).","28-Sep-2022 19:38:12","2022-09-28 19:38:12","28-Sep-2022 19:38:16","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_28092022193812_BoardMeetingNoticeIntimation002.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","28-Sep-2022 15:21:21","2022-09-28 15:21:21","28-Sep-2022 15:21:28","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_28092022152121_SEIntimationforlossofSC_28.09.2022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","27-Sep-2022 10:56:30","2022-09-27 10:56:30","27-Sep-2022 10:56:34","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_27092022105630_Intimation27092022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements regarding despatch of postal ballot","22-Sep-2022 17:41:30","2022-09-22 17:41:30","22-Sep-2022 17:41:35","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_22092022174130_IntimationnewspaperAd.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot","Dr. Reddy's Laboratories Limited has informed the Exchange about despatch of Notice of Postal Ballot","20-Sep-2022 17:41:15","2022-09-20 17:41:15","20-Sep-2022 17:41:20","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_20092022174115_SEIntimationPBNotice.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESPS/SBEB Scheme","Dr. Reddy's Laboratories Limited has informed the Exchange about allotment of shares pursuant to ESOP","17-Sep-2022 23:03:21","2022-09-17 23:03:21","17-Sep-2022 23:03:25","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_17092022230321_SE_intimation_Allotment_16September2022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Letter of Confirmation in lieu of share certificate(s) reported lost/misplaced","16-Sep-2022 16:38:42","2022-09-16 16:38:42","16-Sep-2022 16:38:46","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_16092022163842_SEIntimation_IssueofSCaaproval16092022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","10-Sep-2022 13:10:10","2022-09-10 13:10:10","10-Sep-2022 13:10:45","00:00:35","https://nsearchives.nseindia.com/corporate/DRREDDY_10092022131010_Intimation10092022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 07-Sep-2022 titled ""Dr. Reddy's Laboratories announces the launch of Lenalidomide Capsules in the U.S. with two of six strengths eligible for first-to-market, 180-day exclusivity.","07-Sep-2022 21:17:45","2022-09-07 21:17:45","07-Sep-2022 21:17:47","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_07092022211745_PressRelease07092022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","07-Sep-2022 18:01:57","2022-09-07 18:01:57","07-Sep-2022 18:02:08","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_07092022180157_SEintimation07092022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","06-Sep-2022 23:46:54","2022-09-06 23:46:54","06-Sep-2022 23:46:58","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_06092022234654_Intimation06092022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","DRREDDY : The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr. Reddy's Aurigene ink MoU with DNDi on neglected tropical diseases.  The response from the Company is attached.","02-Sep-2022 14:35:24","2022-09-02 14:35:24","02-Sep-2022 14:35:28","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_02092022143524_Response_to_clarification__Vf__NSE.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","DRREDDY : The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr. Reddy's Aurigene ink MoU with DNDi on neglected tropical diseases.  The response from the Company is awaited.","01-Sep-2022 17:25:21","2022-09-01 17:25:21","01-Sep-2022 17:25:24","00:00:03","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Intimation","25-Aug-2022 17:20:27","2022-08-25 17:20:27","25-Aug-2022 17:20:31","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_25082022172027_Intimation25082022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","25-Aug-2022 14:43:39","2022-08-25 14:43:39","25-Aug-2022 14:43:43","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_25082022144339_SEIntimation_lossofSC_25.08.2022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","24-Aug-2022 17:16:21","2022-08-24 17:16:21","24-Aug-2022 17:16:23","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_24082022171621_Intimation24082022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","22-Aug-2022 15:37:09","2022-08-22 15:37:09","22-Aug-2022 15:37:12","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_22082022153709_SEIntimationcopiesofnewspaperpublication_v1.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transaction","Dr. Reddy's Laboratories Limited has informed the Exchange about related party transaction for the period ended March 2022","16-Aug-2022 23:27:15","2022-08-16 23:27:15","16-Aug-2022 23:27:19","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_16082022232715_RPTH2FY22revised.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call ","06-Aug-2022 16:34:42","2022-08-06 16:34:42","06-Aug-2022 16:34:44","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_06082022163442_Intimation06082022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Issue of Duplicate Share certificate","03-Aug-2022 18:37:21","2022-08-03 18:37:21","03-Aug-2022 18:37:25","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_03082022183721_StockExchangeIntimation_IssueofDupSC03082022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Transcript of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call ","03-Aug-2022 17:25:18","2022-08-03 17:25:18","03-Aug-2022 17:25:26","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_03082022172518_Intimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Cessation","Dr. Reddy's Laboratories Limited  has informed the Exchange about cessation of  Dr. Bruce L A Carter as Independent Director of the company w.e.f. 30-Jul-2022","01-Aug-2022 22:43:45","2022-08-01 22:43:45","01-Aug-2022 22:43:49","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_01082022224345_IntimationDrCarter01082022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Sale or disposal of unit/ division/subsidiary","Dr. Reddy's Laboratories Limited has informed the Exchange about Sale or disposal of unit/ division/subsidiary","30-Jul-2022 12:55:39","2022-07-30 12:55:39","30-Jul-2022 12:55:43","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_30072022125539_SE_Intimation_Imperialsale.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Communication to shareholders as per Reg 30","Dr. Reddy's Laboratories Limited has informed the Exchange about Press Release.","29-Jul-2022 21:24:54","2022-07-29 21:24:54","29-Jul-2022 21:24:56","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_29072022212454_PressRelease29072022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Annual General Meeting","Dr. Reddy's Laboratories Limited has informed the Exchange about Voting results,  Scrutinizer report and  Proceedings of Annual General Meeting held on 29-Jul-2022.","29-Jul-2022 21:08:27","2022-07-29 21:08:27","29-Jul-2022 21:08:30","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_29072022210827_38thAGMOutcome.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Intimation on filing of 6k for Q1 FY23 with SEC","29-Jul-2022 14:40:33","2022-07-29 14:40:33","29-Jul-2022 14:40:40","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_29072022144033_6kintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Communication to shareholders as per Reg 30","Dr. Reddy's Laboratories Limited has informed the Exchange about Audio Recordings of the Earnings call conducted on July 28, 2022","29-Jul-2022 07:50:30","2022-07-29 07:50:30","29-Jul-2022 07:50:34","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_29072022075030_IntimationEarningsCall29072022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Communication to shareholders as per Reg 30","Dr. Reddy's Laboratories Limited has informed the Exchange about Grant of Stock Options to the eligible employees under the Employee Stock Options Schemes of the Company.","28-Jul-2022 18:24:39","2022-07-28 18:24:39","28-Jul-2022 18:24:42","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_28072022182439_IntimationESOP28.07.2022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESPS/SBEB Scheme","Dr. Reddy's Laboratories Limited has informed the Exchange about allotment of 7,426 equity shares of Rs. 5/- each of the Companv, fully paid up.","28-Jul-2022 17:44:51","2022-07-28 17:44:51","28-Jul-2022 17:44:56","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_28072022174451_IntimationESOP28.07.2022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy's Laboratories Limited  has informed the Exchange about appointment of Mr. Arun Madhavan Kumar (DIN: 09665138) as an Additional Director, categorized as Independent, on the Board of the Company.","28-Jul-2022 17:08:33","2022-07-28 17:08:33","28-Jul-2022 17:08:36","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_28072022170833_SE_Intimation_appointment_of_Director.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited  has informed the Exchange about Board Meeting held on 28-Jul-2022 to consider Unaudited Financial Results for the quarter ended June 30, 2022.","28-Jul-2022 16:01:42","2022-07-28 16:01:42","28-Jul-2022 16:01:45","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_28072022160142_OutcomeofBoardMeeting28072022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 27-Jul-2022 titled Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection, 3.5 mg Single-Dose Vial in the U.S. Market","27-Jul-2022 10:47:09","2022-07-27 10:47:09","27-Jul-2022 10:47:17","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_27072022104709_PressRelease27072022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 22-Jul-2022 titled Dr. Reddy￢ﾀﾙs announces the first-to-market launch of over-the-counter, store-brand equivalent of Allegra-Dￂﾮ 24 HR in the U.S. Market","22-Jul-2022 13:53:18","2022-07-22 13:53:18","22-Jul-2022 13:53:22","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_22072022135318_PressRelease22072022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Earnings Call for Q1 FY2023  ","13-Jul-2022 22:53:18","2022-07-13 22:53:18","13-Jul-2022 22:53:21","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_13072022225318_EarningsCallNotification13072022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements","11-Jul-2022 23:53:00","2022-07-11 23:53:00","11-Jul-2022 23:53:09","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_11072022235300_SEintimationnewspaperad.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 08-Jul-2022 titled Dr. Reddy's Laboratories announces the launch of  Fesoterodine Fumarate Extended-Release Tablets in the U.S. market","08-Jul-2022 17:37:15","2022-07-08 17:37:15","08-Jul-2022 17:37:19","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_08072022173715_PressRelease08072022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Intimation","07-Jul-2022 19:36:18","2022-07-07 19:36:18","07-Jul-2022 19:36:22","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_07072022193618_07072022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Business Responsibility & Sustainability Report (BRSR)","Dr. Reddy's Laboratories Limited has informed the Exchange about Business Responsibility & Sustainability Report (BRSR) for the period ended March 31, 2022.","06-Jul-2022 19:36:15","2022-07-06 19:36:15","06-Jul-2022 19:36:21","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_06072022193615_SEIntimation06072022signed.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Annual General Meeting","Dr. Reddy's Laboratories Limited has informed the Exchange about Notice of 38th Annual General Meeting (AGM) and Annual Report 2021-22.","06-Jul-2022 19:01:06","2022-07-06 19:01:06","06-Jul-2022 19:01:10","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_06072022190106_SEIntimation06072022signed.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Update","30-Jun-2022 11:15:39","2022-06-30 11:15:39","30-Jun-2022 11:15:45","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_30062022111539_SEintimation29062022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Closure of trading window","Dr. Reddy's Laboratories Limited has informed the Exchange about Closure of the Trading Window for dealing in securities of the Company from Thursday, June 30, 2022, to Saturday, July 30, 2022 (both days inclusive).","29-Jun-2022 17:10:09","2022-06-29 17:10:09","29-Jun-2022 17:10:13","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_29062022171007_boardmeetingintimation29062022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Transcript of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call ","28-Jun-2022 14:51:48","2022-06-28 14:51:48","28-Jun-2022 14:51:53","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_28062022145148_SEintimationinvestordaytranscript.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 28-Jun-2022 titled Dr. Reddy￢ﾀﾙs Laboratories Limited announces filing of Annual Report on Form 20-F","28-Jun-2022 14:42:57","2022-06-28 14:42:57","28-Jun-2022 14:43:02","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_28062022144257_PressRelease28062022form20F.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements","27-Jun-2022 22:23:13","2022-06-27 22:23:13","27-Jun-2022 22:23:16","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_27062022222313_SEintimationpaperadlossofsharecertificate.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 24-Jun-2022 titled Dr. Reddy's Laboratories announces the acquisition of an injectable product portfolio from Eton Pharma","24-Jun-2022 16:38:13","2022-06-24 16:38:13","24-Jun-2022 16:38:18","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_24062022163813_PressRelease24062022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Intimation - Settlement Agreement with respect to buprenorphine and naloxone sublingual film","24-Jun-2022 15:25:25","2022-06-24 15:25:25","24-Jun-2022 15:25:28","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_24062022152525_SEintimation24062022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of equity shares on exercise of stock options under ESOPs","23-Jun-2022 11:40:33","2022-06-23 11:40:33","23-Jun-2022 18:36:52","06:56:19","https://nsearchives.nseindia.com/corporate/DRREDDY_23062022114033_SEIntimationESOPAllotment.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Investor Presentation","Dr. Reddy's Laboratories Limited has informed the Exchange about Investor Presentation","21-Jun-2022 20:54:15","2022-06-21 20:54:15","21-Jun-2022 20:54:18","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_21062022205414_SEintimationInvestorday.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements for AGM date and book closure","20-Jun-2022 20:42:03","2022-06-20 20:42:03","20-Jun-2022 20:42:06","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_20062022204202_SEintimationPreAGMNewspaperAD.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about TDS communication sent to shareholders","17-Jun-2022 22:31:06","2022-06-17 22:31:06","17-Jun-2022 22:31:09","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_17062022223106_TDSSEintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 14-Jun-2022 titled Dr. Reddy's Laboratories announces the launch of the generic version of Nexavar (sorafenib) Tablets, USP, 200 mg in the U.S. market","14-Jun-2022 10:34:15","2022-06-14 10:34:15","14-Jun-2022 10:34:19","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_14062022103415_PressRelease14062022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call - Investor day on June 21, 2022","13-Jun-2022 18:55:56","2022-06-13 18:55:56","13-Jun-2022 18:55:58","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_13062022185556_SEIntimation13062022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 09-Jun-2022 titled Press Release issued by ￢ﾀﾘOlema Pharmaceuticals, Inc (Nasdaq: OLMA)￢ﾀﾙ announcing an exclusive Collaboration and License Agreement with Aurigene Discovery Technologies Limited, our WOS","09-Jun-2022 17:53:14","2022-06-09 17:53:14","09-Jun-2022 17:53:17","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_09062022175313_PressRelease09062022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Schedule of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about Schedule of Analysts/Institutional Investor Meet/Con. Call in the month of June, 2022","03-Jun-2022 12:13:50","2022-06-03 12:13:50","03-Jun-2022 12:13:54","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_03062022121350_SEIntimation03062022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transaction","Dr. Reddy's Laboratories Limited has informed the Exchange about related party transaction for the half year period ended March 2022","02-Jun-2022 23:54:23","2022-06-02 23:54:23","02-Jun-2022 23:54:27","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_02062022235423_RPTDisclosureH2FY22.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 27-May-2022 titled Dr. Reddy's Laboratories announces the launch of Pemetrexed for Injection USP, in the U.S. Market","27-May-2022 18:15:53","2022-05-27 18:15:53","27-May-2022 18:15:58","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_27052022181545_PressRelease27052022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","27-May-2022 18:11:20","2022-05-27 18:11:20","27-May-2022 18:11:22","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_27052022181120_SEintimationissueofdupsc.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements","27-May-2022 18:07:55","2022-05-27 18:07:55","27-May-2022 18:07:57","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_27052022180755_SEintimationpublicationofpaperadiepfrelated.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","25-May-2022 15:49:10","2022-05-25 15:49:10","25-May-2022 15:49:13","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_25052022154910_SEintimationlossofdupSC25052022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 24-May-2022 titled Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. announce the launch Ketorolac Tromethamine Tablets USP, 10 mg in the U.S. market","24-May-2022 20:38:21","2022-05-24 20:38:21","24-May-2022 20:38:30","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_24052022203817_PressRelease24052022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Recording of Analysts/Institutional Investor Meet/Con. Call","Dr. Reddy's Laboratories Limited has informed the Exchange about transcript of earnings call held on May 19, 2022","24-May-2022 12:17:15","2022-05-24 12:17:15","24-May-2022 12:17:18","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_24052022121710_IntimationtranscriptQ4FY22.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about financial results updates in machine readable format","24-May-2022 11:21:49","2022-05-24 11:21:49","24-May-2022 11:21:54","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_24052022112148_SEintimation19052022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper Advertisements","20-May-2022 19:58:28","2022-05-20 19:58:28","20-May-2022 19:58:33","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_20052022195826_SEintimationonpublicationoffinancialresults.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of other UPSI/material event","Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosure of presentation and the audio recording of the earnings call on Company's website.","20-May-2022 15:50:18","2022-05-20 15:50:18","20-May-2022 15:50:27","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_20052022155014_IntimationEarningscall.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of other UPSI/material event","Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosures under Regulation 30 (LODR).","20-May-2022 15:43:48","2022-05-20 15:43:48","20-May-2022 15:43:50","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_20052022154343_SEintimation19052022_Reg_30.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of other UPSI/material event","Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosure of date of Annual General Meeting.","20-May-2022 15:40:35","2022-05-20 15:40:35","20-May-2022 15:40:39","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_20052022154034_SEintimation19052022_Reg_30.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of other UPSI/material event","Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosure of Grant of Employee Stock Options.","20-May-2022 15:37:04","2022-05-20 15:37:04","20-May-2022 15:37:07","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_20052022153700_SEintimation19052022_Reg_30.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Re-appointment","Dr. Reddy's Laboratories Limited  has informed the Exchange about re-appointment of K Satish Reddy as a Whole-time Director, designated as Chairman.","20-May-2022 13:14:29","2022-05-20 13:14:29","20-May-2022 13:14:33","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_20052022131425_SEintimation19052022_Reg_30.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 13-Jul-2022 to 15-Jul-2022 for the purpose of Dividend.","20-May-2022 11:02:33","2022-05-20 11:02:33","20-May-2022 11:02:40","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_20052022110200_SEintimation19052022_Reg_30.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.","19-May-2022 13:09:52","2022-05-19 13:09:52","19-May-2022 13:11:02","00:01:10","https://nsearchives.nseindia.com/corporate/SEintimation19052022_19052022130952.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited  has informed the Exchange about Board Meeting held on 19-May-2022 to consider financial statements for the period ended March 2022","19-May-2022 12:50:40","2022-05-19 12:50:40","19-May-2022 12:50:49","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_19052022125035_SEintimation19052022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 11-May-2022 titled Dr. Reddy￢ﾀﾙs Laboratories enters into exclusive partnership with HK inno.N Corporation to commercialise novel molecule Tegoprazan in India & select Emerging Markets","11-May-2022 09:10:29","2022-05-11 09:10:29","11-May-2022 09:10:35","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_11052022091019_PressRelease11052022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of other UPSI/material event","Dr. Reddy's Laboratories Limited has informed the Exchange about Earnings call for Q4 and FY22","25-Apr-2022 22:25:36","2022-04-25 22:25:36","25-Apr-2022 22:25:39","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_25042022222529_Earningscall25042022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","G V Prasad (on behalf of all the acquirers) has informed the Exchange about Disclosure under Regulation 10 (6) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.","25-Apr-2022 18:47:21","2022-04-25 18:47:21","25-Apr-2022 18:47:23","00:00:02","https://nsearchives.nseindia.com/corporate/DRREDDY_25042022165644_Disclosure10.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about allotment of shares pursuant to merger","22-Apr-2022 22:29:48","2022-04-22 22:29:48","22-Apr-2022 22:29:53","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_22042022222942_SEintimationallotment.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 20-Apr-2022 titled Dr. Reddy's Laboratories announces the launch of  Posaconazole Delayed-Release Tablets in the U.S. Market","20-Apr-2022 19:40:20","2022-04-20 19:40:20","20-Apr-2022 19:40:29","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_20042022194019_PressRelease20042022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Amalgamation/Merger","Dr. Reddy's Laboratories Limited has informed the Exchange about Effective date for Scheme of Merger ","08-Apr-2022 22:54:05","2022-04-08 22:54:05","08-Apr-2022 22:54:08","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_08042022225357_IntimationINC2808042022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Amalgamation/Merger","Dr. Reddy's Laboratories Limited has informed the Exchange about record date for allotment of shares pursuant to scheme for Merger","08-Apr-2022 19:13:43","2022-04-08 19:13:43","08-Apr-2022 19:13:48","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_08042022191343_BMoutcome08042022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Promoter/Promoter Group of Dr. Reddy's Laboratories Limited has submitted a disclosure under Regulation 31(4) of SEBI Takeover Regulations for the year ended 31-Mar-2022","08-Apr-2022 11:22:33","2022-04-08 11:22:33","08-Apr-2022 11:22:45","00:00:12","https://nsearchives.nseindia.com/corporate/AN_O08042022112233.xlsx"
"DRREDDY","Dr. Reddy's Laboratories Limited","Amalgamation/Merger","Dr. Reddy's Laboratories Limited has informed the Exchange about NCLT Approval of the Scheme of Amalgamationand Arrangement ","07-Apr-2022 18:26:47","2022-04-07 18:26:47","07-Apr-2022 18:27:13","00:00:26","https://nsearchives.nseindia.com/corporate/DRREDDY_07042022182636_SEIntimationNCLTapproval.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of share certificate","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of share certificate","06-Apr-2022 17:56:40","2022-04-06 17:56:40","06-Apr-2022 17:56:46","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_06042022175640_SEIntimationlossofdupsc06042022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 05-Apr-2022 titled Dr. Reddy's Laboratories announces the launch of Methylprednisolone Sodium Succinate for Injection, USP in the U.S. Market","05-Apr-2022 12:38:16","2022-04-05 12:38:16","05-Apr-2022 12:38:22","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_05042022123814_PressRelease05042022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","DRREDDY : The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Himachal Pradesh high court restrains DRL from selling BI's diabetic drug Jardiance.  The response from the Company is attached.","05-Apr-2022 09:30:12","2022-04-05 09:30:12","05-Apr-2022 09:30:18","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_07042022100533_Response_to_clarification_NSE.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Intimation","01-Apr-2022 20:13:13","2022-04-01 20:13:13","01-Apr-2022 20:13:18","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_01042022201312_Intimation01042022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","DRREDDY : The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Himachal Pradesh high court restrains DRL from selling BI's diabetic drug Jardiance.  The response from the Company is awaited.","01-Apr-2022 17:47:20","2022-04-01 17:47:20","01-Apr-2022 17:47:26","00:00:06","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot","Dr. Reddy's Laboratories Limited has informed the Exchange about Voting results and  Scrutinizer report of Postal Ballot","29-Mar-2022 14:48:39","2022-03-29 14:48:39","29-Mar-2022 14:48:48","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_29032022144836_OutcomePB29032022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Closure of trading window","Dr. Reddy's Laboratories Limited has informed the Exchange about Closure of trading window for board meeting scheduled to be held on May 19, 2022","29-Mar-2022 13:19:08","2022-03-29 13:19:08","29-Mar-2022 13:19:13","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_29032022131903_BoardMeetingNoticeIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Allotment of Equity Shares on exercise of ESOP","17-Mar-2022 16:12:32","2022-03-17 16:12:32","17-Mar-2022 16:12:39","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_17032022161228_SEintimation17032022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Resignation","Dr. Reddy's Laboratories Limited  has informed the Exchange about resignation of Vivek Mittal as Interim Compliance Officer of the company w.e.f. 17-Mar-2022","17-Mar-2022 13:07:20","2022-03-17 13:07:20","17-Mar-2022 13:07:35","00:00:15","https://nsearchives.nseindia.com/corporate/DRREDDY_17032022130717_SEintimationKRSappointment.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy's Laboratories Limited  has informed the Exchange about appointment of K Randhir Singh as Compliance Officer of the company w.e.f. 17-Mar-2022","17-Mar-2022 12:08:00","2022-03-17 12:08:00","17-Mar-2022 12:08:13","00:00:13","https://nsearchives.nseindia.com/corporate/DRREDDY_17032022120800_SEintimationKRSappointment.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy's Laboratories Limited  has informed the Exchange about appointment of K Randhir Singh as Company Secretary of the company w.e.f. 17-Mar-2022","17-Mar-2022 12:01:47","2022-03-17 12:01:47","17-Mar-2022 12:02:12","00:00:25","https://nsearchives.nseindia.com/corporate/DRREDDY_17032022120145_SEintimationKRSappointment.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Newspaper Advertisements","Dr. Reddy's Laboratories Limited has informed the Exchange about a copy of Newspaper Advertisement given for despatch of postal ballot notice and e-voting information","28-Feb-2022 21:46:13","2022-02-28 21:46:13","28-Feb-2022 21:46:29","00:00:16","https://nsearchives.nseindia.com/corporate/DRREDDY_28022022214608_SignedSE28022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot","Dr. Reddy's Laboratories Limited has informed the Exchange about the despatch of Notice of Postal Ballot","25-Feb-2022 15:44:12","2022-02-25 15:44:12","25-Feb-2022 15:44:38","00:00:26","https://nsearchives.nseindia.com/corporate/DRREDDY_25022022154412_Stxintimation25022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Agreements/Contracts/Arrangements/ MOU's PARA A","Dr. Reddy's Laboratories Limited has informed the Exchange about acquisition of Nimbus Health GmbH","25-Feb-2022 10:25:00","2022-02-25 10:25:00","25-Feb-2022 10:25:08","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_25022022102500_25022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of other UPSI/material event","Press Release","22-Feb-2022 03:30:25","2022-02-22 03:30:25","22-Feb-2022 03:31:36","00:01:11","https://nsearchives.nseindia.com/corporate/DRREDDY_22022022033025_PressRelease21022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","General updates","Dr. Reddy's Laboratories Limited has informed the Exchange about audit conducted by the USFDA at formulations manufacturing facilities at Duvvada, Visakhapatnam.","21-Feb-2022 11:25:08","2022-02-21 11:25:08","21-Feb-2022 11:25:18","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_21022022112508_21022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange about press release dated 21-Feb-2022 titled Binnopharm Group enters into agreement to acquire two anti-bacterial brands from Dr. Reddy￢ﾀﾙs in the Russia & CIS region.","21-Feb-2022 11:24:06","2022-02-21 11:24:06","21-Feb-2022 11:24:18","00:00:12","https://nsearchives.nseindia.com/corporate/DRREDDY_21022022112406_PressRelease21022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","18-Feb-2022 15:08:54","2022-02-18 15:08:54","18-Feb-2022 15:09:12","00:00:18","https://nsearchives.nseindia.com/corporate/DRREDDY_18022022150854_SEIntimation180222.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","16-Feb-2022 17:12:16","2022-02-16 17:12:16","16-Feb-2022 17:12:24","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_16022022171216_16022022SEIntimationLossofShareCertificates.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","14-Feb-2022 13:23:51","2022-02-14 13:23:51","14-Feb-2022 13:24:13","00:00:22","https://nsearchives.nseindia.com/corporate/DRREDDY_14022022132351_SEIntimationIIFLFireSidechat.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 11, 2022, titled ""Dr. Reddy's Laboratories enters into exclusive salesand distribution agreement with Novartis India Limited for select India brands"".","11-Feb-2022 19:54:40","2022-02-11 19:54:40","11-Feb-2022 19:54:45","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_11022022195440_PressRelease11022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","09-Feb-2022 23:08:54","2022-02-09 23:08:54","09-Feb-2022 23:08:57","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_09022022230854_Intimation09022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 09, 2022, titled ""Press Release"".","09-Feb-2022 17:06:14","2022-02-09 17:06:14","09-Feb-2022 17:06:29","00:00:15","https://nsearchives.nseindia.com/corporate/DRREDDY_09022022170614_PressReleases09022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Updates to press release'.","08-Feb-2022 20:55:55","2022-02-08 20:55:55","08-Feb-2022 20:56:04","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_08022022205555_UpdatetothePressReleaseof03022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 07, 2022, titled ""Dr. Reddy s Laboratories announces DCGI approval to the single-shot Sputnik Light vaccine in India "".","07-Feb-2022 08:01:04","2022-02-07 08:01:04","07-Feb-2022 08:01:08","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_07022022080104_PressRelease07022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 03, 2022, titled ""Press Release"".","03-Feb-2022 15:13:47","2022-02-03 15:13:47","03-Feb-2022 15:13:55","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_03022022151347_PressRelease03022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 02, 2022, titled ""Dr. Reddy s included in S&P Global s Sustainability Yearbook for the 2nd year and Bloomberg Gender-Equality Index for the 5th year in a row"".","02-Feb-2022 13:26:26","2022-02-02 13:26:26","02-Feb-2022 13:26:33","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_02022022132626_PressRelease02022022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation on earnings call transcript and audio'.","01-Feb-2022 22:06:59","2022-02-01 22:06:59","01-Feb-2022 22:07:04","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_01022022220659_IntimationEarningscallaudioandtranscript.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","30-Jan-2022 15:16:04","2022-01-30 15:16:04","30-Jan-2022 15:16:11","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_30012022151603_Q3Financialsadv.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation on filing of form 6k'.","29-Jan-2022 11:11:11","2022-01-29 11:11:11","29-Jan-2022 11:11:21","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_29012022111111_6kintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 6569 securities pursuant to ESOP/ESPS at its meeting held on January 27, 2022","28-Jan-2022 14:46:27","2022-01-28 14:46:27","28-Jan-2022 14:46:42","00:00:15","https://nsearchives.nseindia.com/corporate/DRREDDY_28012022144627_ESOPintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Appointment of Ms Penny Wan as Non- Executive Independent Director of the company w.e.f. January 28, 2022.","28-Jan-2022 13:25:40","2022-01-28 13:25:40","28-Jan-2022 13:25:56","00:00:16","https://nsearchives.nseindia.com/corporate/DRREDDY_28012022132540_Directorappointment.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding  Board meeting held on January 28, 2022.","28-Jan-2022 12:39:23","2022-01-28 12:39:23","28-Jan-2022 12:39:32","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_28012022123923_BMoutcome28012022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2021.","28-Jan-2022 12:35:00","2022-01-28 12:35:00","28-Jan-2022 12:37:02","00:02:02","https://nsearchives.nseindia.com/corporate/BMoutcome28012022_28012022123500.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","22-Jan-2022 17:12:27","2022-01-22 17:12:27","22-Jan-2022 17:12:37","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_22012022171227_StockExchangeIntimationDupSC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 5330  Options.","18-Jan-2022 19:41:02","2022-01-18 19:41:02","18-Jan-2022 19:41:11","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_18012022194102_GrantIntimation18012022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 17, 2022, titled ""Earnings call "".","17-Jan-2022 14:54:03","2022-01-17 14:54:03","17-Jan-2022 14:54:14","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_17012022145403_PressRelease17012022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","10-Jan-2022 16:24:38","2022-01-10 16:24:38","10-Jan-2022 16:24:45","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_10012022162438_10012022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Appointment of Mr K P Krishnan as Independent Director of the company w.e.f. January 07, 2022.","07-Jan-2022 21:24:57","2022-01-07 21:24:57","07-Jan-2022 21:25:04","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_07012022212457_Intimationkrishnan.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","28-Dec-2021 16:53:09","2021-12-28 16:53:09","28-Dec-2021 16:53:15","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_28122021165309_BoardMeetingNoticeIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 28, 2021, titled ""Dr. Reddy's Laboratories receives DCGI approval tolaunch Molnupiravir capsules 200mg (Molflu ) in India"".","28-Dec-2021 16:33:50","2021-12-28 16:33:50","28-Dec-2021 16:33:57","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_28122021163350_PressRelease28122021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 16967  Shares.","18-Dec-2021 20:57:25","2021-12-18 20:57:25","18-Dec-2021 20:57:30","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_18122021205724_ESOPIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","10-Dec-2021 21:29:07","2021-12-10 21:29:07","10-Dec-2021 21:29:11","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_10122021212907_Intimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 09, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Venlafaxine ER Tablets in the U.S. Market"".","09-Dec-2021 21:57:34","2021-12-09 21:57:34","09-Dec-2021 21:57:40","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_09122021215734_PressRelease09122021Venlafaxine.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 09, 2021, titled ""Dr. Reddy's Laboratories announces the launch ofValsartan Tablets, USP in the U.S. Market"".","09-Dec-2021 11:46:18","2021-12-09 11:46:18","09-Dec-2021 11:46:22","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_09122021114618_PressReleases09122021Valsartan.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 09, 2021, titled ""Prestige BioPharma and Dr. Reddy s announce partnership to commercialize trastuzumab biosimilar in select countries in Latin America and Southeast Asia"".","09-Dec-2021 07:44:21","2021-12-09 07:44:21","09-Dec-2021 07:44:27","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_09122021074421_PressRelease09122021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transactions","Dr. Reddy's Laboratories Limited has informed the Exchange about related Party Transactions","27-Nov-2021 21:39:22","2021-11-27 21:39:22","27-Nov-2021 21:39:26","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_27112021213922_RPTQ2FY22.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","12-Nov-2021 15:43:17","2021-11-12 15:43:17","12-Nov-2021 15:43:26","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_12112021154317_IssueofDuplicateShareCertificates.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding filing of Form 6k for Q2 FY22'.","06-Nov-2021 18:15:23","2021-11-06 18:15:23","06-Nov-2021 18:15:27","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_06112021181523_Intimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Transcript","05-Nov-2021 22:19:19","2021-11-05 22:19:19","05-Nov-2021 22:19:26","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_05112021221919_IntimationEarningscalltranscriptQ2FY22.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","30-Oct-2021 22:30:42","2021-10-30 22:30:42","30-Oct-2021 22:30:47","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_30102021223042_SEIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Link of Recording","29-Oct-2021 22:25:49","2021-10-29 22:25:49","29-Oct-2021 22:25:55","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_29102021222549_Intimation29102021earningscall.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 29, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Ephedrine Sulfate Injection USP, 50 mg/mL, Single-Dose Vial in the U.S. Market"".","29-Oct-2021 17:51:13","2021-10-29 17:51:13","29-Oct-2021 17:51:21","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_29102021175113_PressRelease29102021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 32888  Options.","29-Oct-2021 17:40:35","2021-10-29 17:40:35","29-Oct-2021 17:40:43","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_29102021174035_ESopAllotmentnGrant.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 1114  Shares.","29-Oct-2021 17:32:24","2021-10-29 17:32:24","29-Oct-2021 17:32:31","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_29102021173224_ESopAllotmentnGrant.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Resignation","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Resignation of Mr Sandeep Poddar as Company Secretary & Compliance Officer of the company w.e.f. November 18, 2021.","29-Oct-2021 17:26:05","2021-10-29 17:26:05","29-Oct-2021 17:26:22","00:00:17","https://nsearchives.nseindia.com/corporate/DRREDDY_29102021172605_SEintimationCSResignation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","29-Oct-2021 15:06:01","2021-10-29 15:06:01","29-Oct-2021 15:06:18","00:00:17","https://nsearchives.nseindia.com/corporate/DRREDDY_29102021150601_Intimation29102021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021.","29-Oct-2021 13:53:50","2021-10-29 13:53:50","29-Oct-2021 17:06:09","03:12:19","https://nsearchives.nseindia.com/corporate/Q2FY22Financials_29102021135350.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding  Board meeting held on October 29, 2021.","29-Oct-2021 13:53:00","2021-10-29 13:53:00","29-Oct-2021 17:06:14","03:13:14","https://nsearchives.nseindia.com/corporate/DRREDDY_29102021135300_Q2FY22Financials.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","27-Oct-2021 22:28:13","2021-10-27 22:28:13","27-Oct-2021 22:28:17","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_27102021222813_26102021SEIntimationLossofShareCertificates.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","22-Oct-2021 22:10:25","2021-10-22 22:10:25","22-Oct-2021 22:10:30","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_22102021221025_IntimationLossofsharecertificates.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 19, 2021, titled ""Dr. Reddy's Laboratories announces approval for Lenalidomide Capsules from the U.S. Food and Drug Administration (USFDA)"".","19-Oct-2021 08:53:47","2021-10-19 08:53:47","19-Oct-2021 08:53:52","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_19102021085347_PressRelease19102021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 15, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Carmustine for Injection, USP in the U.S. Market"".","15-Oct-2021 22:15:18","2021-10-15 22:15:18","15-Oct-2021 22:15:23","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_15102021221518_PressRelease15102021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 14, 2021, titled ""intimation"".","14-Oct-2021 18:29:35","2021-10-14 18:29:35","14-Oct-2021 18:29:39","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_14102021182935_Intimation14102021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","13-Oct-2021 21:45:42","2021-10-13 21:45:42","13-Oct-2021 21:45:46","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_13102021214542_Lossintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 07, 2021, titled ""Dr. Reddy's to release Q2 FY 22 results on October 29th, 2021 Earnings call slated for October 29th @ 5:30 PM IST / 8:00 AM EDT"".","07-Oct-2021 16:07:27","2021-10-07 16:07:27","07-Oct-2021 16:07:32","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_07102021160727_PressRelease07102021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","06-Oct-2021 22:35:31","2021-10-06 22:35:31","06-Oct-2021 22:35:35","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_06102021223531_Duplicate06102021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","24-Sep-2021 18:22:21","2021-09-24 18:22:21","24-Sep-2021 18:22:27","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_24092021182221_BoardMeetingNoticeIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 2304  Shares.","22-Sep-2021 15:46:44","2021-09-22 15:46:44","22-Sep-2021 15:46:50","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_22092021154644_ESOPIntimation22092021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","09-Sep-2021 20:35:48","2021-09-09 20:35:48","09-Sep-2021 20:35:52","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_09092021203548_Intimation09092021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 07, 2021, titled ""Dr. Reddy s launches Minoxidil for women following first-ever approval in India for the treatment of female pattern hair loss."".","07-Sep-2021 13:01:32","2021-09-07 13:01:32","07-Sep-2021 13:01:37","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_07092021130132_PressRelease07092021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 04, 2021, titled ""Dr. Reddy s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)."".","04-Sep-2021 10:16:59","2021-09-04 10:16:59","04-Sep-2021 10:17:06","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_04092021101659_PressRelease04092021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 17122  Shares pursuant to exercise of ESOPs..","02-Sep-2021 20:04:33","2021-09-02 20:04:33","02-Sep-2021 20:04:37","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_02092021200433_ESOPIntimation02092021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 02, 2021, titled ""Dr. Reddy's Laboratories Canada announces the launch of Reddy-Lenalidomide, one of the first generic medications of its kind for the Canadian Market."".","02-Sep-2021 08:18:01","2021-09-02 08:18:01","02-Sep-2021 08:18:05","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_02092021081801_PressRelease02092021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 31, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Chlordiazepoxide Hydrochloride and Clidinium Bromide Capsules, USP in the U.S. Market."".","31-Aug-2021 11:38:37","2021-08-31 11:38:37","31-Aug-2021 11:38:43","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_31082021113837_PressRelease31082021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","25-Aug-2021 17:48:46","2021-08-25 17:48:46","25-Aug-2021 17:48:52","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_25082021174846_Loss25082021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 19251  Shares. pursuant toexercise of Stock Options","09-Aug-2021 21:03:53","2021-08-09 21:03:53","09-Aug-2021 21:03:58","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_09082021210353_SEIntimation09082021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","06-Aug-2021 20:32:28","2021-08-06 20:32:28","06-Aug-2021 20:32:35","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_06082021203228_06082021Issue.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 04, 2021, titled ""Dr. Reddy s Laboratories announces entry into definitive agreement with BioDelivery Sciences International, Inc., to sell its U.S. and Canada territory rights for ELYXYB (celecoxib oral solution) 25 mg/mL"".","04-Aug-2021 19:21:52","2021-08-04 19:21:52","04-Aug-2021 19:21:57","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_04082021192152_PressRelease04082021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 03, 2021, titled ""Dr. Reddy s announces the re-launch of over-the-counter Naproxen Sodium Tablets USP, 220 mg, store-brand equivalent of Aleveￂﾮ in the U.S. Market."".","03-Aug-2021 17:12:25","2021-08-03 17:12:25","03-Aug-2021 17:12:31","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_03082021171225_PressRelease03082021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates","02-Aug-2021 19:41:22","2021-08-02 19:41:22","02-Aug-2021 19:41:28","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_02082021194122_SEInvestorsIntimation02082021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'intimation'.","02-Aug-2021 18:20:34","2021-08-02 18:20:34","02-Aug-2021 18:20:39","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_02082021182034_Intimation02082021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 28, 2021. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.","28-Jul-2021 19:56:11","2021-07-28 19:56:11","28-Jul-2021 19:56:18","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_28072021195611_AGMOutcome.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding financial results","28-Jul-2021 15:54:50","2021-07-28 15:54:50","28-Jul-2021 15:54:53","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_28072021155449_SEIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates","28-Jul-2021 14:07:22","2021-07-28 14:07:22","28-Jul-2021 14:07:26","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_28072021140722_SEInvestorsIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Form 6-K for Q1-FY22 filed with US SEC'.","27-Jul-2021 22:26:40","2021-07-27 22:26:40","27-Jul-2021 22:26:44","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_27072021222640_Intimation27072021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 27, 2021, titled ""Dr. Reddy s and ICICI Lombard collaborate for pilot launch of first-of-its-kind integrated and cashless digital health solution in India."".","27-Jul-2021 14:30:27","2021-07-27 14:30:27","27-Jul-2021 14:30:32","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_27072021143027_PressRelease27072021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021.","27-Jul-2021 11:23:45","2021-07-27 11:23:45","27-Jul-2021 11:25:03","00:01:18","https://nsearchives.nseindia.com/corporate/Q1FY22SEBI_27072021112345.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","21-Jul-2021 16:47:34","2021-07-21 16:47:34","21-Jul-2021 16:47:42","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_21072021164734_Loss20072021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 07, 2021, titled ""Dr. Reddy's to release Q1 FY 22 results on July 27th, 2021 Earnings call slated for July 27th @ 5:30 PM IST / 8:00 AM EDT"".","07-Jul-2021 16:28:26","2021-07-07 16:28:26","07-Jul-2021 16:28:38","00:00:12","https://nsearchives.nseindia.com/corporate/DRREDDY_07072021162826_PressRelease07072021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","07-Jul-2021 12:12:18","2021-07-07 12:12:18","07-Jul-2021 12:12:28","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_07072021121218_Loss06072021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","03-Jul-2021 20:32:10","2021-07-03 20:32:10","03-Jul-2021 20:32:19","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_03072021203210_03072021SEIntimationnewspaperadvt.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy's Labs denied approval for final trial of Russian-made Sputnik Light.  The response from the Company is attached.","02-Jul-2021 09:34:00","2021-07-02 09:34:00","02-Jul-2021 09:34:48","00:00:48","https://nsearchives.nseindia.com/corporate/DRREDDY_02072021093443_NSEReplytoClarification.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Dr Reddy's Labs denied approval for final trial of Russian-made Sputnik Light.  The response from the Company is awaited.","01-Jul-2021 18:50:00","2021-07-01 18:50:00","01-Jul-2021 18:50:58","00:00:58","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 30, 2021, titled ""Dr. Reddy's Laboratories announces filing of Annual Report on Form 20-F"".","30-Jun-2021 22:40:54","2021-06-30 22:40:54","30-Jun-2021 22:41:01","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_30062021224054_PressRelease30062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 29, 2021, titled ""Pharma Majors Collaborate for Clinical Trial of Investigational Oral Anti-Viral Drug Molnupiravir for COVID-19"".","29-Jun-2021 16:00:11","2021-06-29 16:00:11","29-Jun-2021 16:00:35","00:00:24","https://nsearchives.nseindia.com/corporate/DRREDDY_29062021160011_PressRelease29062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 28, 2021, titled ""Dr. Reddy s Laboratories Announces Commercial Launch of 2DG"".","28-Jun-2021 08:42:09","2021-06-28 08:42:09","28-Jun-2021 08:42:18","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_28062021084209_PressRelease28062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","25-Jun-2021 21:13:27","2021-06-25 21:13:27","25-Jun-2021 21:13:31","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_25062021211327_BoardMeetingNoticeIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 15820  Shares.","24-Jun-2021 17:15:13","2021-06-24 17:15:13","24-Jun-2021 17:15:30","00:00:17","https://nsearchives.nseindia.com/corporate/DRREDDY_24062021171513_ESOPIntimation24062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 22, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Icosapent Ethyl Capsules, 1 gram in the U.S. Market"".","22-Jun-2021 08:38:31","2021-06-22 08:38:31","22-Jun-2021 08:38:37","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_22062021083831_PressRelease22062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation' under Regulation 30.","15-Jun-2021 20:41:39","2021-06-15 20:41:39","15-Jun-2021 20:41:44","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_15062021204139_Intimation15062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","15-Jun-2021 19:48:23","2021-06-15 19:48:23","15-Jun-2021 19:48:31","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_15062021194823_SEAGMIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","14-Jun-2021 19:59:33","2021-06-14 19:59:33","14-Jun-2021 19:59:39","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_14062021195933_Loss14062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transactions","Dr. Reddy's Laboratories Limited has submitted disclosure of related party transactions for the half year ended March 31, 2021.","10-Jun-2021 17:50:01","2021-06-10 17:50:01","10-Jun-2021 17:50:12","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_10062021175001_RPTDisclosureMarch2021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","09-Jun-2021 22:19:36","2021-06-09 22:19:36","09-Jun-2021 22:19:41","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_09062021221933_Issue09062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","09-Jun-2021 22:19:33","2021-06-09 22:19:33","09-Jun-2021 22:19:40","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_09062021221933_Issue09062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 43083  Shares on exercise of ESOPs.","03-Jun-2021 18:53:32","2021-06-03 18:53:32","03-Jun-2021 18:53:39","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_03062021185332_ESOPIntimation03062021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","23-May-2021 23:45:19","2021-05-23 23:45:19","23-May-2021 23:45:25","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_23052021234519_SEIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation of date of Annual General Meeting'.","19-May-2021 22:15:01","2021-05-19 22:15:01","19-May-2021 22:15:15","00:00:14","https://nsearchives.nseindia.com/corporate/DRREDDY_19052021221501_BookClosureandAGMdate.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 13-Jul-2021 to 15-Jul-2021 for the purpose of Dividend.","19-May-2021 21:50:01","2021-05-19 21:50:01","19-May-2021 21:50:17","00:00:16","https://nsearchives.nseindia.com/corporate/DRREDDY_19052021215001_BookClosureandAGMdate.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates","18-May-2021 21:36:59","2021-05-18 21:36:59","18-May-2021 21:37:13","00:00:14","https://nsearchives.nseindia.com/corporate/DRREDDY_18052021213659_SEInvestorsIntimation18052021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding transfer of shares to IEPF.","15-May-2021 19:38:10","2021-05-15 19:38:10","15-May-2021 19:38:15","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_15052021193810_IntimationtoExchangesNewspaperAddMay2021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding financials results.","15-May-2021 15:35:38","2021-05-15 15:35:38","15-May-2021 15:35:48","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_15052021153538_SEIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Analysts/Institutional Investor Meet/Con. Call Updates","Dr. Reddy's Laboratories Limited has informed the Exchange about Analysts/Institutional Investor Meet/Con. Call Updates","15-May-2021 15:03:12","2021-05-15 15:03:12","15-May-2021 15:03:24","00:00:12","https://nsearchives.nseindia.com/corporate/DRREDDY_15052021150311_SEInvestorsIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 138536  Options.","14-May-2021 20:02:14","2021-05-14 20:02:14","14-May-2021 20:02:30","00:00:16","https://nsearchives.nseindia.com/corporate/DRREDDY_14052021200214_GrantIntimation2021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend Updates","Dr. Reddy's Laboratories Limited has informed the Exchange that Board approves Dividend","14-May-2021 15:49:36","2021-05-14 15:49:36","14-May-2021 15:49:43","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_14052021154936_BMoutcome14052021resultsFinal.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2021, recommended Final Dividend of 25 per equity share.","14-May-2021 15:39:10","2021-05-14 15:39:10","14-May-2021 15:39:17","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_14052021153910_BMoutcome14052021resultsFinal.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 14, 2021, recommended Final Dividend of 25 per equity share.","14-May-2021 15:36:18","2021-05-14 15:36:18","14-May-2021 15:36:29","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_14052021153618_BMoutcome14052021resultsFinal.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021.","14-May-2021 12:26:27","2021-05-14 12:26:27","14-May-2021 12:28:02","00:01:35","https://nsearchives.nseindia.com/corporate/BMoutcome14052021resultsFinal_14052021122627.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 14, 2021, titled ""Dr. Reddy s Laboratories Announces Launch of the Sputnik V vaccine in the Indian Market"".","14-May-2021 11:55:16","2021-05-14 11:55:16","14-May-2021 11:55:23","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_14052021115516_PressRelease14052021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 12, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Ertapenem for Injection in the U.S. Market."".","12-May-2021 00:29:05","2021-05-12 00:29:05","12-May-2021 00:29:16","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_12052021002905_PressRelease12052021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Cessation","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Cessation of Mr Bharat Narotam Doshi as Independent Director of the company w.e.f. May 10, 2021.","12-May-2021 00:00:22","2021-05-12 00:00:22","12-May-2021 00:00:33","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_12052021000022_SEIntimationDirectorChange.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 11, 2021, titled ""Dr. Reddy's Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India"".","11-May-2021 22:04:52","2021-05-11 22:04:52","11-May-2021 22:05:12","00:00:20","https://nsearchives.nseindia.com/corporate/DRREDDY_11052021220452_PressRelease11052021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Credit Rating","Dr. Reddy's Laboratories Limited has informed the Exchange about Credit Rating","08-May-2021 19:26:58","2021-05-08 19:26:58","08-May-2021 19:27:07","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_08052021192658_08052021CreditRating.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Acquisition","Dr. Reddy's Laboratories Limited has informed the Exchange about an update on Acquisition","30-Apr-2021 22:53:09","2021-04-30 22:53:09","30-Apr-2021 22:53:19","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_30042021225309_SEIntimationRevisioninSTake.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 29, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Albendazole Tablets, USP in the U.S. Market."".","29-Apr-2021 17:59:26","2021-04-29 17:59:26","29-Apr-2021 17:59:33","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_29042021175926_PressRelease29042021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 23, 2021, titled ""Dr. Reddy's to release Q4 and full year FY 21 results on May 14th, 2021 Earnings call slated for May 14th @ 5:30 PM IST / 8:00 AM EDT"".","23-Apr-2021 16:06:24","2021-04-23 16:06:24","23-Apr-2021 16:06:28","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_23042021160624_PressRelease23042021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","ￂﾠPromoter/Member of the Promoter Group of the Company has informed the Exchange regarding disclosure under Regulation 30 and Regulation 31(4) of SEBI SAST Regulations, 2011ￂﾠas at March 31, 2021.ￂﾠ","15-Apr-2021 09:30:10","2021-04-15 09:30:10","15-Apr-2021 09:30:17","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_15042021093010_DRREDDY.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 13, 2021, titled ""Dr. Reddy's Laboratories Gets Emergency Use Authorisation for Sputnik V in India."".","13-Apr-2021 09:35:30","2021-04-13 09:35:30","13-Apr-2021 09:35:35","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_13042021093530_PressRelease13042021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","09-Apr-2021 18:07:01","2021-04-09 18:07:01","09-Apr-2021 18:07:05","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_09042021180701_IssueofDuplicateShareCertificates09042021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 07, 2021, titled ""Dr. Reddy's Laboratories announces the launch of a generic version of Sapropterin Dihydrochloride Powder for Oral Solution, 100 mg in the U.S. Market."".","07-Apr-2021 12:44:02","2021-04-07 12:44:02","07-Apr-2021 12:44:14","00:00:12","https://nsearchives.nseindia.com/corporate/DRREDDY_07042021124402_PressRelease07042021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Acquisition","Dr. Reddy's Laboratories Limited has informed the Exchange regarding an update on Acquisition","01-Apr-2021 19:46:25","2021-04-01 19:46:25","01-Apr-2021 19:46:31","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_01042021194625_SEDisclosurePharmarackAcquisition.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","01-Apr-2021 19:29:50","2021-04-01 19:29:50","01-Apr-2021 19:29:57","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_01042021192950_SEIntimationNewspaperAdvertisment.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Acquisition","Dr. Reddy's Laboratories Limited has informed the Exchange regarding an update on Acquisition","31-Mar-2021 21:03:49","2021-03-31 21:03:49","31-Mar-2021 21:03:55","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_31032021210349_SEIntimationUpdatesonAcquisition31032021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Acquisition","Dr. Reddy's Laboratories Limited has informed the Exchange about Acquisition","31-Mar-2021 15:03:11","2021-03-31 15:03:11","31-Mar-2021 15:03:16","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_31032021150311_31032021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","29-Mar-2021 18:27:03","2021-03-29 18:27:03","29-Mar-2021 18:27:10","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_29032021182703_BoardMeetingNoticeIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Gunupati Venkateswara Prasad - HUF has submitted to the Exchange a copy of Disclosure under Regulation 10(6)ￂﾠ of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.ￂﾠￂﾠ","26-Mar-2021 20:05:33","2021-03-26 20:05:33","26-Mar-2021 20:05:40","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_26032021200533_GVF_10.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 862  Shares.","19-Mar-2021 20:10:51","2021-03-19 20:10:51","19-Mar-2021 20:10:55","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_19032021201051_ESOPIntimation19032021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Promoter of Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares & Takeover) Regulations, 2011","19-Mar-2021 18:04:05","2021-03-19 18:04:05","19-Mar-2021 18:04:11","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_19032021180405_DRREDDY_REG10_19032021175828.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","10-Mar-2021 14:24:15","2021-03-10 14:24:15","10-Mar-2021 14:24:18","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_10032021142415_Intimation10032021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","09-Mar-2021 14:16:27","2021-03-09 14:16:27","09-Mar-2021 14:16:31","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_09032021141627_IssueofDuplicateShareCertificate.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 2253  Shares.","01-Mar-2021 15:06:26","2021-03-01 15:06:26","01-Mar-2021 15:06:29","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_01032021150626_ESOPIntimation01032021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 22, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Lansoprazole DR Orally Disintegrating Tablets in the U.S. Market."".","22-Feb-2021 10:38:51","2021-02-22 10:38:51","22-Feb-2021 10:38:56","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_22022021103851_PressRelease22022021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 19, 2021, titled ""Dr. Reddy's initiates process for Emergency Use Authorization of Sputnik V"".","19-Feb-2021 14:49:21","2021-02-19 14:49:21","19-Feb-2021 14:49:25","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_19022021144921_PressRelease19022021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 18, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Fluphenazine Hydrochloride Tablets, USP in the U.S. Market"".","18-Feb-2021 10:35:48","2021-02-18 10:35:48","18-Feb-2021 10:35:55","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_18022021103548_PressRelease18022021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 17, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Capecitabine Tablets, USP in the U.S. Market."".","17-Feb-2021 10:38:18","2021-02-17 10:38:18","17-Feb-2021 10:38:23","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_17022021103818_PressRelease17022021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","16-Feb-2021 18:56:58","2021-02-16 18:56:58","16-Feb-2021 18:57:07","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_16022021185658_Loss16022021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","10-Feb-2021 18:10:30","2021-02-10 18:10:30","10-Feb-2021 18:10:41","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_10022021181030_Loss10022021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about issue of Duplicate Share Certificates","10-Feb-2021 13:12:12","2021-02-10 13:12:12","10-Feb-2021 13:12:18","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_10022021131212_09022021IssueofDuplicateShareCertificates.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about issue of Duplicate Share Certificates","10-Feb-2021 13:12:12","2021-02-10 13:12:12","10-Feb-2021 13:12:17","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_10022021131212_09022021IssueofDuplicateShareCertificates.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Form 6K for Q3-FY21 filed with US SEC'.","04-Feb-2021 08:34:40","2021-02-04 08:34:40","04-Feb-2021 08:34:45","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_04022021083440_Intimation04022021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 02, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Vigabatrin Tablets, USP in the U.S. Market"".","02-Feb-2021 12:42:00","2021-02-02 12:42:00","02-Feb-2021 12:42:13","00:00:13","https://nsearchives.nseindia.com/corporate/DRREDDY_02022021124200_PressRelease02022021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication regarding financial results.","31-Jan-2021 13:46:49","2021-01-31 13:46:49","31-Jan-2021 13:46:55","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_31012021134649_SEIntimation31012021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.","29-Jan-2021 11:29:11","2021-01-29 11:29:11","29-Jan-2021 11:31:02","00:01:51","https://nsearchives.nseindia.com/corporate/ResultDec2020_29012021112911.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 27, 2021, titled ""Dr. Reddy s and GRA announces Avigan Pivotal Studies Update"".","27-Jan-2021 13:19:10","2021-01-27 13:19:10","27-Jan-2021 13:19:15","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_27012021131910_PressRelease27012021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 15, 2021, titled ""Dr. Reddy s receives approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India."".","15-Jan-2021 22:08:20","2021-01-15 22:08:20","15-Jan-2021 22:08:23","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_15012021220820_PressRelease15012021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 11, 2021, titled ""Sputnik V meets the primary endpoint of safety in the Phase 2 Clinical Trial in India"".","11-Jan-2021 19:53:44","2021-01-11 19:53:44","11-Jan-2021 19:53:49","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_11012021195344_PressRelease11012021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 11, 2021, titled ""Dr. Reddy's Laboratories to present at the 39th Annual J.P. Morgan Healthcare Conference. "".","11-Jan-2021 19:37:56","2021-01-11 19:37:56","11-Jan-2021 19:38:10","00:00:14","https://nsearchives.nseindia.com/corporate/DRREDDY_11012021193756_PressRelease11012021_2_.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 11, 2021, titled ""Dr. Reddy's Laboratories announces the launch of Febuxostat Tablets in the U.S. Market."".","11-Jan-2021 14:11:03","2021-01-11 14:11:03","11-Jan-2021 14:11:07","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_11012021141103_PressRelease11012021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 08, 2021, titled ""Dr. Reddy's to release Q3 FY 21 results on January 29th, 2021 Earnings call slated for January 29th @ 5:30 PM IST / 7:00 AM EST"".","08-Jan-2021 16:22:04","2021-01-08 16:22:04","08-Jan-2021 16:22:12","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_08012021162204_PressRelease08012021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","04-Jan-2021 16:33:32","2021-01-04 16:33:32","04-Jan-2021 16:33:38","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_04012021163332_Issue04012021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","29-Dec-2020 17:49:06","2020-12-29 17:49:06","29-Dec-2020 17:49:10","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_29122020174906_AdvBMIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","28-Dec-2020 15:02:02","2020-12-28 15:02:02","28-Dec-2020 15:02:13","00:00:11","https://nsearchives.nseindia.com/corporate/DRREDDY_28122020150202_BMIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 13119  Shares.","18-Dec-2020 15:32:34","2020-12-18 15:32:34","18-Dec-2020 15:32:38","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_18122020153234_ESOPIntimation18122020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 09, 2020, titled ""Secondary Listing of Dr. Reddy s ADRs on NSE IFSC Limited (GIFT City, Gujarat, India)"".","09-Dec-2020 13:27:04","2020-12-09 13:27:04","09-Dec-2020 13:27:13","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_09122020132704_PressRelease09122020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","08-Dec-2020 18:55:38","2020-12-08 18:55:38","08-Dec-2020 18:55:44","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_08122020185537_Issue08122020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","08-Dec-2020 18:55:38","2020-12-08 18:55:38","08-Dec-2020 18:55:48","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_08122020185537_Loss08122020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","08-Dec-2020 18:55:37","2020-12-08 18:55:37","08-Dec-2020 18:55:42","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_08122020185537_Issue08122020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'intimation'.","08-Dec-2020 16:32:41","2020-12-08 16:32:41","08-Dec-2020 16:32:45","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_08122020163241_Intimation08122020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 01, 2020, titled ""Dr. Reddy's and RDIF commence clinical trials for Sputnik V vaccine in India."".","01-Dec-2020 18:02:34","2020-12-01 18:02:34","01-Dec-2020 18:02:43","00:00:09","https://nsearchives.nseindia.com/corporate/DRREDDY_01122020180234_PressRelease01122020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 28, 2020, titled ""Dr. Reddy s to acquire select Anti-Allergy brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan"".","28-Nov-2020 20:55:55","2020-11-28 20:55:55","28-Nov-2020 20:55:59","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_28112020205555_Pressrelease28112020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","26-Nov-2020 20:45:54","2020-11-26 20:45:54","26-Nov-2020 20:45:58","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_26112020204554_Loss26112020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","19-Nov-2020 17:11:21","2020-11-19 17:11:21","19-Nov-2020 17:11:28","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_19112020171120_Loss19112020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transactions","Dr. Reddy's Laboratories Limited has informed the Exchange about Disclosure of related party transactions for the half year ended September 30, 2020.","19-Nov-2020 17:11:20","2020-11-19 17:11:20","19-Nov-2020 17:11:27","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_19112020171120_RPTSept2020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'intimation'.","19-Nov-2020 09:00:45","2020-11-19 09:00:45","19-Nov-2020 09:00:49","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_19112020090045_Intimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 12, 2020, titled ""Dr. Reddy's Laboratories announces the launch of Succinylcholine Chloride Injection USP, 200 mg/10 mL (20 mg/mL) in the U.S. Market"".","12-Nov-2020 20:22:39","2020-11-12 20:22:39","12-Nov-2020 20:22:42","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_12112020202239_PressRelease12112020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","09-Nov-2020 18:05:53","2020-11-09 18:05:53","09-Nov-2020 18:05:57","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_09112020180552_Loss.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Form 6K for Q2 and H1 FY21 filed with US SEC '.","29-Oct-2020 22:51:13","2020-10-29 22:51:13","29-Oct-2020 22:51:17","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_29102020225112_intimation29102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","29-Oct-2020 22:24:19","2020-10-29 22:24:19","29-Oct-2020 22:24:23","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_29102020222419_SEIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 29, 2020, titled ""Dr. Reddy's partners with Department of Biotechnology - Biotechnology Industry Research Assistance Council for Sputnik V vaccine clinical trials in India"".","29-Oct-2020 11:03:07","2020-10-29 11:03:07","29-Oct-2020 11:03:12","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_29102020110307_PressRelease29102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates - Venkatreddy Mareddy","28-Oct-2020 16:54:49","2020-10-28 16:54:49","28-Oct-2020 16:54:53","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_28102020165449_issueofduplicate28102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates - Pooja bhattad","28-Oct-2020 16:54:49","2020-10-28 16:54:49","28-Oct-2020 16:54:52","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_28102020165449_issueofduplicate28102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 15718  Shares.","28-Oct-2020 16:20:51","2020-10-28 16:20:51","28-Oct-2020 16:20:54","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_28102020162051_Grantandallotment.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 3244  Options.","28-Oct-2020 16:19:08","2020-10-28 16:19:08","28-Oct-2020 16:19:13","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_28102020161908_Grantandallotment.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'inprinciple Board approval for secondary listing of ADRS on NSE IFSC subject to necessary approvals '.","28-Oct-2020 13:44:23","2020-10-28 13:44:23","28-Oct-2020 13:44:28","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_28102020134423_outcomeofBM.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 28, 2020, titled ""Intimation regarding appointment of new Chief Financial Officer"".","28-Oct-2020 13:36:00","2020-10-28 13:36:00","28-Oct-2020 13:36:13","00:00:13","https://nsearchives.nseindia.com/corporate/DRREDDY_28102020133600_CFOIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2020.","28-Oct-2020 13:25:44","2020-10-28 13:25:44","28-Oct-2020 13:27:01","00:01:17","https://nsearchives.nseindia.com/corporate/Q2FY21Financialresults_28102020132544.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'intimation'.","22-Oct-2020 11:45:09","2020-10-22 11:45:09","22-Oct-2020 11:45:19","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_22102020114509_22102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 20, 2020, titled ""Dr. Reddy s announces the re-launch of over-the-counter Famotidine Tablets USP, 10 mg and 20 mg, store-brand equivalent of Pepcid ACￂﾮ in the U.S. Market"".","20-Oct-2020 12:32:25","2020-10-20 12:32:25","20-Oct-2020 12:32:30","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_20102020123225_PressRelease20102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 17, 2020, titled ""Dr. Reddy s and RDIF receive approval to conduct clinical trial for Sputnik V vaccine in India"".","17-Oct-2020 15:35:20","2020-10-17 15:35:20","17-Oct-2020 15:35:23","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_17102020153520_PressRelease17102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","14-Oct-2020 18:27:50","2020-10-14 18:27:50","14-Oct-2020 18:27:54","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_14102020182750_Loss14102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 12, 2020, titled ""Dr. Reddy's to release Q2 FY 21 results on October 28th, 2020Earnings call slated for October 28th @ 5:30 PM IST / 8:00 AM EDT"".","12-Oct-2020 16:34:06","2020-10-12 16:34:06","12-Oct-2020 16:34:11","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_12102020163406_PressRelease12102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","08-Oct-2020 10:55:51","2020-10-08 10:55:51","08-Oct-2020 10:55:54","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_08102020105551_Issue.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 05, 2020, titled ""Dr. Reddy s Laboratories joins Science Based Targets initiative (SBTi) and sets 2030 GHG emission targets"".","05-Oct-2020 13:56:09","2020-10-05 13:56:09","05-Oct-2020 13:56:13","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_05102020135609_PressRelease05102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 03, 2020, titled """"Dr. Reddy's Laboratories announces the launch of a generic version of Sapropterin Dihydrochloride Tabletsfor Oral Use in the U.S. Market"""".","03-Oct-2020 11:28:59","2020-10-03 11:28:59","03-Oct-2020 11:29:05","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_03102020112859_PressRelease03102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 01, 2020, titled """"Dr. Reddy's Laboratories announces the launch of Cinacalcet Tablets in the U.S. Market"""".","01-Oct-2020 12:23:23","2020-10-01 12:23:23","01-Oct-2020 12:23:28","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_01102020122323_PressRelease01102020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","30-Sep-2020 19:06:06","2020-09-30 19:06:06","30-Sep-2020 19:06:12","00:00:06","https://nsearchives.nseindia.com/corporate/DRREDDY_30092020190606_30092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","29-Sep-2020 19:28:43","2020-09-29 19:28:43","29-Sep-2020 19:28:53","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_29092020192843_NewspaperAdvertisementforBoardMeeting.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","27-Sep-2020 21:08:36","2020-09-27 21:08:36","27-Sep-2020 21:08:41","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_27092020210836_BoardMeetingNoticeIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 26, 2020, titled ""Dr. Reddy's Laboratories announces the launch of Dimethyl Fumarate Delayed-Release Capsules in the U.S. Market"".","26-Sep-2020 13:58:18","2020-09-26 13:58:18","26-Sep-2020 13:58:21","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_26092020135818_PressRelease26092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 25, 2020, titled ""Dr. Reddy's announces the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection in the U.S. Market"".","25-Sep-2020 11:48:44","2020-09-25 11:48:44","25-Sep-2020 11:48:49","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_25092020114844_PressRelease25092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","24-Sep-2020 18:36:32","2020-09-24 18:36:32","24-Sep-2020 18:36:36","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_24092020183632_Loss24092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of 14284  Shares.","23-Sep-2020 15:31:59","2020-09-23 15:31:59","23-Sep-2020 15:32:11","00:00:12","https://nsearchives.nseindia.com/corporate/DRREDDY_23092020153159_ESOPIntimation23092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 17, 2020, titled ""Dr. Reddy's Laboratories announces settlement ofU.S. Revlimidￂﾮ (lenalidomide) Capsules patent litigation with Celgene, a Bristol MyersSquibb Company"".","17-Sep-2020 16:29:42","2020-09-17 16:29:42","17-Sep-2020 16:29:45","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_17092020162942_PressRelease17092020celegene.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 17, 2020, titled ""Dr. Reddy s announces the launch of Over-the-Counter Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% and 0.1%, the storebrandequivalent of Patadayￂﾮ, the Eye Allergy Drop in the U.S. Market. "".","17-Sep-2020 10:38:32","2020-09-17 10:38:32","17-Sep-2020 10:38:36","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_17092020103832_PressRelease17092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 16, 2020, titled ""RDIF and Dr. Reddy s to cooperate on clinical trials and supply of 100 million doses of Sputnik V vaccine to India"".","16-Sep-2020 14:56:32","2020-09-16 14:56:32","16-Sep-2020 14:56:37","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_16092020145632_PressRelease16092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","14-Sep-2020 19:27:59","2020-09-14 19:27:59","14-Sep-2020 19:28:09","00:00:10","https://nsearchives.nseindia.com/corporate/DRREDDY_14092020192758_IssueofDuplicateShareCertificate12092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 09, 2020, titled ""Press Releases on  Dr. Reddy's Laboratories announces the launch of Redyx in India.  and  Dr. Reddy's Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltarenￂﾮ Arthritis Pain in the U.S. Market. "".","09-Sep-2020 10:06:58","2020-09-09 10:06:58","09-Sep-2020 10:07:03","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_09092020100658_PressRelease09092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 07, 2020, titled ""Dr. Reddy's Laboratories announces the launch ofFulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe in the U.S. Market"".","07-Sep-2020 17:21:23","2020-09-07 17:21:23","07-Sep-2020 17:21:27","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_07092020172123_PressRelease07092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 03, 2020, titled """"Dr. Reddy's Laboratories announces the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, in the U.S. Market"""".","03-Sep-2020 11:47:18","2020-09-03 11:47:18","03-Sep-2020 11:47:22","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_03092020114718_PressRelease03092020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","28-Aug-2020 11:26:37","2020-08-28 11:26:37","28-Aug-2020 11:26:41","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_28082020112637_28082020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 27, 2020, titled ""Dr. Reddy's Laboratories announces the launch of Penicillamine Capsules USP, 250 mg in the U.S. Market"".","27-Aug-2020 12:33:59","2020-08-27 12:33:59","27-Aug-2020 12:34:03","00:00:04","https://nsearchives.nseindia.com/corporate/DRREDDY_27082020123359_PressRelease27082020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 19, 2020, titled ""Dr. Reddy's Laboratories announces the launch of AVIGANￂﾮ (Favipiravir) in India. "".","19-Aug-2020 11:47:52","2020-08-19 11:47:52","19-Aug-2020 11:47:59","00:00:07","https://nsearchives.nseindia.com/corporate/DRREDDY_19082020114752_PressRelease19082020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 22479 securities pursuant to ESOP/ESPS at its meeting held on August 17, 2020","17-Aug-2020 18:56:04","2020-08-17 18:56:04","17-Aug-2020 18:56:12","00:00:08","https://nsearchives.nseindia.com/corporate/DRREDDY_17082020185604_ESOPIntimation17082020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","11-Aug-2020 21:34:28","2020-08-11 21:34:28","11-Aug-2020 21:34:33","00:00:05","https://nsearchives.nseindia.com/corporate/DRREDDY_11082020213428_Lossofshcert11082020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 11, 2020, titled ""Dr. Reddy's Laboratories announces the First-to-Market launch of the generic version of Ciprodexￂﾮ (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market."".","11-Aug-2020 08:58:59","2020-08-11 08:58:59","11-Aug-2020 08:59:02","00:00:03","https://nsearchives.nseindia.com/corporate/DRREDDY_11082020085859_PressRelease11082020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","31-Jul-2020 19:21:00","2020-07-31 19:21:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31072020192143_IssueofDuplicateShareCertificate.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","31-Jul-2020 19:21:00","2020-07-31 19:21:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31072020192143_IssueofDuplicateShareCertificate.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 30, 2020. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.","30-Jul-2020 17:24:00","2020-07-30 17:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30072020172412_OutcomeOfAGM30072020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","30-Jul-2020 15:02:00","2020-07-30 15:02:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30072020150217_SEIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding filing of Form 6-K for the quarter ended June 30, 2020'.","30-Jul-2020 08:11:00","2020-07-30 08:11:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30072020081116_Intimation30072020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.","29-Jul-2020 13:21:16","2020-07-29 13:21:16","-","-","https://nsearchives.nseindia.com/corporate/Q1FY21SEBI_29072020132116.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 27, 2020, titled ""Dr. Reddy's Laboratories received approval of XEGLYZE (abametapir) lotion, 0.74%, in the U.S."".","27-Jul-2020 10:35:00","2020-07-27 10:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27072020103551_PressRelease27072020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 20, 2020, titled ""Dr. Reddy's to release Q1 FY 21 results on July 29th,2020 Earnings call slated for July 29th @ 5:30 PM IST / 8:00 AM EDT"".","20-Jul-2020 16:09:00","2020-07-20 16:09:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20072020160944_PressRelease20072020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Loss of Share Certificates","Dr. Reddy's Laboratories Limited has informed the Exchange about Loss of Share Certificates","16-Jul-2020 21:01:00","2020-07-16 21:01:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_16072020210142_Loss16072020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 14, 2020, titled ""Dr. Reddy's Laboratories announces the launch of Over-The-Counter Nicotine Polacrilex Lozenges, 2 mg and 4 mg, the store brand version of Nicoretteￂﾮ Lozenges in the U.S. Market "".","14-Jul-2020 13:16:00","2020-07-14 13:16:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14072020131648_PressRelease14072020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","07-Jul-2020 17:23:00","2020-07-07 17:23:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_07072020172354_SEIntimation07072020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 30, 2020","06-Jul-2020 11:06:00","2020-07-06 11:06:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06072020110615_SEIntimationNoticeOfAGMAnnualReportFY2020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 01, 2020, titled ""Dr. Reddy s partners with FUJIFILM and Global Response Aid for Aviganￂﾮ (favipiravir), a potential treatment of COVID-19"".","01-Jul-2020 12:25:00","2020-07-01 12:25:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01072020122520_PressRelease01072020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","27-Jun-2020 21:35:00","2020-06-27 21:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27062020213525_BoardMeetingNoticeIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","25-Jun-2020 20:35:00","2020-06-25 20:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_25062020203535_NewspaperadAGMnoticeBC.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release (Revised)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a revised press release dated Jun 23, 2020, titled ""Dr. Reddy's Laboratories to present at the BarclaysSpec Pharma Fireside Chat Series (revised PR with conference id)"".","23-Jun-2020 21:59:00","2020-06-23 21:59:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_23062020215915_PressRelease23062020revised.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 23, 2020, titled ""Dr. Reddy's Laboratories to present at the Barclays Spec Pharma Fireside Chat Series"".","23-Jun-2020 15:21:00","2020-06-23 15:21:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_23062020152127_PressRelease23062020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 19, 2020, titled ""Dr. Reddy's Laboratories announces the launch of Abiraterone Acetate Tablets USP, 250 mg in the U.S. Market"".","19-Jun-2020 14:22:00","2020-06-19 14:22:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_19062020142241_PressRelease19062020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Copy of Newspaper Publication","Dr. Reddy's Laboratories Limited has informed the Exchange about Copy of Newspaper Publication","18-Jun-2020 20:31:00","2020-06-18 20:31:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_18062020203129_SEintimation18062020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation of date of AGM and Book Closure '.","17-Jun-2020 20:27:00","2020-06-17 20:27:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_17062020202759_BookclosureandAGMnotice.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that Register of Members & Share Transfer Books of the Company will remain closed from 15-Jul-2020 to 17-Jul-2020 for the purpose of Dividend.","17-Jun-2020 20:11:00","2020-06-17 20:11:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_17062020201129_BookclosureandAGMnotice.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  46390 Equity Shares under ESOP","17-Jun-2020 19:42:00","2020-06-17 19:42:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_17062020194240_ESOPIntimatin.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 16, 2020, titled ""Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F"".","16-Jun-2020 10:16:00","2020-06-16 10:16:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_16062020101616_PressRelease16062020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 13, 2020, titled ""Dr. Reddy's Laboratories enters into a Licensing Agreement with Gilead Sciences for Remdesivir"".","13-Jun-2020 13:48:00","2020-06-13 13:48:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_13062020134817_PressRelease13062020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 12, 2020, titled ""Dr. Reddy's Laboratories announces the launch of ColchicineTablets USP, 0.6 mg in the U.S. Market"".","12-Jun-2020 16:00:00","2020-06-12 16:00:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12062020160051_PressRelease12062020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 10, 2020, titled ""Press Release"".","10-Jun-2020 13:55:00","2020-06-10 13:55:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_10062020135545_PR10062020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transactions","Dr. Reddy's Laboratories Limited has informed the Exchange about disclosure of related party transactions for the half year ended March 31, 2020.","06-Jun-2020 10:15:00","2020-06-06 10:15:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06062020101526_RPTMarch2020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","30-May-2020 17:52:00","2020-05-30 17:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30052020175235_30052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","28-May-2020 12:37:00","2020-05-28 12:37:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_28052020123700_28052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 387984  Options.","21-May-2020 17:56:00","2020-05-21 17:56:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_21052020175646_Grantintimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Board meeting outcome'.","20-May-2020 17:06:00","2020-05-20 17:06:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20052020170603_IntimationGVPrasad.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.","20-May-2020 13:25:28","2020-05-20 13:25:28","-","-","https://nsearchives.nseindia.com/corporate/SEINTIMATIONFinalQ4FY20_20052020132528.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","20-May-2020 09:19:00","2020-05-20 09:19:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20052020091943_SEIntimation20052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement for transfer of equity shares to IEPF.'.","19-May-2020 18:13:00","2020-05-19 18:13:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_19052020181315_IEPFNotice19052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","16-May-2020 15:36:00","2020-05-16 15:36:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_16052020153606_16052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","13-May-2020 12:21:00","2020-05-13 12:21:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_13052020122121_13052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","08-May-2020 09:15:00","2020-05-08 09:15:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_08052020091509_Intimation08052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Earnings call notification - Q4 and FY20 results'.","07-May-2020 13:08:00","2020-05-07 13:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_07052020130839_PressRelease07052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 06, 2020, titled ""Dr. Reddy's Laboratories received approval for their NDA, ELYXYB  (celecoxib oral solution) 25 mg/mL, in the U.S"".","06-May-2020 17:08:00","2020-05-06 17:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06052020170843_PressRelease06052020II.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 06, 2020, titled ""Dr. Reddy's Laboratories announces the launch of Desmopressin Acetate Injection USP, 4 mcg/mL in the U.S. Market"".","06-May-2020 12:24:00","2020-05-06 12:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06052020122455_PressRelease06052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Credit Rating","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Credit Rating","01-May-2020 18:36:00","2020-05-01 18:36:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01052020183638_IntimationofCreditRating01052020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 27, 2020, titled ""Dr. Reddy's Laboratories announces the launch of Fenofibrate Tablets USP, in the U.S. Market"".","27-Apr-2020 11:42:00","2020-04-27 11:42:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27042020114218_PressRelease27042020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 14, 2020, titled ""Dr. Reddy's Laboratories announces the launchof an authorized generic version of NitroDurￂﾮ (nitroglycerin) Transdermal InfusionSystem in the U.S. Market. "".","14-Apr-2020 13:21:00","2020-04-14 13:21:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14042020132123_PressRelease14042020Nitroglycerine.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 14, 2020, titled ""Dr. Reddy's Laboratories announces the launchof Amphetamine Sulfate Tablets USP, in the U.S. Market"".","14-Apr-2020 13:17:00","2020-04-14 13:17:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14042020131743_PressRelease14042020Amphetamine.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Promoters of Dr. Reddy's Laboratories Limited has informed the Exchange regarding Disclosures under Regulations 30(3) and 31(5) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulations, 2011","13-Apr-2020 12:36:00","2020-04-13 12:36:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_13042020123604_DRREDDY.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","09-Apr-2020 15:54:00","2020-04-09 15:54:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_09042020155415_09042020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding  Board meeting held on March 27, 2020.","27-Mar-2020 11:24:00","2020-03-27 11:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27032020112448_Outcome27032020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 20, 2020, titled ""Dr. Reddy's Laboratories announces the launch ofPyrimethamine Tablets USP, 25 mg, first-wave generic version of Daraprimￂﾮ in the U.S. Market"".","20-Mar-2020 09:07:00","2020-03-20 09:07:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20032020090702_PressRelease20032020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 19, 2020, titled ""Dr. Reddy's Laboratories announces first-to-market launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Single-dose Prefilled Syringe in the U.S. Market"".","19-Mar-2020 11:13:00","2020-03-19 11:13:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_19032020111338_PressRelease19032020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 17, 2020, titled ""Dr. Reddy's Laboratories announces the launch of Ziprasidone Mesylate for Injection in the U.S. Market"".","17-Mar-2020 14:30:00","2020-03-17 14:30:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_17032020143011_PressRelease17032020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'newspaper advertisement'.","14-Mar-2020 22:18:00","2020-03-14 22:18:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14032020221821_StockExchangeIntimationNewspaperAddMarch142020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  8934 Equity Shares under ESOP","12-Mar-2020 13:09:00","2020-03-12 13:09:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12032020130938_ESOPIntimation.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","05-Mar-2020 19:30:00","2020-03-05 19:30:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_05032020193030_05032020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Revised Intimation'.","28-Feb-2020 19:15:00","2020-02-28 19:15:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_28022020191503_IntimationRevised28022020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","28-Feb-2020 14:42:00","2020-02-28 14:42:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_28022020144237_Intimation28022020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 27, 2020, titled ""Dr. Reddy's Laboratories announces the first generic launch of Naproxen and Esomeprazole Magnesium Delayed-Release Tablets in the U.S. Market"".","27-Feb-2020 12:52:00","2020-02-27 12:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27022020125243_PressRelease27022020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","27-Feb-2020 12:10:00","2020-02-27 12:10:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27022020121059_Intimation27022020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","20-Feb-2020 19:36:00","2020-02-20 19:36:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20022020193645_20022020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","16-Feb-2020 13:29:00","2020-02-16 13:29:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_16022020132943_Intimation16022020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","14-Feb-2020 16:57:00","2020-02-14 16:57:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14022020165738_Intimation14022020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 12, 2020, titled ""Dr. Reddy s Laboratories to acquire select business divisions of Wockhardt in India"".","12-Feb-2020 12:28:00","2020-02-12 12:28:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12022020122829_PressRelease12022020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 07, 2020, titled ""Press release issued by our wholly owned subsidiary  Aurigene Discovery Technologies Limited  regarding amendment of collaboration with  Curis, Inc. (Nasdaq: CRIS)  for development and commercialization of CA-170"".","07-Feb-2020 16:17:00","2020-02-07 16:17:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_07022020161726_PressRelease07022020Auri.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 07, 2020, titled ""Dr. Reddy's Laboratories announces the launch ofTrientine Hydrochloride Capsules USP, 250 mg, in the U.S. Market"".","07-Feb-2020 11:42:00","2020-02-07 11:42:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_07022020114251_PressRelease07022020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Filing of form 6K'.","01-Feb-2020 08:34:00","2020-02-01 08:34:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01022020083412_Intimation6K.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","29-Jan-2020 09:24:00","2020-01-29 09:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_29012020092445_29012020.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Unaudited Financial Results for the quarter and nine months ended December 31, 2019 - Advertisement '.","28-Jan-2020 20:52:00","2020-01-28 20:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_28012020204959_Stxintimationnewspaperfinancials_344.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 2400  Options.","27-Jan-2020 16:23:00","2020-01-27 16:23:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27012020162204_GrantJan2020_194.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.","27-Jan-2020 11:52:51","2020-01-27 11:52:51","-","-","https://nsearchives.nseindia.com/corporate/ResultDec2019_27012020115251.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 13, 2020, titled ""Dr. Reddy's Laboratories Limited to present at the 38th Annual J.P. Morgan Healthcare Conference"".","13-Jan-2020 14:55:00","2020-01-13 14:55:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_13012020145458_PressRelease13012020_004.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 10, 2020, titled ""Dr. Reddy's to release Q3 FY 20 results on January 27, 2020  Earnings call slated for January 27, 2020 @ 6:30 PM IST / 8:00 AM EST"".","10-Jan-2020 16:39:00","2020-01-10 16:39:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_10012020163917_PressRelease10012020_014.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Proceedings of Court Convened General Meeting held on January 02, 2020. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.","03-Jan-2020 12:15:00","2020-01-03 12:15:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_03012020121444_OutcomeofNCLTmeeting_005.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  1810 Equity Shares under ESOP","31-Dec-2019 14:30:00","2019-12-31 14:30:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31122019142949_ESOPIntimation_330.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 30, 2019, titled ""Dr. Reddy's Laboratories announces the launch of Sodium Nitroprusside Injection, 50 mg/2 mL (25 mg/mL) Single-dose Vial in the U.S. Market"".","30-Dec-2019 14:15:00","2019-12-30 14:15:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30122019141538_PressRelease30122019_008.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper publication for board meeting '.","27-Dec-2019 14:44:00","2019-12-27 14:44:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27122019144412_BMNewspaperAD_007.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","26-Dec-2019 17:16:00","2019-12-26 17:16:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_26122019171631_BMNotice_011.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 06, 2019, titled ""Dr. Reddy's Laboratories announces the launch of Deferasirox Film-Coated Tablets, in the U.S. Market"".","06-Dec-2019 12:58:00","2019-12-06 12:58:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06122019125541_PressRelease06122019filmcoatedtabs_004.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 06, 2019, titled ""Dr. Reddy's Laboratories announces the launch of Deferasirox Tablets for Oral Suspension, in the U.S. Market"".","06-Dec-2019 12:58:00","2019-12-06 12:58:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06122019125810_PressRelease06122019oraltabs_005.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 04, 2019, titled ""Dr. Reddy's Laboratories announces the launch of Bortezomib for Injection 3.5 mg/vial for Intravenous use only in the U.S. Market"".","04-Dec-2019 11:49:00","2019-12-04 11:49:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_04122019113840_PressRelease04122019_003.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Amalgamation/Merger","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper publication and notice for NCLT convened unsecured creditors meeting","02-Dec-2019 16:59:00","2019-12-02 16:59:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_02122019165931_NewspaperadtoexchangesUnsecuredCreditors_015.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Amalgamation/Merger","Dr. Reddy's Laboratories Limited has informed the Exchange about Newspaper publication and notice for NCLT convened equity shareholder meeting","02-Dec-2019 16:54:00","2019-12-02 16:54:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_02122019165358_NewspaperadtoexchangesEquityShareholders_014.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of Court Covened General Meeting to be held on January 02, 2020","02-Dec-2019 10:08:00","2019-12-02 10:08:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_02122019095024_DrReddy_105.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  15590 Equity Shares under ESOP","29-Nov-2019 17:52:00","2019-11-29 17:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_29112019175142_ESOPIntimation_015.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transactions","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of  Disclosure of Related Party Transactions for the period ended September 30, 2019.","28-Nov-2019 08:24:00","2019-11-28 08:24:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_2811201975839_Sept2019_005.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Amalgamation/Merger","Dr. Reddy's Laboratories Limited has informed the Exchange about Amalgamation/Merger","25-Nov-2019 13:15:00","2019-11-25 13:15:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_25112019131448_Intimation25112019_002.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 22, 2019, titled ""Dr. Reddy's Laboratories announces launch of Doxercalciferol Injection in the U.S. Market"".","22-Nov-2019 14:39:00","2019-11-22 14:39:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_22112019143937_PressRelease22112019_004.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Wockhardt: Cipla, Dr Reddy's Labs, Carlyle & Asian Investment Fund PAG are in the fray to acquire select business segments of the company, said sources..  The response from the Company is attached.","19-Nov-2019 12:44:00","2019-11-19 12:44:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_18112019145541_Replytoclarification18112019_081.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Wockhardt: Cipla, Dr Reddy's Labs, Carlyle & Asian Investment Fund PAG are in the fray to acquire select business segments of the company, said sources..  The response from the Company is awaited.","18-Nov-2019 12:33:00","2019-11-18 12:33:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2019, titled ""Dr. Reddy s Laboratories enters Nutrition Segment with Celevida in India."".","14-Nov-2019 15:10:00","2019-11-14 15:10:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14112019151013_PressRelease14112019_012.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper publication of unaudited financial results for the quarter and half-year ended September 30, 2019'.","04-Nov-2019 16:06:00","2019-11-04 16:06:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_04112019160629_NewspaperAdfinancials04112019_045.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding filing of Form 6K for quarter and half-year ended September 30, 2019'.","01-Nov-2019 22:29:00","2019-11-01 22:29:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01112019222900_PressRelase01112019_022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 7256  Options.","01-Nov-2019 12:04:00","2019-11-01 12:04:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01112019120438_Grant01112019_007.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.","01-Nov-2019 11:25:00","2019-11-01 11:25:00","-","-","https://nsearchives.nseindia.com/corporate/Q2FY20financials_01112019112500.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","26-Oct-2019 15:13:00","2019-10-26 15:13:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_26102019151333_Intimation26102019_024.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","23-Oct-2019 13:07:00","2019-10-23 13:07:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_23102019130741_Intimation23102019_045.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 23, 2019, titled ""Dr. Reddy s confirms its voluntary nationwide recall of allRanitidine products in the U.S. Market"".","23-Oct-2019 12:51:00","2019-10-23 12:51:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_23102019125139_PressRelease23102019_044.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 14, 2019, titled ""Dr. Reddy's to release Q2 FY 20 results on November 1, 2019 Earnings call slated for November 1, 2019 @ 6:30 PM IST / 9:00 AM EDT"".","14-Oct-2019 14:59:00","2019-10-14 14:59:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14102019145439_PressRelease14102019_066.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding ''Further to intimation dated July 12, 2019 with regard to the audit of our API manufacturing plant 2 at Bollaram, Hyderabad, the Company would like to inform that the Company have received the Establishment Inspection Report (EIR) from US FDA, for the above-referred facility, indicating closure of the audit and the inspection classification of this facility is determined as Voluntary Action Initiated (VAI)'","09-Oct-2019 12:06:00","2019-10-09 12:06:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_09102019115002_DRREDDY_068.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Board Meeting notice newspaper advertisement'.","26-Sep-2019 16:49:00","2019-09-26 16:49:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_26092019164858_BoardMeetingnewspaperad_261.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","24-Sep-2019 15:35:00","2019-09-24 15:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_24092019153517_BMIntimation_097.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 16, 2019, titled ""Dr. Reddyￂﾒs announces the launch of over-the-counter, store-brand equivalent of Prevacidￂﾮ 24HR Capsules (Lansoprazole Delayed-Release Capsules USP, 15 mg) in the U.S. Market"".","16-Sep-2019 11:48:00","2019-09-16 11:48:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_16092019114803_PressRelease16092019_076.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","12-Sep-2019 18:51:00","2019-09-12 18:51:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12092019185050_Intimation12092019_138.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 11, 2019, titled ""Dr. Reddy's Laboratories announces the launch of Fosaprepitant for Injection in the U.S. Market"".","11-Sep-2019 14:23:00","2019-09-11 14:23:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_11092019142058_PressRelease11092019_141.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 06, 2019, titled ""Dr. Reddy's Laboratories Limited to present at the Morgan Stanley Annual Global Healthcare Conference"".","06-Sep-2019 17:29:00","2019-09-06 17:29:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06092019172930_PressRelease06092019_321.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  31908 Equity Shares under ESOP","05-Sep-2019 12:46:00","2019-09-05 12:46:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_05092019124551_ESOPIntimation_175.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 05, 2019, titled ""Dr. Reddy's Laboratories announces the launch of Bupropion Hydrochloride Extended-Release Tablets, USP (SR) in the U.S. Market"".","05-Sep-2019 12:37:00","2019-09-05 12:37:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_05092019123624_PressRelease05092019_168.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","20-Aug-2019 19:14:00","2019-08-20 19:14:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20082019191132_Intimation20082019_314.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 20, 2019, titled ""Dr. Reddy's Laboratories announces the launch ofVigabatrin Powder for Oral Solution, USP in the U.S. Market"".","20-Aug-2019 10:55:00","2019-08-20 10:55:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20082019105502_PressRelease20082019_023.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 19, 2019, titled ""Dr. Reddy's Laboratories announcesthe launch of Versavoￂﾮ (bevacizumab biosimilar) in India"".","19-Aug-2019 12:41:00","2019-08-19 12:41:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_19082019123719_PressRelease19082019_134.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Setback For Dr. Reddys As U.S. FDA Hands Out Complete Response Letter For NuvaRing.  The response from the Company is attached.","14-Aug-2019 15:36:00","2019-08-14 15:36:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14082019140159_Response14082019_324.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned Setback For Dr. Reddys As U.S. FDA Hands Out Complete Response Letter For NuvaRing.  The response from the Company is awaited.","14-Aug-2019 11:58:00","2019-08-14 11:58:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","09-Aug-2019 11:22:00","2019-08-09 11:22:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_09082019112211_Intimation_09082019_032.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","01-Aug-2019 11:31:00","2019-08-01 11:31:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01082019113130_Intimation01082019_063.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Director(s)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.","30-Jul-2019 19:25:00","2019-07-30 19:25:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30072019192324_IntimationOG_429.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 30, 2019. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.","30-Jul-2019 19:21:00","2019-07-30 19:21:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30072019192131_AGMOutcome_426.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding filing of Form 6K for Q1FY20 with SEC'.","30-Jul-2019 14:22:00","2019-07-30 14:22:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30072019142055_PressRelease30072096kfiling_140.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 30, 2019, titled ""Dr. Reddy's Laboratories announces the launch of Pregabalin Capsules in the U.S. Market"".","30-Jul-2019 14:12:00","2019-07-30 14:12:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30072019140407_PressRelease30072019_133.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Amalgamation/Merger","Dr. Reddy's Laboratories Limited has informed the Exchange about Amalgamation/Merger","29-Jul-2019 16:35:00","2019-07-29 16:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_29072019163451_IntimationDRHL_300.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Director(s)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.","29-Jul-2019 16:21:00","2019-07-29 16:21:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_29072019162117_IDintimation_286.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 29, 2019, titled ""Intimation regarding change of CEO"".","29-Jul-2019 16:06:00","2019-07-29 16:06:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_29072019160627_CEOintimation_264.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.","29-Jul-2019 15:54:44","2019-07-29 15:54:44","-","-","https://nsearchives.nseindia.com/corporate/Financials_29072019155444.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 23, 2019, titled ""Dr. Reddy's Laboratories announces the launch of Ramelteon Tablets, in the U.S. Market"".","23-Jul-2019 15:05:00","2019-07-23 15:05:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_23072019150503_PressRelease23072019_160.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 20, 2019, titled ""Dr. Reddyￂﾒs Laboratories announces closure of the transaction to divest ZEMBRACEￂﾮ SYMTOUCHￂﾮ and TOSYMRATM to Upsher-Smith Laboratories, LLC"".","20-Jul-2019 13:21:00","2019-07-20 13:21:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20072019132127_PressRelease20072019_038.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 19, 2019, titled ""Dr. Reddyￂﾒs announces the launch of over-the-counter,store-brand equivalent of Allegra-Dￂﾮ 12 HR Allergy and Congestion Extended-Release Tablets (fexofenadine HCl 60 mg and pseudoephedrine HCl 120 mg) in the U.S. Market"".","19-Jul-2019 11:06:00","2019-07-19 11:06:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_19072019110022_PressRelease19072019_028.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","12-Jul-2019 14:29:00","2019-07-12 14:29:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12072019142935_Intimation12072019_116.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 10, 2019, titled ""Dr. Reddy's to release Q1 FY 20 results on July 29, 2019 Earnings call slated for July 29, 6:30 PM IST / 9:00 AM EDT"".","10-Jul-2019 12:23:00","2019-07-10 12:23:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_10072019122237_PressReleases10072019_056.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 09, 2019, titled ""Dr. Reddyￂﾒs announces the launch of the over-the-counter store brand equivalent of Mucinexￂﾮ D Extended Release Tablets in two strengths in the U.S. Marketￂﾔ"".","09-Jul-2019 11:32:00","2019-07-09 11:32:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_09072019113203_PressRelease09072019_043.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper Publication - Notice of AGM and e-voting information'.","08-Jul-2019 12:29:00","2019-07-08 12:29:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_08072019122746_NSPpublicationNoticeAndEvoting_101.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 03, 2019, titled ""Dr. Reddy's Laboratories announces first-to-market launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial in the U.S. Market"".","03-Jul-2019 12:22:00","2019-07-03 12:22:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_03072019122138_PressReleases03072019_065.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement regarding board meeting notice'.","28-Jun-2019 16:44:00","2019-06-28 16:44:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_28062019164438_BMnewspaperadvertisement28062019_447.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  7086 Equity Shares under ESOP","27-Jun-2019 15:54:00","2019-06-27 15:54:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27062019155314_Allotment27062019_165.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 25, 2019, titled ""Dr. Reddy's Laboratories announces the launch of Tobramycin Inhalation Solution, USP in the U.S. Market"".","25-Jun-2019 14:17:00","2019-06-25 14:17:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_25062019141507_PressRelease25062019_137.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 22, 2019, titled ""Dr. Reddy's Laboratories announces the launch ofPhytonadione Injectable Emulsion USP, 10 mg/ml Single-Dose Ampules in the U.S. Market"".","22-Jun-2019 17:39:00","2019-06-22 17:39:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_22062019173858_PressRelease22062019_048.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","22-Jun-2019 17:29:00","2019-06-22 17:29:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_22062019172816_Intimation22062019_047.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 14, 2019, titled ""Dr. Reddyￂﾒs Laboratories announces entering into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLCￂﾔ"".","14-Jun-2019 09:13:00","2019-06-14 09:13:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14062019091318_PressRelease14062019_022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 14, 2019, titled ""Dr. Reddyￂﾒs Laboratories announces entering into a definitive agreement to sell its neurology branded products to Upsher-Smith Laboratories, LLCￂﾔ"".","14-Jun-2019 09:13:00","2019-06-14 09:13:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14062019091318_PressRelease14062019_022.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper Advertisement'.","13-Jun-2019 18:09:00","2019-06-13 18:09:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_13062019180818_NSPpublicationBookClosure_286.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Related Party Transactions","Dr. Reddy's Laboratories Limited has informed the Exchange that Disclosure of related party transactions","12-Jun-2019 19:39:00","2019-06-12 19:39:00","-","-","https://nsearchives.nseindia.com/corporate/janilj_1262019193850_RPT12062019_396.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 12, 2019, titled ""Dr. Reddy's Laboratories Limited to present at theￂﾠGoldman Sachs 40th Annual Global Healthcare Conference"".","12-Jun-2019 12:14:00","2019-06-12 12:14:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12062019121151_PressRelease12062019_067.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  40806 Equity Shares under ESOP","10-Jun-2019 18:24:00","2019-06-10 18:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_10062019182352_ESOPIntimation_306.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 10, 2019, titled ""Dr. Reddy's Laboratories Limited through its wholly owned subsidiary, Dr. Reddyￂﾒs Laboratories SA, announces positive topline results from Phase 2b study of PPC-06 in patients with moderate to severe plaque psoriasis"".","10-Jun-2019 11:22:00","2019-06-10 11:22:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_10062019112138_PressRelease10062019_057.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from July 17, 2019 to July 19, 2019 ( both days inclusive) for the purpose of Annual General Meeting to be held on July 30, 2019 and declaration of final dividend.","07-Jun-2019 12:48:00","2019-06-07 12:48:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_762019123448_Bookclosurenotice_070.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 03, 2019, titled ""Dr. Reddy's Laboratories announces filing of Annual Report on Form 20-F"".","03-Jun-2019 21:55:00","2019-06-03 21:55:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_03062019215405_PressRelease0306201920F_532.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 03, 2019, titled ""Dr. Reddy's Laboratories announces the re-launch of Zenataneￂﾮ (Isotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg in the U.S. Market"".","03-Jun-2019 19:27:00","2019-06-03 19:27:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_03062019192559_PressRelease03062019Iso_498.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","30-May-2019 19:26:00","2019-05-30 19:26:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30052019192511_Intimation30052019_499.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper Publication - Transfer of Equity Shares to IEPF'.","29-May-2019 18:46:00","2019-05-29 18:46:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_29052019184311_DRLNewspaperPublicationIEPF_sw_577.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 360022  Options.","17-May-2019 18:27:00","2019-05-17 18:27:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_17052019182634_Grantofstockoption_452.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 17, 2019, recommended Final Dividend of 20 per equity share.","17-May-2019 15:08:00","2019-05-17 15:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_17052019150732_Q4andFY19financialresults_183.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.","17-May-2019 15:00:38","2019-05-17 15:00:38","-","-","https://nsearchives.nseindia.com/corporate/Q4andFY19financialresults_17052019150038.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 15, 2019, titled ""Dr. Reddy's Laboratories announces the launch ofDaptomycin for Injection, 500mg/vial single-dose vial in the U.S. Market"".","15-May-2019 10:12:00","2019-05-15 10:12:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_15052019101122_PressRelease15052019_036.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","DRREDDY: The Exchange had sought clarification from the Company with respect to news item captioned- titled ""Pharma stocks bleed as US states file lawsuit against generic drug firms"". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company was aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is attached.","14-May-2019 17:06:00","2019-05-14 17:06:00","-","-","https://nsearchives.nseindia.com/corporate/zrizvi_145201917554_14052019replytoclarification_067.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from the Company with respect to news item captioned- titled ""Pharma stocks bleed as US states file lawsuit against generic drug firms"". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company was aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is awaited.","13-May-2019 19:15:00","2019-05-13 19:15:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 06, 2019, titled ""Dr. Reddy's Laboratories announces the launch ofTestosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation) in the U.S. Market"".","06-May-2019 10:28:00","2019-05-06 10:28:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06052019102753_PressRelease06052019_037.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","DRREDDY:ￂﾠThe Exchange had sought clarification from the Company with respect to news item captioned- "" Dr Reddy's gets Chinese regulator nod for anti-blood clotting drug "". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is attached.","25-Apr-2019 16:48:00","2019-04-25 16:48:00","-","-","https://nsearchives.nseindia.com/corporate/zrizvi_2542019164656_Replytoclarification25042019_734.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from the Company with respect to news item captioned- "" Dr Reddy's gets Chinese regulator nod for anti-blood clotting drug "". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is awaited.","25-Apr-2019 06:40:00","2019-04-25 06:40:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'intimation'.","19-Apr-2019 12:24:00","2019-04-19 12:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_19042019122357_Intimation19042019_017.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","The Promoter along with PAC has submitted to the Exchange a copy of Annual Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares and Takeovers), Regulations, 2011 as on March 31, 2019.","18-Apr-2019 14:36:00","2019-04-18 14:36:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_18042019113656_DRREDDYSLABORATORIESLIMITED_154.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 17, 2019, titled ""Dr. Reddy's to release Q4 and full year FY 19 results on May 17, 2019 Earnings call slated for May 17, 6:00 PM IST / 8:30 AM EDT"".","17-Apr-2019 18:48:00","2019-04-17 18:48:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_17042019184626_Pressrelease17042019_115.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'intimation'.","15-Apr-2019 19:34:00","2019-04-15 19:34:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_15042019193247_Intimation_323.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 13, 2019, titled ""Dr. Reddy's Laboratories announces acquisition of ANDA portfolio"".","13-Apr-2019 20:34:00","2019-04-13 20:34:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_13042019203325_PressRelease13042019_058.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement for Board meeting notice'.","05-Apr-2019 18:35:00","2019-04-05 18:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_05042019183454_Newspaperadvertisement_472.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","02-Apr-2019 09:32:00","2019-04-02 09:32:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_02042019093113_Intimation02042019_029.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 02, 2019, titled ""Promius Pharma, LLC. (a wholly owned subsidiary of Dr. Reddyￂﾒs Laboratories Ltd.) announces the sale and assignment of the US rights for its marketed dermatology brands to Encore Dermatology"".","02-Apr-2019 09:00:00","2019-04-02 09:00:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_02042019085938_02042019_005.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Code of Conduct under SEBI(PIT) Reg., 2015","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Code of Conduct under SEBI(PIT) Reg., 2015","29-Mar-2019 18:15:00","2019-03-29 18:15:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_29032019181409_Policyintimation29032019_368.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'intimation'.","29-Mar-2019 18:05:00","2019-03-29 18:05:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_29032019180422_29032019_350.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 27, 2019, titled ""Dr. Reddy's Laboratories launches Tadalafil Tablets USP in the U.S. Market"".","27-Mar-2019 11:42:00","2019-03-27 11:42:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27032019114145_PressRelease27032019_033.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Appointment of Mr Allan Oberman as Non- Executive Independent Director of the company w.e.f. March 26, 2019.","26-Mar-2019 17:08:00","2019-03-26 17:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_26032019170723_AllanObermanAppointmentSEintimation_204.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Postal Ballot. Further, the company has informed the Exchange regarding voting results.","24-Mar-2019 13:31:00","2019-03-24 13:31:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_24032019132924_PostalBallotOutcome2019_068.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","22-Mar-2019 20:31:00","2019-03-22 20:31:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_22032019203052_Intimation22032019USClassaction_248.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","22-Mar-2019 18:35:00","2019-03-22 18:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_22032019183406_Intimation22032019_210.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  5087 Equity Shares under ESOP","14-Mar-2019 11:06:00","2019-03-14 11:06:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_14032019110419_ESOPIntimation_029.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 22, 2019, titled ""Postal Ballot notice-Advertisement"".","22-Feb-2019 13:09:00","2019-02-22 13:09:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_22022019130808_Newspaperintimation_064.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","22-Feb-2019 12:30:00","2019-02-22 12:30:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_22022019122901_Intimation22022019_058.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Postal Ballot Notice'.","21-Feb-2019 09:48:00","2019-02-21 09:48:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_21022019094435_SE21022019_006.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 20, 2019, titled """"Dr. Reddy's Laboratories announces the re-launch ofits Buprenorphine and Naloxone Sublingual Film after favorable ruling in patent litigation"""".","20-Feb-2019 21:40:00","2019-02-20 21:40:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20022019213940_PR20022019_243.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","16-Feb-2019 13:43:00","2019-02-16 13:43:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_16022019134218_PressRelease16022019_042.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 12, 2019, titled ""Dr. Reddy's Laboratories Limited to present at the Edelweiss India Conference 2019."".","12-Feb-2019 17:43:00","2019-02-12 17:43:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12022019174212_PressRelease12022019_366.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 12, 2019, titled ""Dr. Reddy's Laboratories launches Tadalafil Tablets USP in the U.S. Market"".","12-Feb-2019 11:01:00","2019-02-12 11:01:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12022019110012_PressRelease12022019_027.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","08-Feb-2019 17:56:00","2019-02-08 17:56:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_08022019175600_08022019_395.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from the Company with respect to news item captioned- ""US firm names DRL in Price- fixing plaint "". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is attached.","06-Feb-2019 13:05:00","2019-02-06 13:05:00","-","-","https://nsearchives.nseindia.com/corporate/Mchheda_62201913416_Replytoclarification_080.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from the Company with respect to news item captioned- ""US firm names DRL in Price- fixing plaint "". In this regard, you are advised to provide clarification/confirmation on the news item in detail including the following: a) Whether such event stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order. b) The material impact of this article on the Company. c) Whether company are aware of any information that has not been announced to the Exchanges under Regulation 30 of Listing Regulations. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under Regulation 30 of the Listing Regulations. The response from the Company is awaited.","05-Feb-2019 15:06:00","2019-02-05 15:06:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 02, 2019, titled ""Form 6-K for the quarter ended December 31, 2018"".","02-Feb-2019 20:39:00","2019-02-02 20:39:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_02022019203819_PressRelease6K02022019_289.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.","01-Feb-2019 14:43:18","2019-02-01 14:43:18","-","-","https://nsearchives.nseindia.com/corporate/Q3FY19Result_01022019144318.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 2916  Options.","31-Jan-2019 18:19:00","2019-01-31 18:19:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31012019181906_Grantofoptions_382.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Appointment of Mrs Shikha Sanjaya Sharma as Independent Director of the company w.e.f. January 31, 2019.","31-Jan-2019 18:17:00","2019-01-31 18:17:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31012019181607_ShikhaSharmaIntimation31012019_379.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","28-Jan-2019 14:48:00","2019-01-28 14:48:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_28012019144734_Intimation28012019_184.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 28, 2019, titled ""Dr. Reddy's and its US subsidiary, Promius Pharma, announce FDA approval for TOSYMRA (sumatriptan nasal spray) 10mg in the US market"".","28-Jan-2019 08:21:00","2019-01-28 08:21:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_28012019082011_PressRelease28012019_011.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 24, 2019, titled ""Dr. Reddy's Laboratories announces the launch ofPropofol Injectable Emulsion, USP in the U.S. Market"".","24-Jan-2019 11:51:00","2019-01-24 11:51:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_24012019115024_PressRelease24012019_034.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","15-Jan-2019 20:06:00","2019-01-15 20:06:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_15012019200413_15012019_272.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 11, 2019, titled ""Dr. Reddy's to release Q3 FY19 results on February 1, 2019, Earnings call slated for February 1, 6:30 PM IST / 8:00 AM EST"".","11-Jan-2019 13:22:00","2019-01-11 13:22:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_11012019132046_PressRelease11012019_047.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 07, 2019, titled ""Dr. Reddy's Laboratories Limited to present at the 37th Annual J.P. Morgan Healthcare Conference"".","07-Jan-2019 17:17:00","2019-01-07 17:17:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_07012019171651_PressRelease07012019_177.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 27, 2018, titled ""Dr. Reddy's Laboratories announces the launch ofSevelamer Carbonate for Oral Suspension in the U.S. Market"".","27-Dec-2018 11:28:00","2018-12-27 11:28:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27122018112637_PressRelease27122018_015.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 24, 2018, titled ""Press Release"".","24-Dec-2018 11:08:00","2018-12-24 11:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_24122018110621_PressRelease24122018_030.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  15004 Equity Shares under ESOP","15-Dec-2018 20:32:00","2018-12-15 20:32:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_15122018203111_ESOPIntimation_050.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 11, 2018, titled ""Dr. Reddyￂﾒs announces the launch of over-the-counter store brand equivalent of Prilosec OTCￂﾮ  (Omeprazole Delayed-Release) Tablets, 20 mg in the U.S. Market."".","11-Dec-2018 10:29:00","2018-12-11 10:29:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_11122018102843_PressRelease11122018_011.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 28, 2018, titled ""Press Release"".","28-Nov-2018 10:52:00","2018-11-28 10:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_28112018105024_PressRelease28112018_021.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 20, 2018, titled ""Dr. Reddy's Laboratories announces favorable outcome in Buprenorphine and Naloxone Sublingual Film patent litigation "".","20-Nov-2018 23:50:00","2018-11-20 23:50:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_20112018234833_20112018_351.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","16-Nov-2018 18:43:00","2018-11-16 18:43:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_16112018184319_Intimation16112018_638.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","12-Nov-2018 12:18:00","2018-11-12 12:18:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12112018121741_12112018_952.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Updatse'.","02-Nov-2018 19:09:00","2018-11-02 19:09:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_02112018190850_IntimationCTO4_773.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Form 6-K for the quarter ended September 30, 2018, filed with United States Securities and Exchange Commission'.","01-Nov-2018 18:52:00","2018-11-01 18:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01112018184955_Pressrelease6k01112018_043.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 31, 2018, titled ""Dr. Reddy's Laboratories announces the launch ofAtomoxetine Capsules, USP in the U.S. Market"".","31-Oct-2018 11:58:00","2018-10-31 11:58:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31102018115756_PressRelease31102018_061.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","30-Oct-2018 17:35:00","2018-10-30 17:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30102018173421_30102018intimation_273.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.","26-Oct-2018 14:50:05","2018-10-26 14:50:05","-","-","https://nsearchives.nseindia.com/corporate/Q2_26102018145005.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Director(s)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Change in Director(s) of the company.","25-Oct-2018 19:29:00","2018-10-25 19:29:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_25102018192831_PressRelease25102018_865.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reply to Clarification Sought","DRREDDY:The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to announcement dated 15-Oct-2018, regarding regarding a press release dated October 15, 2018, titled ""Dr. Reddy's Laboratories announces the sale of its API manufacturing business unit in Jeedimetla, Hyderabad ""."". On basis of above the Company is required to clarify following: 1. Additionally, in case of a slump sale, indicative disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale.2. Whether the transaction would fall within related party transactions? If yes, whether the same is done at ""arm's length"";3. Brief details of buyers and whether any of the buyers belong to the promoter/ promoter group/group companies. If yes, details thereof.4. Consideration received from such sale/disposal;5. The expected date of completion of sale/disposal;6. Date on which the agreement for sale has been entered into;7. The amount and percentage of the turnover or revenue or income and net worth contributed by such unit or division of the listed entity during the last financial year;The response of the Company is attached.","22-Oct-2018 16:55:00","2018-10-22 16:55:00","-","-","https://nsearchives.nseindia.com/corporate/Mchheda_22102018165455_Replytoclarification22102018_751.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Clarification","DRREDDY:The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to announcement dated 15-Oct-2018, regarding regarding a press release dated October 15, 2018, titled ""Dr. Reddy's Laboratories announces the sale of its API manufacturing business unit in Jeedimetla, Hyderabad ""."". On basis of above the Company is required to clarify following: 1. Additionally, in case of a slump sale, indicative disclosures provided for amalgamation/merger, shall be disclosed by the listed entity with respect to such slump sale.2. Whether the transaction would fall within related party transactions? If yes, whether the same is done at ""arm's length"";3. Brief details of buyers and whether any of the buyers belong to the promoter/ promoter group/group companies. If yes, details thereof.4. Consideration received from such sale/disposal;5. The expected date of completion of sale/disposal;6. Date on which the agreement for sale has been entered into;7. The amount and percentage of the turnover or revenue or income and net worth contributed by such unit or division of the listed entity during the last financial year;The response of the Company is awaited.","19-Oct-2018 20:03:00","2018-10-19 20:03:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 15, 2018, titled ""Dr. Reddy's Laboratories receives approval forAspirin and Extended-Release Dipyridamole Capsules in the U.S. Market"".","15-Oct-2018 14:47:00","2018-10-15 14:47:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_15102018144639_Pressrelease15102018_201.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 15, 2018, titled ""Dr. Reddy's Laboratories announces the sale of itsAPI manufacturing business unit in Jeedimetla, Hyderabad "".","15-Oct-2018 08:43:00","2018-10-15 08:43:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_15102018084232_15102018_097.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 09, 2018, titled ""Dr. Reddy's Laboratories announces the launch ofColesevelam Hydrochloride Tablets in the U.S. Market"".","09-Oct-2018 17:39:00","2018-10-09 17:39:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_09102018173744_PressRelease09102018_119.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 03, 2018, titled ""Earnings call press release"".","03-Oct-2018 17:57:00","2018-10-03 17:57:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_03102018175636_PressRelease03102018_231.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 02, 2018, titled ""Press Release"".","02-Oct-2018 13:24:00","2018-10-02 13:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_02102018132406_02102018_972.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 01, 2018, titled ""Dr. Reddy's Laboratories announces that it hasregained worldwide rights to DF A-02."".","01-Oct-2018 08:56:00","2018-10-01 08:56:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01102018085554_PR3_465.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 01, 2018, titled ""Dr. Reddy's Laboratories announces the sale of itsantibiotic manufacturing site and its related assets in Bristol, Tennessee"".","01-Oct-2018 08:54:00","2018-10-01 08:54:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01102018085357_PR2_463.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 01, 2018, titled ""Dr. Reddy's Laboratories announces the launch ofImatinib Mesylate Tablets, USP in the U.S. Market"".","01-Oct-2018 08:52:00","2018-10-01 08:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01102018085129_PR1_459.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Limited has submitted to the Exchange vide letter dated September 26, 2018 a copy of Disclosure under Regulation 10(6) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.","26-Sep-2018 19:33:00","2018-09-26 19:33:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract3_26092018185400_DR_106_584.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  15977 Equity Shares under ESOP","25-Sep-2018 17:20:00","2018-09-25 17:20:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_25092018171858_ESOPIntimation_182.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 320700  Options.","24-Sep-2018 15:35:00","2018-09-24 15:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_24092018153309_ESOPGrant24092018_231.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Ltd has submitted to the Exchange a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","19-Sep-2018 10:28:00","2018-09-19 10:28:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_19092018101200_Reg30disclosuresFY2018_Redacted_268.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 12, 2018, titled ""Dr. Reddy's Laboratories announces the launch ofNeostigmine Methylsulfate Injection, USP in the U.S. Market"".","12-Sep-2018 16:55:00","2018-09-12 16:55:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12092018165434_12092018PR_433.PDF"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 12, 2018, titled ""Dr. Reddy's Laboratories Limited to present at the Morgan Stanley Annual Global Healthcare Conference"".","12-Sep-2018 11:49:00","2018-09-12 11:49:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_12092018114534_PR12092018_325.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Limited has submitted to the Exchange, vide letter dated September 10, 2018, a copy of disclosure under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","11-Sep-2018 09:12:00","2018-09-11 09:12:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_11092018072629_DRH_REG10_008.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Limited has submitted to the Exchange, vide letter dated September 03, 2018 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","05-Sep-2018 13:23:00","2018-09-05 13:23:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract4_05092018122835_67_DR_216.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy disclosure under regulation 10(5) of SEBI (Substantial Acquisition of Shares and takeovers regulations, 2011)","04-Sep-2018 09:42:00","2018-09-04 09:42:00","-","-","https://nsearchives.nseindia.com/corporate/cdharod_04092018094133_sast_290.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  31046 Equity Shares under ESOP","23-Aug-2018 14:19:00","2018-08-23 14:19:00","-","-","https://nsearchives.nseindia.com/corporate/listcontract1_23082018141356_DRREDDY_664.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","23-Aug-2018 11:46:00","2018-08-23 11:46:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_23082018114413_Intimation23082018_617.pdf"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Limited has submitted to the Exchange, vide letter dated August 13, 2018 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","14-Aug-2018 08:43:00","2018-08-14 08:43:00","-","-","https://nsearchives.nseindia.com/corporate/DRH_Reg10_14082018084345.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 07, 2018, titled ""Form 6-K for the quarter ended June 30, 2018, filed with US SEC"".","07-Aug-2018 11:57:00","2018-08-07 11:57:00","-","-","https://nsearchives.nseindia.com/corporate/Form6K07082018_07082018115754_683.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddyￂﾒs Holdings Limited has submitted to the Exchange a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","07-Aug-2018 10:25:00","2018-08-07 10:25:00","-","-","https://nsearchives.nseindia.com/corporate/DRHL10_05_07082018101754_07082018102454.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 27, 2018. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.","27-Jul-2018 19:52:00","2018-07-27 19:52:00","-","-","https://nsearchives.nseindia.com/corporate/OutcomeAGM27072018_27072018195220_459.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 128260  Options.","27-Jul-2018 19:07:00","2018-07-27 19:07:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPGrantJuly2018_27072018190706_414.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from the Company with respect to news item captioned- AstraZeneca sues DRL on patent. The response from the Company is attached.","27-Jul-2018 08:53:00","2018-07-27 08:53:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_27072018084521_27072018085236_27072018085310.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.","26-Jul-2018 14:55:26","2018-07-26 14:55:26","-","-","https://nsearchives.nseindia.com/corporate/Q1FY19financialsresults_26072018145526.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 26, 2018, titled ""Dr. Reddy's Laboratories announces the launch of Hervyctaￂﾮ (trastuzumab biosimilar) in India"".","26-Jul-2018 09:26:00","2018-07-26 09:26:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease26072018_26072018092608_804.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reply to Clarification Sought","The Exchange had sought clarification from the Company with respect to news item captioned- AstraZeneca sues DRL on patent. In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is attached.","25-Jul-2018 19:46:00","2018-07-25 19:46:00","-","-","https://nsearchives.nseindia.com/corporate/Replytoclarification_25072018194658.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from the Company with respect to news item captioned- AstraZeneca sues DRL on patent In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.","25-Jul-2018 15:51:00","2018-07-25 15:51:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 20, 2018, titled ""Dr. Reddyￂﾒs announces the launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg in the U.S. Market"".","20-Jul-2018 10:58:00","2018-07-20 10:58:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease20072018_20072018105806_012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reply to Clarification Sought","The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to announcement dated 14-Jul-2018, regarding a press release dated July 14, 2018, titled ""Press Release"".On basis of above the Company is required to clarify following:1. Quantum of claims, if any2. Expected financial implications, if any, due to compensation, penalty etc;3. Brief details of litigation viz. name(s) of the opposing party, court/ tribunal/agency where litigation is filed, brief details of dispute/litigation;The response of the Company is attached.","17-Jul-2018 19:43:00","2018-07-17 19:43:00","-","-","https://nsearchives.nseindia.com/corporate/17072018clarification_17072018194316.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Clarification","DRREDDY:The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to announcement dated 14-Jul-2018, regarding "" Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 14, 2018, titled ""Press Release""."".  On basis of above the Company is required to clarify following: 1. Quantum of claims, if any<br> 2. Expected financial implications, if any, due to compensation, penalty etc;<br> 3. Brief details of litigation viz. name(s) of the opposing party, court/ tribunal/agency where litigation is filed, brief details of dispute/litigation;<br>   The response of the Company is awaited.","16-Jul-2018 18:12:00","2018-07-16 18:12:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 14, 2018, titled ""Press Release"".","14-Jul-2018 13:05:00","2018-07-14 13:05:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease14072018_14072018130543_391.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 11, 2018, titled ""Dr. Reddy's Laboratories announces the launch ofHydroxychloroquine Sulfate Tablets, USP in the U.S. Market"".","11-Jul-2018 11:28:00","2018-07-11 11:28:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease11072018_11072018112830_057.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 09, 2018, titled ""Dr. Reddyￂﾒs and UCB India enter into an agreement to co-promote and distribute Briviactￂﾮ for the treatment of Epilepsy in India"".","09-Jul-2018 14:59:00","2018-07-09 14:59:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease09072018_09072018145931_224.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 25606 Equity Shares under ESOP","09-Jul-2018 10:31:00","2018-07-09 10:31:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_09072018103110.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement regarding Notice of 34th Annual General Meeting of the Company and e-voting information'.","05-Jul-2018 18:40:00","2018-07-05 18:40:00","-","-","https://nsearchives.nseindia.com/corporate/Newspaperadvertisement_05072018184026_341.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 05, 2018, titled ""Press Release"".","05-Jul-2018 12:39:00","2018-07-05 12:39:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease05072018_05072018123932_098.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Notice of 34th AGM and Annual Report 2018'.","04-Jul-2018 16:24:00","2018-07-04 16:24:00","-","-","https://nsearchives.nseindia.com/corporate/NoticeofAGMAnnualReport2018_04072018162432_485.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","04-Jul-2018 13:33:00","2018-07-04 13:33:00","-","-","https://nsearchives.nseindia.com/corporate/BMintimation_04072018133352_414.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 02, 2018, titled ""Press Release"".","02-Jul-2018 17:17:00","2018-07-02 17:17:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease02072018_02072018171748_832.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'intimation'.","29-Jun-2018 10:39:00","2018-06-29 10:39:00","-","-","https://nsearchives.nseindia.com/corporate/29062018_29062018103958_038.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","28-Jun-2018 09:05:00","2018-06-28 09:05:00","-","-","https://nsearchives.nseindia.com/corporate/28062018_28062018090534_974.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Dr. Reddyￂﾒs Employees Stock Option Scheme, 2018'.","23-Jun-2018 16:53:00","2018-06-23 16:53:00","-","-","https://nsearchives.nseindia.com/corporate/ApprovalofESOS_23062018165311_032.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 19, 2018, titled ""Dr. Reddy's Laboratories announces the launch ofLevetiracetam in Sodium Chloride Injection in the U.S. Market"".","19-Jun-2018 11:59:00","2018-06-19 11:59:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease19062018_19062018115911_048.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 16, 2018, titled ""As attached"".","16-Jun-2018 10:39:00","2018-06-16 10:39:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease16062018_16062018103931_017.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 16, 2018, titled ""Dr. Reddyￂﾒs Laboratories Limited announces filing of Annual Report on Form 20-F"".","16-Jun-2018 10:25:00","2018-06-16 10:25:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleasefor20Ffiling_16062018102553_016.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 15, 2018, titled ""As attached"".","15-Jun-2018 07:42:00","2018-06-15 07:42:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease15062018_15062018074248_247.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Resignation","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Resignation of Mr Hans Peter Hasler as Independent Director of the company w.e.f. Jun 14, 2018.","14-Jun-2018 16:26:00","2018-06-14 16:26:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation14062018_14062018162658_134.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  43232 Equity Shares under ESOP","12-Jun-2018 16:53:00","2018-06-12 16:53:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation12062018_12062018165341_145.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 09, 2018, titled ""Dr. Reddy's Laboratories Limited to present at the Goldman Sachs 39th Annual Global Healthcare Conference"".","09-Jun-2018 15:29:00","2018-06-09 15:29:00","-","-","https://nsearchives.nseindia.com/corporate/Pressrelease09062018_09062018152923_370.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Results Updates","Dr. Reddy's Laboratories Limited has informed the Exchange that Intimation under Regulation 33(3)(b)(i) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015","08-Jun-2018 16:57:00","2018-06-08 16:57:00","-","-","https://nsearchives.nseindia.com/corporate/CFSIntimation08062018_08062018165752_188.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 05, 2018, titled ""Press Release"".","05-Jun-2018 17:58:00","2018-06-05 17:58:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease05062018_05062018175832_959.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from July 18, 2018 to July 20, 2018(both days inclusive) for the purpose of Annual General Meeting of the Company is scheduled to be held on July 27, 2018 and Dividend","04-Jun-2018 19:46:00","2018-06-04 19:46:00","-","-","https://nsearchives.nseindia.com/corporate/DR_AGMBOOK_04062018194625.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","02-Jun-2018 13:21:00","2018-06-02 13:21:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation02062018_02062018132148_033.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","25-May-2018 17:58:00","2018-05-25 17:58:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation25052018_25052018175805_432.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 127158  Options.","24-May-2018 19:11:00","2018-05-24 19:11:00","-","-","https://nsearchives.nseindia.com/corporate/GrantofstockoptionMay2018_24052018191126_517.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 22, 2018  have recommended a final dividend of Rs. 20/- (400%) per equity share of Rs. 5/- face value for the financial year 2017-18.","22-May-2018 13:45:00","2018-05-22 13:45:00","-","-","https://nsearchives.nseindia.com/corporate/Drreddy_22052018134013.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.","22-May-2018 13:06:06","2018-05-22 13:06:06","-","-","https://nsearchives.nseindia.com/corporate/Q4FY2018Financialresults_22052018130606.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release (Revised)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a revised press release dated April 25, 2018, titled ""Dr. Reddy's to release Q4 and full year FY18 results on May 22, 2018, Earnings call slated for May 22, 6:30 PM IST / 9:00 AM EDT"".","25-Apr-2018 17:41:00","2018-04-25 17:41:00","-","-","https://nsearchives.nseindia.com/corporate/RevisedPressRelease25042018_25042018174139_242.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 25, 2018, titled ""Dr. Reddy's to release Q4 and full year FY18 results on May 22, 2018, Earnings call slated for May 22, 6:30 PM IST / 9:00 AM EDT"".","25-Apr-2018 12:09:00","2018-04-25 12:09:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease25042018_25042018120924_079.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","24-Apr-2018 11:58:00","2018-04-24 11:58:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation24042018_24042018115831_691.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  19089 Equity Shares under ESOP","19-Apr-2018 11:32:00","2018-04-19 11:32:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_19042018113243.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","Promoter of the Company has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","12-Apr-2018 09:24:00","2018-04-12 09:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDYS_12042018092413.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015","10-Apr-2018 20:05:00","2018-04-10 20:05:00","-","-","https://nsearchives.nseindia.com/corporate/BMNotice_10042018200552_437.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'updates'.","10-Apr-2018 11:29:00","2018-04-10 11:29:00","-","-","https://nsearchives.nseindia.com/corporate/10042018_10042018112956_003.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 02, 2018, titled ""As attached"".","02-Apr-2018 12:53:00","2018-04-02 12:53:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleases02042018_02042018125341_198.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 29, 2018, titled ""as attached"".","29-Mar-2018 10:27:00","2018-03-29 10:27:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease29032018_29032018102722_589.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 26, 2018, titled ""Press Release"".","26-Mar-2018 10:05:00","2018-03-26 10:05:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease26032018_26032018100527_038.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","16-Mar-2018 15:04:00","2018-03-16 15:04:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation16032018_16032018150446_341.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 16, 2018, titled ""Dr. Reddy's Laboratories announces the launch ofLevocetirizine Dihydrochloride Tablets USP, 5 mg in the U.S. Market"".","16-Mar-2018 11:24:00","2018-03-16 11:24:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease16032018_16032018112449_283.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  17383 Equity Shares under ESOP","12-Mar-2018 15:03:00","2018-03-12 15:03:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation_12032018150338_633.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation '.","09-Mar-2018 15:19:00","2018-03-09 15:19:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation09032018_09032018151915_341.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Update as attached.'.","25-Feb-2018 16:33:00","2018-02-25 16:33:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation25022018_25022018163348_506.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'updates'.","19-Feb-2018 11:57:00","2018-02-19 11:57:00","-","-","https://nsearchives.nseindia.com/corporate/Update19022018_19022018115757_459.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 05, 2018, titled ""Form 6-K for the quarter ended December 31, 2017, filed with United States Securities and Exchange Commission"".","05-Feb-2018 12:45:00","2018-02-05 12:45:00","-","-","https://nsearchives.nseindia.com/corporate/05022018_05022018124537_193.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 02, 2018, titled ""Dr. Reddy's Laboratories announces the launch ofTetrabenazine Tablets in the U.S. Market"".","02-Feb-2018 11:25:00","2018-02-02 11:25:00","-","-","https://nsearchives.nseindia.com/corporate/Pressreleases02022018_02022018112508_078.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.","25-Jan-2018 11:55:57","2018-01-25 11:55:57","-","-","https://nsearchives.nseindia.com/corporate/Q3FY18financialresults_25012018115557.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","24-Jan-2018 18:51:00","2018-01-24 18:51:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation24012018_24012018185131_487.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has submitted the Exchange a copy Srutinizers report of  Postal Ballot. Further, the company has informed the Exchange regarding voting results.","20-Jan-2018 19:20:00","2018-01-20 19:20:00","-","-","https://nsearchives.nseindia.com/corporate/Postalballotoutcome20012018_20012018192033_894.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 16, 2018, titled ""Dr. Reddy's to release Q3 FY18 results on January 25, 2018 Earnings call slated for January 25, 6.30 PM IST / 8.00 AM EST"".","16-Jan-2018 11:56:00","2018-01-16 11:56:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease16012018_16012018115634_398.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 06, 2018, titled ""Dr. Reddy's Laboratories Limited to present at the 36th Annual J.P. Morgan Healthcare Conference"".","06-Jan-2018 11:11:00","2018-01-06 11:11:00","-","-","https://nsearchives.nseindia.com/corporate/PR06012018_06012018111143_310.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""Dr Reddy's cracks on buzz of issues raised in EIR for Duvvada plant"". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dr. Reddy's Laboratories Limited has submitted their response.","03-Jan-2018 14:37:00","2018-01-03 14:37:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_7252_reply_03012018143740.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""Dr Reddy's cracks on buzz of issues raised in EIR for Duvvada plant"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","03-Jan-2018 13:04:00","2018-01-03 13:04:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  6260 Equity Shares under ESOP","27-Dec-2017 18:50:00","2017-12-27 18:50:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimationDec272017_27122017185004_818.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 26, 2017, titled ""Dr. Reddy's Laboratories announces the launch of Melphalan Hydrochloride for Injection in the U.S. Market."".","26-Dec-2017 14:21:00","2017-12-26 14:21:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease26122017_26122017142147_467.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Newspaper advertisement regarding despatch of postal ballot notice and form'.","21-Dec-2017 15:50:00","2017-12-21 15:50:00","-","-","https://nsearchives.nseindia.com/corporate/Newspaperadvertisement20122017_21122017155050_891.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Despatch of postal ballot notice and form '.","20-Dec-2017 19:37:00","2017-12-20 19:37:00","-","-","https://nsearchives.nseindia.com/corporate/DespatchIntimation20122017_20122017193700_757.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 19, 2017, titled ""Dr. Reddyￂﾒs announces it has reached a settlement with the US Government regarding companyￂﾒs compliance with the Consumer Product Safety Act"".","19-Dec-2017 08:26:00","2017-12-19 08:26:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease19122017_19122017082654_334.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""Aurobindo, DRL lead race to buy orchid"". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dr. Reddy's Laboratories Limited has submitted their response.","18-Dec-2017 14:47:00","2017-12-18 14:47:00","-","-","https://nsearchives.nseindia.com/corporate/NSE_clarification_18122017144730.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""Aurobindo, DRL lead race to buy orchid"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and  b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","18-Dec-2017 12:11:00","2017-12-18 12:11:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Amendments to ESOP schemes'.","11-Dec-2017 20:35:00","2017-12-11 20:35:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation11122017_11122017203548_357.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation'.","11-Dec-2017 20:20:00","2017-12-11 20:20:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation11122017_11122017202029_354.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding receipt of EIR.'.","01-Dec-2017 15:54:00","2017-12-01 15:54:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation_01122017155454_554.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 01, 2017, titled ""Dr. Reddyￂﾒs Announces Approval of Impoyzￂﾙ (clobetasol propionate) Cream, 0.025% First-Cycle NDA Approval"".","01-Dec-2017 09:56:00","2017-12-01 09:56:00","-","-","https://nsearchives.nseindia.com/corporate/PR_01122017095655_366.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation '.","30-Nov-2017 13:44:00","2017-11-30 13:44:00","-","-","https://nsearchives.nseindia.com/corporate/Update30112017_30112017134440_114.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Update'.","29-Nov-2017 12:11:00","2017-11-29 12:11:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation29112017_29112017121140_600.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Receipt of EIR from USFDA '.","21-Nov-2017 10:15:00","2017-11-21 10:15:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation21112017_21112017101506_886.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 14, 2017, titled ""Dr. Reddy's Laboratories announces the launch of Clofarabine Injection in the U.S. Market"".","14-Nov-2017 13:12:00","2017-11-14 13:12:00","-","-","https://nsearchives.nseindia.com/corporate/PR14112017_14112017131253_612.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'This is to inform you that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended September 30, 2017, with the United States Securities and Exchange Commission on November 8, 2017. '.","09-Nov-2017 08:57:00","2017-11-09 08:57:00","-","-","https://nsearchives.nseindia.com/corporate/6k09112017_09112017085724_497.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 02, 2017, titled ""Dr. Reddy's Laboratories announces the launch ofgeneric Azacitidine for Injection in the Canadian Market."".","02-Nov-2017 19:18:00","2017-11-02 19:18:00","-","-","https://nsearchives.nseindia.com/corporate/PR02112017_02112017191835_764.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.","31-Oct-2017 11:26:36","2017-10-31 11:26:36","-","-","https://nsearchives.nseindia.com/corporate/ResultQ2FY18_31102017112636.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Appointment of Mr. Prasad R Menon as an Additional Director, categorized as Independent, on the Board of the Company.'.","30-Oct-2017 16:00:00","2017-10-30 16:00:00","-","-","https://nsearchives.nseindia.com/corporate/Appointment_30102017160023_176.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 16, 2017, titled ""Dr. Reddy's to release Q2 FY18 results on October 31, 2017 Earnings call slated for October 31, 6.30 PM IST / 9.00 AM EDT"".","16-Oct-2017 18:29:00","2017-10-16 18:29:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease16102017_16102017182901_742.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 7987 securities pursuant to ESOP/ESPS at its meeting held on October 12, 2017","12-Oct-2017 13:48:00","2017-10-12 13:48:00","-","-","https://nsearchives.nseindia.com/corporate/Drreddy3_12102017134826.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Ltd has submitted to the Exchange, vide letter dated October 05, 2017 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","05-Oct-2017 10:56:00","2017-10-05 10:56:00","-","-","https://nsearchives.nseindia.com/corporate/0837_10_05102017105602.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 29, 2017, titled ""Dr. Reddy's Laboratories announces the launch of Sevelamer Carbonate Tablets in the U.S. Market"".","29-Sep-2017 21:42:00","2017-09-29 21:42:00","-","-","https://nsearchives.nseindia.com/corporate/29092017_29092017214227_386.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 28, 2017, titled ""Intimation"".","28-Sep-2017 10:23:00","2017-09-28 10:23:00","-","-","https://nsearchives.nseindia.com/corporate/28092017_28092017102332_039.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Ltd has submitted to the Exchange, vide letter dated September 26, 2017 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","26-Sep-2017 15:38:00","2017-09-26 15:38:00","-","-","https://nsearchives.nseindia.com/corporate/0801_001_26092017153825.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of Equity Shares on exercise of ESOP.","21-Sep-2017 18:56:00","2017-09-21 18:56:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation_21092017185641.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding audit by USFDA of our Custom Pharmaceutical Services (CPS) facility, Technology Development Centre (TDC-1) at Miyapur, Hyderabad'.","21-Sep-2017 12:21:00","2017-09-21 12:21:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation21092017Miyapur_21092017122107_072.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation regarding audit of our Formulation Srikakulam Plant (SEZ) Unit II, Andhra Pradesh, '.","21-Sep-2017 10:03:00","2017-09-21 10:03:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation21092017_21092017100342_029.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Audit of our API Mirfield Plant, United Kingdom, by the US FDA'.","15-Sep-2017 20:42:00","2017-09-15 20:42:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation15092017_15092017204259_634.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 12, 2017, titled "" Aurigene Discovery Technologies Limited, a wholly owned subsidiary of Dr Reddy s Laboratories Limited, and Curis Inc., announce CA-170 program update following data presented at ESMO 2017.  "".","12-Sep-2017 17:52:00","2017-09-12 17:52:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease12092017aurigene_12092017175222_311.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 12, 2017, titled ""Please find enclosed a Press Release on  Dr. Reddy's Laboratories Limited to present at the Morgan Stanley Annual Global Healthcare Conference. "".","12-Sep-2017 17:44:00","2017-09-12 17:44:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease12092017morgan_12092017174432_305.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'Intimation on audit '.","08-Sep-2017 11:01:00","2017-09-08 11:01:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease08092017_08092017110104_089.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 06, 2017, titled ""Press Releases"".","06-Sep-2017 11:32:00","2017-09-06 11:32:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleases06092017_06092017113211_022.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""Dr Reddy's settles patent row with Vivus"". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dr. Reddy's Laboratories Limited has submitted their response.","01-Sep-2017 14:48:00","2017-09-01 14:48:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_6955_reply_01092017144856.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 01, 2017, titled ""Intimation about judgment issued by the United States District Court, for the District of Delaware"".","01-Sep-2017 12:53:00","2017-09-01 12:53:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation01092017_01092017125337_073.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""Dr Reddy's settles patent row with Vivus"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","01-Sep-2017 10:45:00","2017-09-01 10:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 28, 2017, titled ""Dr. Reddy's Laboratories announces the launch ofCefixime for Oral Suspension, USP in the U.S. Market"".","28-Aug-2017 11:31:00","2017-08-28 11:31:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease28082017_28082017113157_014.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding 'U.S. Securities Class Action Lawsuit Filed'.","28-Aug-2017 10:26:00","2017-08-28 10:26:00","-","-","https://nsearchives.nseindia.com/corporate/28082017_28082017102624_009.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy s Holdings Ltd. has submitted to the Exchange, vide letter dated August 22, 2017 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","22-Aug-2017 16:26:00","2017-08-22 16:26:00","-","-","https://nsearchives.nseindia.com/corporate/Drreddys_10_22082017162612.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 22, 2017, titled ""Dr. Reddy s Laboratories announces the out-licensing of DFD-06 to Encore Dermatology"".","22-Aug-2017 10:11:00","2017-08-22 10:11:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease22082017_22082017101126_625.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  36215 Equity Shares under ESOP","21-Aug-2017 15:02:00","2017-08-21 15:02:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation21082017_21082017150233_454.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Ltd has submitted to the Exchange, vide letter dated August 11, 2017 a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","11-Aug-2017 17:43:00","2017-08-11 17:43:00","-","-","https://nsearchives.nseindia.com/corporate/Reg30disclosuresFY2015_11082017174241.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange that Intimation regarding betapharm Arzneimittel GmbH, Germany (our wholly-owned subsidiary) .","10-Aug-2017 14:42:00","2017-08-10 14:42:00","-","-","https://nsearchives.nseindia.com/corporate/10082017intimation_10082017144246_942.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 09, 2017, titled ""Form 6-K for the quarter ended June 30, 2017, filed with United States Securities Exchange Commission"".","09-Aug-2017 13:07:00","2017-08-09 13:07:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleases09082017_09082017130719_164.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 28, 2017. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results.","28-Jul-2017 18:17:00","2017-07-28 18:17:00","-","-","https://nsearchives.nseindia.com/corporate/OutcomeAGM28072017_28072017181753_463.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 27, 2017, titled ""Please find enclosed a Press Release on  Dr. Reddy s and CHD Bioscience Announce Global License and Commercialization Agreement for Phase III Clinical Trial Candidate for Mitigation of Surgical Site Infections ."".","27-Jul-2017 16:21:00","2017-07-27 16:21:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease27072017_27072017162100_327.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended June 30, 2017.","27-Jul-2017 14:26:43","2017-07-27 14:26:43","-","-","https://nsearchives.nseindia.com/corporate/Q1FY18Outcome_27072017142643.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange that the audit of API Cuernavaca Plant at Mexico, by the US FDA, has been completed with zero observations.","21-Jul-2017 11:05:00","2017-07-21 11:05:00","-","-","https://nsearchives.nseindia.com/corporate/Announcement21072017_21072017110558_048.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 14, 2017, titled ""Dr. Reddy's to release Q1 FY18 results on July 27, 2017. Earnings call slated for July 27, 6.30 PM IST / 9.00 AM EDT.  "".","14-Jul-2017 16:33:00","2017-07-14 16:33:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease14072017_14072017163318_217.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 6400  Options to an employee.","11-Jul-2017 20:10:00","2017-07-11 20:10:00","-","-","https://nsearchives.nseindia.com/corporate/Grant11072017_11072017201010_861.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting (AGM) and Annual Report 2016-17 .","05-Jul-2017 19:40:00","2017-07-05 19:40:00","-","-","https://nsearchives.nseindia.com/corporate/AR201617_05072017194011_203.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Shareholders meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 28, 2017","05-Jul-2017 19:40:00","2017-07-05 19:40:00","-","-","https://nsearchives.nseindia.com/corporate/Nsp_05072017194012_204.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Trading Window.","04-Jul-2017 19:55:00","2017-07-04 19:55:00","-","-","https://nsearchives.nseindia.com/corporate/BMNotice_04072017195550_164.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 18739 Equity Shares under ESOP","04-Jul-2017 15:25:00","2017-07-04 15:25:00","-","-","https://nsearchives.nseindia.com/corporate/EsopIntimation03072017_04072017152505.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of Equity Shares on exercise of ESOP.","20-Jun-2017 14:15:00","2017-06-20 14:15:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation20062017_20062017141542.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 20, 2017, titled "" Dr. Reddy s Laboratories Limited announces filing of Annual Report on Form 20-F for FY2017 ."".","20-Jun-2017 11:07:00","2017-06-20 11:07:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease20062017_20062017110706_315.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 16, 2017, titled ""Intimation on completion of USFDA audit"".","16-Jun-2017 18:10:00","2017-06-16 18:10:00","-","-","https://nsearchives.nseindia.com/corporate/16062017_16062017181052_673.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from the Company with respect to news item captioned ""Dr Reddy's recalls 3.25L cartons Cipla-made acne drug from US"". The response from the Company is attached.","15-Jun-2017 11:35:00","2017-06-15 11:35:00","-","-","https://nsearchives.nseindia.com/corporate/Replytoclarification15062017_15062017113503_181.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from the Company with respect to news item captioned ""Dr Reddy's recalls 3.25L cartons Cipla-made acne drug from US"". In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.","14-Jun-2017 17:48:00","2017-06-14 17:48:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange vide letter dated June 13, 2017 that ""This is in reference to our intimation dated February 21,2017 with regard to the audit of our API manufacturing plant at Miryalaguda, by the US FDA, wherein we were issued a form 483 with three observations. In this regard, we would now like to inform you that we have received an Establishment Inspection Report (EIR) from the US FDA today as closure of audit, for the above-referred facility.""","14-Jun-2017 08:22:00","2017-06-14 08:22:00","-","-","https://nsearchives.nseindia.com/corporate/13June2017_14062017082242_857.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Transfer of Equity shares to IEPF.","09-Jun-2017 18:14:00","2017-06-09 18:14:00","-","-","https://nsearchives.nseindia.com/corporate/IEPFnoticeJune92017_09062017181423_258.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 06, 2017, titled ""Dr. Reddy's Laboratories announces the launch of Bivalirudin for Injection in the U.S. Market"".","06-Jun-2017 11:19:00","2017-06-06 11:19:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease06062017_06062017111920_080.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated Jun 05, 2017, titled ""Dr. Reddy's Laboratories Limited to present at the Jefferies 2017 Global Healthcare Conference"".","05-Jun-2017 18:35:00","2017-06-05 18:35:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleases01062017_05062017183502_637.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of 46634 Equity Shares under ESOP","02-Jun-2017 16:48:00","2017-06-02 16:48:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation_02062017164825.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from July 19, 2017 to July 21, 2017(both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the Annual General Meeting, scheduled to be held on July 28, 2017.","01-Jun-2017 15:27:00","2017-06-01 15:27:00","-","-","https://nsearchives.nseindia.com/corporate/AGMBookClosure2017_01062017152754_670.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange that the audit of Company Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh by the US FDA, has been completed on May 25, 2017 with zero observations.","25-May-2017 17:53:00","2017-05-25 17:53:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation_25052017175322_193.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 17, 2017, titled ""Dr. Reddy's Laboratories announces USFDA approval for the launch of Doxorubicin Hydrochloride Liposome Injection in the U.S. Market."".","17-May-2017 12:46:00","2017-05-17 12:46:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease17052017_17052017124625_208.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Grant of 214516  Options. This is to inform you that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 11, 2017, has granted 151,212 stock options, exercisable at par value of Rs.5/- under  Dr. Reddy s Employees Stock Option Scheme, 2002  and 63,304 stock options, exercisable at par value of Rs.5/- under  Dr. Reddy s Employees ADR Stock Option Scheme, 2007  to the employees of the Company.This is for your information and records.","12-May-2017 18:29:00","2017-05-12 18:29:00","-","-","https://nsearchives.nseindia.com/corporate/GrantofStockOptions2017_12052017182902_507.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that Board of Directors at its meeting held on May 12, 2017, recommended Final Dividend of Rs. 20 per equity share.","12-May-2017 13:21:00","2017-05-12 13:21:00","-","-","https://nsearchives.nseindia.com/corporate/FY2017Results_12052017132150_172.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2017.","12-May-2017 13:10:50","2017-05-12 13:10:50","-","-","https://nsearchives.nseindia.com/corporate/FY2017Results_12052017131050.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 28, 2017, titled ""This is to inform you that the audit of our Formulations Manufacturing Plant   3 at Bachupally, Hyderabad by the US FDA, has been completed today. We have been issued a Form 483 with 11 observations. These observations are mostly procedural in nature, reflecting the need to improve people capabilities and strengthen documentation and laboratory systems. We will address them comprehensively within the stipulated time. "".","28-Apr-2017 19:18:00","2017-04-28 19:18:00","-","-","https://nsearchives.nseindia.com/corporate/28042017_28042017191818_447.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 27, 2017, titled ""Dr. Reddy's Laboratories announces the launch of Ezetimibe and Simvastatin Tablets in the U.S. Market."".","27-Apr-2017 10:08:00","2017-04-27 10:08:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease27042017_27042017100852_011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 25, 2017, titled ""Please find enclosed a Press Release on  Dr. Reddy's to release Q4 and Full Year FY17 results on May 12, 2017 Earnings call slated for May 12, 6.00 PM IST / 8.30 AM EDT. "".","25-Apr-2017 14:37:00","2017-04-25 14:37:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease25042017_25042017143720_177.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 21, 2017, titled ""Dr. Reddy's Laboratories announces the launch ofProgesterone Capsules in the U.S. Market"".","21-Apr-2017 18:34:00","2017-04-21 18:34:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease21042017_21042017183441_397.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 14, 2017, titled ""Intimation"". Audit of our API Srikakulam Plant (SEZ) Andhra Pradesh by USFDA has been completed today with no observations","14-Apr-2017 18:58:00","2017-04-14 18:58:00","-","-","https://nsearchives.nseindia.com/corporate/14042017_14042017185811_790.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","Satish Reddy has submitted to the Exchange a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011","12-Apr-2017 11:33:00","2017-04-12 11:33:00","-","-","https://nsearchives.nseindia.com/corporate/DrReaddy_30_12042017113357.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has submitted the Exchange a Copies of Newspaper advertisement dated April 8, 2017 regarding transfer of equity shares to IEPF.","10-Apr-2017 19:02:00","2017-04-10 19:02:00","-","-","https://nsearchives.nseindia.com/corporate/Newspaperadtoexchanges_10042017190229_318.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 04, 2017, titled ""Intimation"" regarding completion of audit by  USFDA.","04-Apr-2017 19:31:00","2017-04-04 19:31:00","-","-","https://nsearchives.nseindia.com/corporate/04042017_04042017193107_175.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned  USFDA started Srikakulam inspection on march 27. No major observation from USFDA yet on Srikakulam plant. . The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dr. Reddy's Laboratories Limited has submitted their response.","03-Apr-2017 15:43:00","2017-04-03 15:43:00","-","-","https://nsearchives.nseindia.com/corporate/Replytoclarification03042017_03042017154333.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned USFDA started Srikakulam inspection on march 27. No major observation from USFDA yet on Srikakulam plant. . In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","03-Apr-2017 15:02:00","2017-04-03 15:02:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 27, 2017, titled ""Dr. Reddy s and Integra LifeSciences enter into an agreement to market and distribute DuraGen Plus  and Suturable DuraGen  Dural Regeneration in India."".","27-Mar-2017 12:24:00","2017-03-27 12:24:00","-","-","https://nsearchives.nseindia.com/corporate/pressrelease27032017_27032017122422_400.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""US FDA finds repeat observations from 2015 warning letter. Failed to maintain complete data to ensure compliance."". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dr. Reddy's Laboratories Limited has submitted their response.","21-Mar-2017 12:30:00","2017-03-21 12:30:00","-","-","https://nsearchives.nseindia.com/corporate/Replytoclarification21032017_21032017123058.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""US FDA finds repeat observations from 2015 warning letter. Failed to maintain complete data to ensure compliance."" In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","21-Mar-2017 10:41:00","2017-03-21 10:41:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  8973 Equity Shares under ESOP","14-Mar-2017 14:48:00","2017-03-14 14:48:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation12032017_14032017144822_997.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 08, 2017, titled ""Intimation regarding completion of audit of our formulation manufacturing facility at Duvvada, Visakhapatnam, by the US FDA."".","08-Mar-2017 19:43:00","2017-03-08 19:43:00","-","-","https://nsearchives.nseindia.com/corporate/Intimation08032017_08032017194357_674.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reply to Clarification Sought","DRREDDY:The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to announcement dated March 03, 2017, regarding a press release dated March 03, 2017, titled ""Dr. Reddy's Laboratories announces acquisition of 100% stake in Imperial Credit Private Limited, a Non-Banking Finance Company (NBFC). On basis of above the Company was required to clarify following: 1. Name of the target entity, details in brief such as size, turnover etc;2. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at ""arm's length"";3. Brief details of any governmental or regulatory approvals required for the acquisition;4. Indicative time period for completion of the acquisition;5. Nature of consideration - whether cash consideration or share swap and details of the same;6. Percentage of shareholding / control acquired and / or number of shares acquired;7. Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief).The response of the Company is attached.","06-Mar-2017 15:58:00","2017-03-06 15:58:00","-","-","https://nsearchives.nseindia.com/corporate/Clarification06032017_06032017155856_400.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Clarification","DRREDDY:The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to announcement dated March 03, 2017, regarding a press release dated March 03, 2017, titled ""Dr. Reddy's Laboratories announces acquisition of 100% stake in Imperial Credit Private Limited, a Non-Banking Finance Company (NBFC). On basis of above the Company is required to clarify following: 1. Name of the target entity, details in brief such as size, turnover etc;2. Whether the acquisition would fall within related party transactions and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at ""arm's length"";3. Brief details of any governmental or regulatory approvals required for the acquisition;4. Indicative time period for completion of the acquisition;5. Nature of consideration - whether cash consideration or share swap and details of the same;6. Percentage of shareholding / control acquired and / or number of shares acquired;7. Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief).The response of the Company is awaited.","06-Mar-2017 11:01:00","2017-03-06 11:01:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 03, 2017, titled ""Dr. Reddy's Laboratories announces acquisition of 100% stake in Imperial Credit Private Limited, a Non-Banking Finance Company (NBFC)"".","03-Mar-2017 20:01:00","2017-03-03 20:01:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease03032017_03032017200100_159.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange ""The audit of  API manufacturing plant at Miryalaguda, by the US FDA, has been completed on February 21, 2017. We have been issued a Form 483 with three observations, which we are addressing""","21-Feb-2017 18:32:00","2017-02-21 18:32:00","-","-","https://nsearchives.nseindia.com/corporate/21022017_21022017183214_564.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reply to Clarification Sought","DRREDDY:The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to announcement dated 16-Feb-2017, regarding a press release dated February 16, 2017, titled ""Dr. Reddy's announces US district court's opinion relating to patent infringement.""On basis of above the Company is required to clarify following: 1. Expected financial implications, if any, due to compensation, penalty etc;2. Quantum of claims, if anyThe response of the Company is attached.","17-Feb-2017 12:48:00","2017-02-17 12:48:00","-","-","https://nsearchives.nseindia.com/corporate/Clarification17022017_17022017124842_494.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Clarification","DRREDDY:The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to announcement dated 16-Feb-2017, regarding a press release dated February 16, 2017, titled ""Dr. Reddy's announces US district court's opinion relating to patent infringement.""On basis of above the Company is required to clarify following: 1. Expected financial implications, if any, due to compensation, penalty etc;2. Quantum of claims, if anyThe response of the Company is awaited.","16-Feb-2017 20:09:00","2017-02-16 20:09:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 16, 2017, titled ""Dr. Reddy's announces US district court's opinion relating to patent infringement"".","16-Feb-2017 09:32:00","2017-02-16 09:32:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease16022017_16022017093232_050.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 13, 2017, titled ""Form 6-K for the quarter ended December 31, 2016, filed with United States Securities Exchange Commission"".","13-Feb-2017 13:42:00","2017-02-13 13:42:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease13022017_13022017134221_190.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2016.","04-Feb-2017 13:45:04","2017-02-04 13:45:04","-","-","https://nsearchives.nseindia.com/corporate/Q3FY17financialresults_04022017134504.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from the Company with respect to recent news item captioned  Korean Company files suit against DRL The response from the Company is enclosed.","27-Jan-2017 15:22:00","2017-01-27 15:22:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease27012017_27012017152237_338.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from the Company with respect to recent news item captioned  Korean Company files suit against DRL In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.","27-Jan-2017 12:31:00","2017-01-27 12:31:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 23, 2017, titled ""Dr. Reddy's Q3-FY17 Earnings Call Notification"".Dr. Reddy's to release Q3 FY17 results on Feb 4, 2017  Earnings call slated for Feb 4, 6.30 PM IST / 8.00 AM EST","23-Jan-2017 11:24:00","2017-01-23 11:24:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleases23012017_23012017112453_188.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Limited has submitted to the Exchange, vide letter dated January 16, 2017 a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 f SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","16-Jan-2017 17:20:00","2017-01-16 17:20:00","-","-","https://nsearchives.nseindia.com/corporate/DRHL_10_16012017172026.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""FDA to re-audit three Dr.Reddy's Labs plants"". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dr. Reddy's Laboratories Limited has submitted their response.","12-Jan-2017 13:37:00","2017-01-12 13:37:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_6589_reply_12012017133736.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""FDA to re-audit three Dr.Reddy's Labs plants"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","12-Jan-2017 10:38:00","2017-01-12 10:38:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 09, 2017, titled ""Dr. Reddy's Laboratories Limited to present at the J.P. Morgan 35th Annual Healthcare Conference"".","09-Jan-2017 18:29:00","2017-01-09 18:29:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease09012017_09012017182904_453.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Limited has submitted to the Exchange, vide letter dated January 06, 2017 a copy of disclosure under Regulation 10(5) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","06-Jan-2017 18:35:00","2017-01-06 18:35:00","-","-","https://nsearchives.nseindia.com/corporate/02.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  6105 Equity Shares under ESOP","06-Jan-2017 12:20:00","2017-01-06 12:20:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation05012017_06012017122045_162.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of ESOP/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of  15850 Equity Shares under ESOP","05-Dec-2016 11:42:00","2016-12-05 11:42:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation_05122016114212_062.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 05, 2016, titled ""Dr. Reddy's Laboratories announces the launch ofNystatin and Triamcinolone Acetonide Cream, USP in the U.S. Market"".","05-Dec-2016 11:07:00","2016-12-05 11:07:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease05122016_05122016110731_036.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company vide a circular resolution passed on November 15, 2016, has granted 496 stock options, exercisable at par value of Rs.5/- under ''Dr. Reddy s Employees Stock Option Scheme, 2002 to an employee of the Company''.","16-Nov-2016 12:19:00","2016-11-16 12:19:00","-","-","https://nsearchives.nseindia.com/corporate/Grantof496stockoptions_16112016121902_070.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Form 6-K for the quarter ended September 30, 2016, filed with the United States Securities Exchange Commission","11-Nov-2016 14:50:00","2016-11-11 14:50:00","-","-","https://nsearchives.nseindia.com/corporate/11112016_11112016145043_841.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 11, 2016, titled ""Dr. Reddy's Laboratories announces the launch ofRaloxifene HCl Tablets, USP in the U.S. Market"".","11-Nov-2016 14:27:00","2016-11-11 14:27:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease11112016_11112016142748_807.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2016.","07-Nov-2016 13:15:21","2016-11-07 13:15:21","-","-","https://nsearchives.nseindia.com/corporate/Q2FY17financialresults_07112016131521.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 26, 2016 titled ""Dr. Reddy's Laboratories announces new strategic deal with Gland Pharma in the U.S. Market"".","26-Oct-2016 17:46:00","2016-10-26 17:46:00","-","-","https://nsearchives.nseindia.com/corporate/Pressreleases26102016_26102016174624_146.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Results Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange a Copy of Unaudited Financial Results for the quarter ended September 30, 2016.","25-Oct-2016 11:34:00","2016-10-25 11:34:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_B_25102016113449.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 14, 2016 titled "" Dr. Reddy's to release Q2 FY17 results on October 25, 2016, Earnings call slated for October 25, 6.30 PM IST / 9.00 AM EDT."".","14-Oct-2016 18:02:00","2016-10-14 18:02:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleases14102016_14102016180225_304.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 13, 2016 titled ""Dr. Reddy's Laboratories announces the launch of Aripiprazole tablets, USP tablets in the U.S. Market"".","13-Oct-2016 11:44:00","2016-10-13 11:44:00","-","-","https://nsearchives.nseindia.com/corporate/Pressrelease13102016_13102016114458_092.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 10, 2016 titled ""Dr. Reddy's Laboratories announces the launch of Lamotrigine Orally Disintegrating Tablets in the U.S. Market"".","10-Oct-2016 17:01:00","2016-10-10 17:01:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease10102016_10102016170121_422.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 7,  2016  titled ""Leading global pharmaceutical company, Dr. Reddys Laboratories now in Colombia"".","07-Oct-2016 18:44:00","2016-10-07 18:44:00","-","-","https://nsearchives.nseindia.com/corporate/Pressreleases07102016_07102016184414_670.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange that Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 13,188 equity shares of Rs.5/- each of the Company, fully paid up, on September 22, 2016, to Employee on exercise of the Stock Options.","23-Sep-2016 11:39:00","2016-09-23 11:39:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation22092016_23092016113958_096.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance and Compensation Committee vide a circular resolution dated September 20, 2016 has granted 292 stock options, exercisable at par value of Rs. 5/- under ""Dr. Reddy's Employee Stock Option Scheme, 2002"" to an employee of the Company.","21-Sep-2016 13:31:00","2016-09-21 13:31:00","-","-","https://nsearchives.nseindia.com/corporate/4431_001_21092016133158_152.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 19 , 2016 titled ""Dr. Reddy's Laboratories announces the launch of Paricalcitol Injection in the U.S. Market"".","19-Sep-2016 17:21:00","2016-09-19 17:21:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleases19092016_19092016172125_564.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 16, 2016, titled ""Dr. Reddy''s Expands Strategic Collaboration with Amgen in India"".","16-Sep-2016 14:12:00","2016-09-16 14:12:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleases16092016_16092016141223_625.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 13, 2016, titled ""Dr Reddy s listed on Dow Jones Sustainability Indices 2016"".","14-Sep-2016 08:27:00","2016-09-14 08:27:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease13092016_14092016082748_784.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding press release dated September 02, 2016 titled "" Dr. Reddy's Laboratories announces the launch of Bupropion HCl Extended-Release Tablets, USP (SR) in the U.S. Market .""","02-Sep-2016 19:59:00","2016-09-02 19:59:00","-","-","https://nsearchives.nseindia.com/corporate/Pressrelease02092016_02092016195926_785.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limitedhas informed the Exchange regarding a press release dated September 1, 2016 titled ""Dr. Reddy s announces Purple Health, a unique patient-centric platform that takes care beyond the pill"".","01-Sep-2016 11:50:00","2016-09-01 11:50:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease01092016_01092016115056_189.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 29, 2016 titled ""Dr. Reddy's Laboratories launches Nitroglycerin sublingual tablets USP in the U.S. Market"".","29-Aug-2016 12:16:00","2016-08-29 12:16:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease29082016_29082016121640_378.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Allotment of Equity Shares on exercise of ESOP.","22-Aug-2016 18:43:00","2016-08-22 18:43:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation22082016_22082016184306_834.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange that Dr. Reddy s completes acquisition of product portfolio from TEVA","04-Aug-2016 08:03:00","2016-08-04 08:03:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease03082016_04082016080335_003.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Regulation 44(3) of SEBI (LODR), Reg., 2015","Dr. Reddy's Laboratories Limited has submitted to the Exchange the details of voting results of the Annual General Meeting of the Company held on the July 27, 2016 along with Scrutinizer's Report.","28-Jul-2016 09:03:00","2016-07-28 09:03:00","-","-","https://nsearchives.nseindia.com/corporate/PostAGMintimation_28072016090305_029.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on July 26, 2016, had granted 157,272 equity shares of Rs.5/- to Employees, pursuant to 'Employee Stock Option Schemes'.","28-Jul-2016 08:46:00","2016-07-28 08:46:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPGrant26072016_28072016084601_019.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 26, 2016 titled ""Dr.Reddy's Q1 FY17 Financial Results"".","27-Jul-2016 08:45:00","2016-07-27 08:45:00","-","-","https://nsearchives.nseindia.com/corporate/Q1FY17financialresultsFinal_27072016084504_716.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 26, 2016 with respect to the Unaudited Financial Result for the quarter ended June 30, 2016.","26-Jul-2016 14:48:00","2016-07-26 14:48:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_26072016144808.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended June 30, 2016.","26-Jul-2016 14:40:27","2016-07-26 14:40:27","-","-","https://nsearchives.nseindia.com/corporate/Q1FY17financialresults_26072016144027.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 18, 2016, titled ""Dr. Reddy's Laboratories announces the launch of Omeprazole and Sodium bicarbonate capsules in the U.S. Market"".","18-Jul-2016 11:02:00","2016-07-18 11:02:00","-","-","https://nsearchives.nseindia.com/corporate/Pressrelease18072016_18072016110252_877.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the exchange regarding a Press Release titled ""Dr. Reddy's to release Q1 FY17 results on July 26, 2016. Earnings call slated for July 26, 6.30 PM IST / 9.00 AM EDT.""","12-Jul-2016 20:41:00","2016-07-12 20:41:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease12072016_12072016204114_698.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange that Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 90,290 equity shares of Rs.5/- each of the Company, fully paid up, on July 11, 2016, to Employees on exercise of their Stock Options.","12-Jul-2016 11:11:00","2016-07-12 11:11:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPIntimation_12072016111141_331.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Annual General Meeting Updates","Dr. Reddy's Laboratories Limited has submitted the Exchange a notice of Annual General Meeting and E-voting instructions published in newspapers","04-Jul-2016 17:34:00","2016-07-04 17:34:00","-","-","https://nsearchives.nseindia.com/corporate/Evotinginstructions_04072016173408_534.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Post Buyback Public Announcement","Kotak Mahindra Capital Company Limited  has submitted to the Exchange a copy of Post Buyback Public Advertisement for the attention of the Equity Shareholders/Beneficial Owners of Equity Shares of Dr. Reddy's Laboratories Limited.(Target Company).","30-Jun-2016 13:08:00","2016-06-30 13:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_02.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Post Buyback Public Announcement","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of Post Buyback Public Advertisement for the attention of the Equity Shareholders/Beneficial Owners of Equity Shares of the Company.","30-Jun-2016 09:37:00","2016-06-30 09:37:00","-","-","https://nsearchives.nseindia.com/corporate/DRLPostbuybackPA_30062016093734_761.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Closure of Buy Back","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Closure of Buyback of equity shares of Rs. 5/- each ( Equity Shares ) of Dr. Reddy s Laboratories Limited ( Company ).","28-Jun-2016 14:37:00","2016-06-28 14:37:00","-","-","https://nsearchives.nseindia.com/corporate/IntimationofBuybackClosure_28062016143701_045.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated June 24, 2016, titled ""Dr. Reddy s Laboratories Limited announces filing of Annual Report on Form 20-F"" .","24-Jun-2016 11:06:00","2016-06-24 11:06:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease24062016_24062016110623_938.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment of Director","Dr. Reddy's Laboratories Limited has informed the Exchange regarding ""Appointment of Mr. Hans Peter Hasler as an Additional Director, categorized as Independent on the Board of the Company"".","17-Jun-2016 19:11:00","2016-06-17 19:11:00","-","-","https://nsearchives.nseindia.com/corporate/HanspeterIntimation_17062016191150_298.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Press release Dated June 11, 2016 title "" Dr. Reddy's to acquire product portfolio from TEVA for US Market .""","11-Jun-2016 11:51:00","2016-06-11 11:51:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease11062016_11062016115149_395.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from July 20, 2016 to July 22, 2016(both days inclusive) for the purpose of payment of Dividend and Annual General Meeting of the Company is scheduled to be held on July 27, 2016.","03-Jun-2016 16:18:00","2016-06-03 16:18:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_AGM_03062016161801.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated June 01, 2016, titled ""Promius Pharma Launches Sernivo (betamethasone dipropionate) Spray, 0.05% New Product For Mild to Moderate Plaque Psoriasis"".","01-Jun-2016 11:10:00","2016-06-01 11:10:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease01062016_01062016111007_142.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 25, 2016 titled ""Dr. Reddy''s enters the branded consumer health arena through the acquisition of six OTC brands"".","25-May-2016 15:00:00","2016-05-25 15:00:00","-","-","https://nsearchives.nseindia.com/corporate/pressrelease25052016_25052016150028_264.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the standalone financial results along with the Auditors Report for the period ended 31-Mar-2016.","12-May-2016 13:16:55","2016-05-12 13:16:55","-","-","https://nsearchives.nseindia.com/corporate/Q4andFY16_12052016131655.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 12, 2016, titled ""Dr. Reddy' Q4 and FY 16 Financial Results"".","12-May-2016 13:16:00","2016-05-12 13:16:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_12052016131635.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 12, 2016 have recommended a final dividend of Rs.20/- (400%) per equity share of Rs.5/- face value, for the financial year 2015-16.","12-May-2016 13:15:00","2016-05-12 13:15:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_12052016131505.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended March 31, 2016.","12-May-2016 13:14:15","2016-05-12 13:14:15","-","-","https://nsearchives.nseindia.com/corporate/Q4andFY16_12052016131415.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment of Director","Dr. Reddy's Laboratories Limited has informed the Exchange that  Mr. Bharat Doshi as has been appointed as an Additional Independent Director on the Board of the Company effective May 11, 2016.","11-May-2016 15:02:00","2016-05-11 15:02:00","-","-","https://nsearchives.nseindia.com/corporate/IntimationofBharatDoshiappointment_11052016150236_827.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 26, 2016, titled ""Dr. Reddy's to release Q4 and Full Year FY16 results on May 12, 2016 //Earnings call slated for May 12, 6.30 PM IST / 9.00 AM EDT"".","26-Apr-2016 16:59:00","2016-04-26 16:59:00","-","-","https://nsearchives.nseindia.com/corporate/26042016_26042016165937_474.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Trading Window","Dr. Reddy's Laboratories Limited has informed the Exchange that, the trading window for dealing in equity shares of the Company will remain closed from April 25, 2016 till May 14, 2016 (both days inclusive).","25-Apr-2016 07:56:00","2016-04-25 07:56:00","-","-","https://nsearchives.nseindia.com/corporate/Tradingwindow_25042016075607_666.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 19, 2016, titled"" ZEMBRACE SymTouch (sumatriptan injection) 3 mg, approved by the FDA in January 2016 for the acute treatment of migraine with or without aura in adults, is now commercially available in the U.S."".","19-Apr-2016 12:08:00","2016-04-19 12:08:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleases19042016_19042016120815_896.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","Satish Reddy has submitted to the Exchange vide letter dated April 11, 2016 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","18-Apr-2016 09:23:00","2016-04-18 09:23:00","-","-","https://nsearchives.nseindia.com/corporate/Dr_30_18042016092339.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Public Announcement - Buyback of Shares","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the Public Announcement made in relation to the Buyback of equity shares by Dr. Reddy's Laboratories Limited (the ""Company"") from the BSE Limited (""BSE"") and the National Stock Exchange of India Limited (""NSE"" and together with the BSE, the ""Stock Exchanges""), pursuant to the provisions of Regulation 15(c) and 15(d) of, and in compliance with, the Securities and Exchange Board of India (Buy Back of Securities) Regulations, 1998 (including any statutory modification(s), or re-enactment for the time being in force) (""Buyback Regulations"").","12-Apr-2016 08:53:00","2016-04-12 08:53:00","-","-","https://nsearchives.nseindia.com/corporate/PAbuybackfullAd_12042016085308_700.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Buyback","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a copy of the Special Resolution passed by the Members of the Company through postal ballot conducted as per Section 110 of the Companies Act, 2013 and the corresponding rules thereunder.","07-Apr-2016 19:22:00","2016-04-07 19:22:00","-","-","https://nsearchives.nseindia.com/corporate/BSENSEPBResolution_07042016192225_645.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Regulation 44(3) of SEBI (LODR), Reg., 2015","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the details of Voting results of Postal Ballot along with Scrutinizer's Reports pursuant to regulation 44 (3) of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015 .","04-Apr-2016 08:05:00","2016-04-04 08:05:00","-","-","https://nsearchives.nseindia.com/corporate/PBResults02042016_04042016080520_107.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange that regarding a press release dated March 31, 2016 titled "" Dr. Reddy s Laboratories Acquires the Rights to Investigational Anticancer Agent E7777 for U.S, Europe and Certain Emerging Markets from Eisai"".","31-Mar-2016 11:52:00","2016-03-31 11:52:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease31032016_31032016115230_992.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 28, 2016, titled ""Dr. Reddy's Laboratories and XenoPort Enter Into a U.S. Licensing Agreement for XP23829"".","28-Mar-2016 09:59:00","2016-03-28 09:59:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease28032016_28032016095944_298.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 11, 2016 titled ""Dr. Reddy's and TR-Pharm Announce Strategic Collaboration in Turkey "".","11-Mar-2016 11:07:00","2016-03-11 11:07:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease11032016_11032016110735_235.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of the Postal Ballot Notice, Pursuant to Section 110 of the Companies Act, 2013.","01-Mar-2016 14:47:00","2016-03-01 14:47:00","-","-","https://nsearchives.nseindia.com/corporate/PBNoticedespatch_01032016144718_793.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 17, 2016 titled ""Dr. Reddy's Laboratories Limited's (""Company"") Board approves the proposal for Buyback of its Equity Shares"".","17-Feb-2016 14:55:00","2016-02-17 14:55:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease17022016_17022016145559_475.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of the earnings call transcript for Q3-FY16.","17-Feb-2016 08:23:00","2016-02-17 08:23:00","-","-","https://nsearchives.nseindia.com/corporate/BSENSEearningscalltranscript_17022016082346_363.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Form 6K for the quarter and nine months ended December 31, 2015.","10-Feb-2016 20:16:00","2016-02-10 20:16:00","-","-","https://nsearchives.nseindia.com/corporate/Form6Knoticetoexchanges_10022016201634_021.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 09, 2016, titled "" Dr.Reddy's Q3 and 9M FY16 Financial Results"".","09-Feb-2016 13:22:00","2016-02-09 13:22:00","-","-","https://nsearchives.nseindia.com/corporate/DReddy_pr_09022016132251.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended December 31, 2015.","09-Feb-2016 13:20:03","2016-02-09 13:20:03","-","-","https://nsearchives.nseindia.com/corporate/Q3FY16results_09022016132003.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 08, 2016 titled ""Promius Pharma Receives FDA Approval for Sernivo (betamethasone dipropionate) Spray, 0.05%"".","08-Feb-2016 09:12:00","2016-02-08 09:12:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease08022016_08022016091238_034.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 01, 2016, titled ""Dr. Reddy's Laboratories Receives USFDA Tentative Approval for ZenavodTM (doxycycline) Capsules, 40 mg for the Treatment of Rosacea in Adults"".","01-Feb-2016 12:41:00","2016-02-01 12:41:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease01022016_01022016124139_142.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 29, 2016 titled ""Dr. Reddy's Laboratories Ltd. receives FDA approval for ZEMBRACETMSymTouchTM (sumatriptan succinate) Injection for the acute treatment of migraines in adults"".","29-Jan-2016 13:44:00","2016-01-29 13:44:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease29012016_29012016134456_183.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 30, 2015 titled "" Dr. Reddy's announces the relaunch of Esomeprazole Magnesium Delayed-Release Capsules, USP"" .","30-Dec-2015 12:03:00","2015-12-30 12:03:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease30122015_30122015120341.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange that the Company has formulated a Policy on Determination of Materiality. The said policy can be viewed at our website www.drreddys.com. Further the Contact details of the persons authorised for determining the materiality of any event or information.","23-Dec-2015 18:04:00","2015-12-23 18:04:00","-","-","https://nsearchives.nseindia.com/corporate/23122015_23122015180434.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 18, 2015, titled ""Dr. Reddy's promotes access to Community Health in Vizianagaram District"".","18-Dec-2015 19:03:00","2015-12-18 19:03:00","-","-","https://nsearchives.nseindia.com/corporate/Press_Release_Dec_18,_2015_18122015190307.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange that the Company has submitted response to the USFDA on December 7, 2015.","08-Dec-2015 18:35:00","2015-12-08 18:35:00","-","-","https://nsearchives.nseindia.com/corporate/Update08122015_08122015183550.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 07, 2015, titled ""Dr. Reddy s signs MoU with Life Sciences Sector Skill Development Council and Vishnu Institute of Pharmaceutical Education and Research to Strengthen the Skilled Labour Pool in the Life Science Industry"".","07-Dec-2015 11:27:00","2015-12-07 11:27:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_07122015112705.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 19,138 equity shares of Rs. 5/ - each of the Company, fully paid up, on December 4, 2015, to Employees on exercise of their Stock Options as per the following details.a) 18,958 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002.b) 180 equity shares of Rs. 5/- each underlying 180 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","04-Dec-2015 13:25:00","2015-12-04 13:25:00","-","-","https://nsearchives.nseindia.com/corporate/Stock_Exch_letter_Dec_4,_2015_04122015132558.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""USFDA note: Dr reddy's did not have data protection system"". The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Dr. Reddy's Laboratories Limited has submitted their response.","26-Nov-2015 16:04:00","2015-11-26 16:04:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_149_News_Verification_26112015_105602_reply_26112015160425.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 26, 2015, titled ""Update on USFDA warning letter"".","26-Nov-2015 14:31:00","2015-11-26 14:31:00","-","-","https://nsearchives.nseindia.com/corporate/Drreedy_PR_26112015143123.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited., with respect to recent news item captioned ""USFDA note: Dr Reddy's did not have data protection system"". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","26-Nov-2015 11:28:00","2015-11-26 11:28:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","News about Dr. Reddy's Laboratories Limited.The media had reports that ""Dr. Reddy's tanks 7% as Lundin Law probes violation of norms, Dr. Reddy has received warning letter from USFDA on Nov 5, probe in DRL concerning possible violation of federal security law"".The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.Dr. Reddy's Laboratories Limited has vide its letter inter-alia stated, ""Dr. Reddy's has always adhered to all disclosure requirements both of the Securities and Exchange Commission (SECs) and Indian Stock Exchanges; including accounting practices as per the International Financial Reporting Standards (IFRS) and the Indian Accounting Standards. The Company has no further comment on what might be advertorial Press releases by law firms and refutes all allegations.""","19-Nov-2015 12:48:00","2015-11-19 12:48:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 19, 2015.","19-Nov-2015 12:07:00","2015-11-19 12:07:00","-","-","https://nsearchives.nseindia.com/corporate/PressReleaseNov192015_19112015120747.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited, with respect to recent news item captioned ""Dr. Reddy's tanks 7% as Lundin Law probes violation of norms, Dr. Reddy has received warning letter from USFDA on Nov 5, probe in DRL concerning possible violation of federal security law"". In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","19-Nov-2015 11:30:00","2015-11-19 11:30:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 18, 2015 titled ""Dr. Reddy's announces the completion of Fondaparinux intellectual property purchase"".","18-Nov-2015 08:53:00","2015-11-18 08:53:00","-","-","https://nsearchives.nseindia.com/corporate/Press_Release_November_18,_2015_18112015085353.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 10, 2015 titled ""Statement from Dr. Reddy's regarding the receipt of Temporary Restraining Order (TRO) for esomeprazole capsules""","10-Nov-2015 15:20:00","2015-11-10 15:20:00","-","-","https://nsearchives.nseindia.com/corporate/Statement_from_Dr_10112015152040.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 06, 2015 titled ""Dr. Reddy's to hold a Conference Call on Nov 09, 2015 at 4.00 PM IST/5.30 AM EST"".","07-Nov-2015 11:31:00","2015-11-07 11:31:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease06112015call_07112015113134.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 06, 2015 titled ""Dr. Reddy's to hold a Conference Call on Nov 9, 2015 at 4.00 PM IST / 5.30 AM EST"".","07-Nov-2015 11:12:00","2015-11-07 11:12:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease06112015call_07112015111226_027.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 06, 2015 titled ""Dr. Reddy s statement on the receipt of Warning Letter from US FDA"".","06-Nov-2015 10:12:00","2015-11-06 10:12:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease06112015_06112015101250.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 04, 2015 titled ""Biocodex inks distribution pact with Dr. Reddy's to market its flagship products in Romania'' .","04-Nov-2015 11:36:00","2015-11-04 11:36:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease04112015_04112015113619.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 02, 2015 titled ""Dr. Reddy's strengthens OTC portfolio-launches Nise D Spray"".","02-Nov-2015 11:15:00","2015-11-02 11:15:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease02112015_02112015111553.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 29, 2015 titled ""Dr. Reddy's Q2 and H1 FY16 Financial Results"".","29-Oct-2015 16:17:00","2015-10-29 16:17:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_Pressrelease_29102015161754.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2015.","29-Oct-2015 16:11:07","2015-10-29 16:11:07","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_29102015161107.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of Disclosure pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.","30-Sep-2015 19:41:00","2015-09-30 19:41:00","-","-","https://nsearchives.nseindia.com/corporate/FormC30092015_30092015194103_471.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","News about Dr. Reddy's Laboratories Limited.The media had reports that ""Dr Reddy's to buy IP rights for Alchemia drug for $17.5 million"".The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the company.Dr. Reddy's Laboratories Limited has vide its letter inter-alia stated, ""We would like to clarify that the aforementioned news article regarding purchase of IP rights for Alchemia drug at $17.5 million is a transaction in the regular course of the business. We already have an existing technology licensing agreement with Alchemia. Proposed transaction just represents a conversion of the said licensing agreement into a proposed IP ownership structure. At this stage we have only signed a binding term sheet with the party and a definitive agreement has not yet been reached. Further, we believe that the impact of this transaction is not material to our operations, warranting a stock exchange intimation under clause 36 of the Listing Agreement.""","28-Sep-2015 14:05:00","2015-09-28 14:05:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited., with respect to recent news item captioned ""Dr Reddy's to buy IP rights for Alchemia drug for $17.5 million"" . In this regard, the Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such negotiations were taking place and b) Whether you/company are aware of any information that has not been announced to the Exchanges which could explain the aforesaid movement in the trading. The response from the company is awaited.","28-Sep-2015 11:45:00","2015-09-28 11:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 28, 2015 titled ""Dr. Reddy's announces the Launch of Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg"".","28-Sep-2015 10:02:00","2015-09-28 10:02:00","-","-","https://nsearchives.nseindia.com/corporate/Press_Release_28092015_28092015100237.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of the Scrutinizer's Report along with the results (through e-voting and postal ballot) of the postal ballot process are enclosed herewith.","21-Sep-2015 08:11:00","2015-09-21 08:11:00","-","-","https://nsearchives.nseindia.com/corporate/Postalballotresults_21092015081131_125.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 14, 2015, titled""Dr. Reddy s Laboratories signs commercialization deal with Hatchtech"".","14-Sep-2015 09:58:00","2015-09-14 09:58:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_14092015095853.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 9, 2015 titled ""PanTheryx and Dr. Reddy's Announce an Agreement to Market PanTheryx's Proprietary Nutritional Intervention for Pediatric Infectious Diarrhea"".","09-Sep-2015 20:08:00","2015-09-09 20:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_press_09092015200808.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 04, 2015, titled ""Dr. Reddy s launches MINTOP PRO TM ProcapilTM Hair Therapy""","04-Sep-2015 16:47:00","2015-09-04 16:47:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_press_01_04092015164735.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 30,593 equity shares of Rs.5/ - each of the Company, fully paid up, on September 2, 2015, to Employees on exercise of their Stock Options as per the following details .a) 24,409 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002.b) 6,184 equity shares of Rs. 5/- each underlying 6,184 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","02-Sep-2015 13:33:00","2015-09-02 13:33:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_esop_02092015133333.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 27, 2015 titled ""Dr. Reddy's Announces Management Changes.""","27-Aug-2015 18:03:00","2015-08-27 18:03:00","-","-","https://nsearchives.nseindia.com/corporate/Dr_press_27082015180305.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","Dr. Reddy's Laboratories Limited has submitted to the Exchange a clarification on media report captioned ""DRL recalls dementia capsules in US"". The Company has clarified that ""The Company have recalled one batch of USP 1.5mg Rivastigmine Tartarate capsule from US market. This is a batch specific voluntary recall in conformance with our quality assurance norms practiced. The business impact from this will not be substantial"".","24-Aug-2015 11:16:00","2015-08-24 11:16:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_newsclarification_24082015111607.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of Notice of Postal Ballot pursuant to section 110 of the Companies Act, 2013 along with Postal Ballot Form.","18-Aug-2015 16:41:00","2015-08-18 16:41:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_cover.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 12, 2015 titled ""Dr. Reddy s announces the Launch of PRAMIPEXOLE Dihydrochloride Extended-Release Tablets.""","12-Aug-2015 17:49:00","2015-08-12 17:49:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease12082015_12082015174910_541.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 6, 2015 titled ""Dr. Reddy s Announces Strategic Collaboration with Amgen in India"".","06-Aug-2015 10:03:00","2015-08-06 10:03:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_press_06082015100324.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Outcome of Annual General Meeting of the Company held on July 31, 2015 as per Clause 35A of the Listing Agreement-Voting Results along with the Scrutinizer's Report.","01-Aug-2015 11:10:00","2015-08-01 11:10:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_35A_01082015111047.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release (Revised)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a revised press release dated July 30, 2015 titled ""Dr. Reddy's Q1 FY16 Financial Results"".","30-Jul-2015 19:38:00","2015-07-30 19:38:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy__30072015193811.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 30, 2015 titled "" Dr. Reddy Q1 FY 16 Financial Results "".","30-Jul-2015 13:55:00","2015-07-30 13:55:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_30072015135503.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Jun-2015.","30-Jul-2015 13:51:56","2015-07-30 13:51:56","-","-","https://nsearchives.nseindia.com/corporate/DR_30072015135156.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 13, 2015, titled ""Dr. Reddy's announces the Launch of MEMANTINE HYDROCHLORIDE TABLETS, USP"".","13-Jul-2015 15:39:00","2015-07-13 15:39:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_pr_13072015153934.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Annual General Meeting Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of the newspaper advertisement regarding Notice of Annual General Meeting and E-voting information.","08-Jul-2015 19:10:00","2015-07-08 19:10:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_Agm_08072015191045.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 01, 2015 titled ""Dr. Reddy's Unveils New Corporate Brand Identity"".","01-Jul-2015 17:11:00","2015-07-01 17:11:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease01072015_07012015171101_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","Dr. Reddy's Laboratories Limited has informed the Exchange vide letter dated June 30, 2015 regarding Clarification on media report.","30-Jun-2015 18:28:00","2015-06-30 18:28:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06302015182802_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the board of directors of the Company has allotted 63,862 equity shares of Rs.5/- each of the Company, fully paid up, on June 23, 2015, to Employees on exercise of their stock options.","24-Jun-2015 12:41:00","2015-06-24 12:41:00","-","-","https://nsearchives.nseindia.com/corporate/AllotmentIntimation_06242015124102_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated June 19, 2015, titled ""Dr. Reddy s launches HAiROOTZ in India - its first OTC hair growth supplement"".","22-Jun-2015 08:20:00","2015-06-22 08:20:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_06222015082002_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange vide letter dated June 19, 2015 that this is in reference to Company's earlier communication dated April 1, 2015 with regard to acquisition of select portfolio of the established products business of UCB in India. In this regard, the Company has now inform that the Company has concluded the transaction"".","19-Jun-2015 11:57:00","2015-06-19 11:57:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_01_06192015115701_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the press released dated June 18, 2015, titled, ""Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F.""","18-Jun-2015 10:58:00","2015-06-18 10:58:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease18062015_06182015105801_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Code of Conduct under SEBI(PIT) Reg., 2015","Dr. Reddy's Laboratories Limited has informed the Exchange that the Company has formulated the following Codes under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015:  a) Code of Practices and Procedures for Fair Disclosure of Un-published Price Sensitive Information. Published on the Company 's official website www.drreddys.com.  b) Code of Conduct to Regulate, Monitor and Report Insider Trading. ","10-Jun-2015 12:45:00","2015-06-10 12:45:00","-","-","https://nsearchives.nseindia.com/corporate/dr_100620150001_06102015124502_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that the Register of Members & share transfer books of the Company will remain closed from July 14, 2015 to July 17, 2015 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 31, 2015.","05-Jun-2015 19:56:00","2015-06-05 19:56:00","-","-","https://nsearchives.nseindia.com/corporate/drreeddyy_06052015195601_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the nomination, Governance & Compensation Committee of the board of directors of the Company has Allotted 112,886 Equity shares of Rs.5/- each of the Company, fully paid up, on June 04, 2015, to Employees on exercise of their stock options.","05-Jun-2015 16:01:00","2015-06-05 16:01:00","-","-","https://nsearchives.nseindia.com/corporate/Allotmentintimation_06052015160101_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 112,886 equity shares of Rs. 5/ - each of the Company , fully paid up, on June 4, 2015, to Employees on exercise of their Stock Options as per the following details .  a) 95,948 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002 .  b) 16,938 equity shares of Rs. 5/- each underlying 16,938 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007. ","05-Jun-2015 15:54:00","2015-06-05 15:54:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_allot_06052015155401_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy's Holdings Ltd has submitted to the Exchange vide letter dated June 01, 2015 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","02-Jun-2015 13:08:00","2015-06-02 13:08:00","-","-","https://nsearchives.nseindia.com/corporate/drreddya_290001_06022015130801_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 29, 2015 ""Dr Reddy's Laboratories Limited and AstraZeneca Pharma India Limited entered into a distribution agreement for saxagliptin and its fixed dose combination with metformin, in Type 2 Diabetes"".","29-May-2015 18:52:00","2015-05-29 18:52:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease29052015_05292015185201_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange that with reference to letter dated may 20, 2015 informing about Grant of Stock Options by the Company, that a grant of 1,600 option was erroneously included under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" instead of being included under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"".  Accordingly, the corrected grants to be read as-  102,224 stock options, exercisable at par value of Rs. 5/- under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and 40,184 stock options, exercisable at par value of Rs. 5/ under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"".  The total grant of 142,408 stock options and other terms and conditions of such grant remains the same.","22-May-2015 19:40:00","2015-05-22 19:40:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_05222015194001_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company on May 11, 2015, has granted 103,824 stock options, exercisable at par value of Rs. 5/- under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and 38,584 stock options, exercisable at par value of Rs. 5/- under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"" to the employees of the Company.","20-May-2015 19:23:00","2015-05-20 19:23:00","-","-","https://nsearchives.nseindia.com/corporate/Stockexchangeintimation_05202015192302_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 15, 2015 titled ""Dr. Reddy's launches Somazina for stroke patients in India"".","15-May-2015 16:35:00","2015-05-15 16:35:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease15052015_05152015163502_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange that the Company is holding an Investor Day on May 18, 2015, Monday at Hyderabad (India) for institutional investors and analysts to discuss its R&D strategy, investments and road-map for future.    The presentation and transcript would be uploaded on our website, post event","15-May-2015 08:49:00","2015-05-15 08:49:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_update_05152015084902_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 12, 2015 have recommended a final dividend of Rs.20/- (400%) per equity share of Rs.5/- face value, for the financial year 2014-15.","12-May-2015 13:35:00","2015-05-12 13:35:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 12, 2015 titled ""Dr. Reddy's Q4 & FY15 Financial Results"".","12-May-2015 13:30:00","2015-05-12 13:30:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_press_05122015133002_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited, Dr. Reddy's Laboratories Limited has submitted to the exchange the standalone financial results along with the Auditors Report for the period ended 31-Mar-2015.","12-May-2015 13:27:02","2015-05-12 13:27:02","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY-resuylts_05122015132701_.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc. under Reg.30 of SEBI (SAST) Reg.2011","Satish Reddy has submitted to the Exchange vide letter dated April 08, 2015 a copy of disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","17-Apr-2015 17:48:00","2015-04-17 17:48:00","-","-","https://nsearchives.nseindia.com/corporate/drreddys_satish_04172015174802_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 07, 2015 titled ""Dr. Reddy's Laboratories and its subsidiary Promius PharmaTM announce the filing of three NDAs with the USFDA"".","07-Apr-2015 20:13:00","2015-04-07 20:13:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease07042015_04072015201301_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the press release dated April 01, 2015, titled ""Dr. Reddy's Laboratories to acquire select portfolio of the established products business of UCB in India"".","01-Apr-2015 12:30:00","2015-04-01 12:30:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease01042015_04012015123002_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 23, 2015, titled ""Dr. Reddy s Laboratories enters into partnership with Hetero to accelerate access to treatment for Hepatitis C in India""..   ","23-Mar-2015 16:14:00","2015-03-23 16:14:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_Pr_03232015161401_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that pursuant to Dr Reddy's Employees Stock Option Scheme, 2002, the Nomination, Governance & Compensation Committee of the Board of Director of the Company has allotted 1,445 equity shares of Rs 5/- each of the Company, fully paid up, on March 20, 2015, to Employees on exercise of their Stock Options.","20-Mar-2015 16:35:00","2015-03-20 16:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_03202015163502_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to a news item captioned ""DRL may buy Belgian co s india ops for $135m"". The Company has clarified that ""We do not comment on market speculations. Any M&A transaction or similar other event, if material in nature, we will be communicated to the Stock Exchanges by the Company, at an appropriate time whenever it becomes certain"". ","11-Mar-2015 16:03:00","2015-03-11 16:03:00","-","-","https://nsearchives.nseindia.com/corporate/NEWSCLARIFICATION_DRREADY_03112015160301_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""DRL may buy Belgian co's India ops for $135m"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. . If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under clause 36 of the Listing Agreement. The response from the Company is awaited.","11-Mar-2015 12:09:00","2015-03-11 12:09:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 29, 2015, titled ""Dr. Reddy's Q3 and 9 Months FY15 Financial Results"".","29-Jan-2015 13:20:00","2015-01-29 13:20:00","-","-","https://nsearchives.nseindia.com/corporate/dr_01292015132001_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 31-Dec-2014.","29-Jan-2015 13:11:02","2015-01-29 13:11:02","-","-","https://nsearchives.nseindia.com/corporate/DREDDYS_31Dec14_S_01292015131102_.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange vide letter dated January 22, 2015 regarding a press release dated January 21, 2015 titled ""Curis and Aurigene Announce Collaboration, License and Option Agreement to Discover, Develop and Commercialize Small Molecule Antagonists for Immuno-oncology and Precision Oncology Targets"".","22-Jan-2015 15:39:00","2015-01-22 15:39:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease22012015_01222015153902_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to a news item captioned ""Maharashtra suspends Dr Reddy's licenses"". In this regard, the Company has clarified that :   ""The order relates only to the wholesale licence of the Clearing and Forwarding agent. In our opinion there has been no violation of any statute or regulation by the Company and it has been in compliance. The product being investigated is not a drug and is neither manufactured nor marketed by us. An interim stay has been granted today by the High Court for two weeks. Dr. Reddy's shall approach the State (Minister) on January 12, 2015 as directed by the Court.  This is not expected to be material to the Company's operations or consolidated results and hence we did not see a stock exchange notification necessary"".","09-Jan-2015 17:27:00","2015-01-09 17:27:00","-","-","https://nsearchives.nseindia.com/corporate/1303_001_01092015172702_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to news item captioned ""Maharashtra suspends Dr Reddy's licenses"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.","09-Jan-2015 11:16:00","2015-01-09 11:16:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 13,890 equity shares of Rs.5/- each of the Company, fully paid up, on January 1, 2015, to Employees on exercise of their Stock Options as per the following details: a) 13,800 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. b) 90 equity shares of Rs. 5/- each underlying 90 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","02-Jan-2015 13:56:00","2015-01-02 13:56:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_01_01022015135601_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to a news item captioned ""Indian pharma now under Canada lens .     The Company has clarified that :    In keeping with current regulations of Health Canada, the Company has voluntarily placed under quarantine all APIs and the formulations based on APIs produced at our API facility in Srikakulam district of Andhra Pradesh intended for use in Canada. Our products continue to meet intended quality standards, and we believe that, our APIs and Finished drug products manufactured using these APIs pose no risk to the health and safety of the Canadian people. The Company is working with the agency for a satisfactory resolution of the matter. At this stage, it has no implication on any activity at the plant and hence, these are not expected to be material to the Company s operations or consolidated results. ","26-Dec-2014 13:19:00","2014-12-26 13:19:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to news item captioned ""Indian pharma now under Canada lens"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.","26-Dec-2014 13:11:00","2014-12-26 13:11:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 19, 2014, titled ""Dr. Reddy s Laboratories closes the acquisition of Habitrol Brand from Novartis"".","19-Dec-2014 10:46:00","2014-12-19 10:46:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_PR_12192014104601_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated December 16, 2014  titled ""Dr. Reddy s announces the Launch of Valganciclovir Tablets, USP"".","16-Dec-2014 11:46:00","2014-12-16 11:46:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_12162014114601_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange vide letter dated December 11, 2014 a copy of disclosures under Regulations 13(4), 13(4A) & 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","12-Dec-2014 08:51:00","2014-12-12 08:51:00","-","-","https://nsearchives.nseindia.com/corporate/FormD11122014_12122014085101_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to a news item captioned ""Germany bans 80 generic drugs for insufficient trials"". The Company has clarified that ""Dr. Reddy s through its local entity Betapharm is proceeding in line with the instructions of the regulator. Overall impact on the financials of this action is expected to be non-material"".","11-Dec-2014 17:06:00","2014-12-11 17:06:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to news item captioned ""Germany bans 80 generic drugs for insufficient trials"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.","11-Dec-2014 15:34:00","2014-12-11 15:34:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange, vide letter dated December 5, 2014, a copy of the disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","05-Dec-2014 21:00:00","2014-12-05 21:00:00","-","-","https://nsearchives.nseindia.com/corporate/FormD05122014_12052014210003_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange vide letter dated December 1, 2014 a copy of disclosure under regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulation, 1992.","01-Dec-2014 17:09:00","2014-12-01 17:09:00","-","-","https://nsearchives.nseindia.com/corporate/FormD01122014_12012014170901_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange vide letter dated November 28, 2014 a copy of disclosure under regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulation, 1992.","28-Nov-2014 17:51:00","2014-11-28 17:51:00","-","-","https://nsearchives.nseindia.com/corporate/PrabhkaranNair_11282014175103_3.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange vide letter dated November 27, 2014 a copy of disclosure under regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulation, 1992.","27-Nov-2014 20:26:00","2014-11-27 20:26:00","-","-","https://nsearchives.nseindia.com/corporate/FormD27112014_11272014202601_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to news item dated November 27, 2014, captioned ""Srikakulam plant gets Form 483 for lapses: DRL"". In this regard Company has clarified as under:   a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company.    The Company has received some inspectional observations from the US FDA after their visit to our API manufacturing facility in Srikakulam district of Andhra Pradesh. The Company is committed to respond to the agency within stipulated timelines with our remedial plans and start implementing the necessary measures immediately. At this stage, it has no implication on any activity at the plant. Hence, these are not expected to be material to the Company's operations or consolidated results.    b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. If so, you are advised to provide the said information and the reasons for not disclosing the same to the Exchange earlier as required under clause 36 of the Listing Agreement.    For reasons stated in response to question (a) above, we did not see a stock exchange notification necessary.","27-Nov-2014 17:07:00","2014-11-27 17:07:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange has sought clarification from Dr. Reddy's Laboratories Limited with respect to recent news item captioned ""Srikakulam plant gets Form 483 for lapses: DRL"". In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.","27-Nov-2014 12:45:00","2014-11-27 12:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange vide letter dated November 24, 2014 a copy of disclosure under regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulation, 1992.","24-Nov-2014 17:54:00","2014-11-24 17:54:00","-","-","https://nsearchives.nseindia.com/corporate/FormD24112014_11242014175401_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 24, 2014 titled ""Dr. Reddy's announces the Launch of Docetaxel Injection USP"".","24-Nov-2014 11:26:00","2014-11-24 11:26:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease24112014_11242014112601_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated November 20, 2014 titled ""Dr. Reddy's announces the Launch of Over-the-Counter Fexofenadine Hydrochloride 60 mg and Pseudoephedrine Hydrochloride 120 mg Extended - Release Tablets"".","20-Nov-2014 15:24:00","2014-11-20 15:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_Pr_11202014152402_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange vide letter dated November 14, 2014 a copy of disclosure under regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulation, 1992.","14-Nov-2014 18:28:00","2014-11-14 18:28:00","-","-","https://nsearchives.nseindia.com/corporate/FormD14112014_11142014182801_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange, vide letter dated November 11, 2014 copies of disclosures under regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulation, 1992.","11-Nov-2014 18:20:00","2014-11-11 18:20:00","-","-","https://nsearchives.nseindia.com/corporate/FormD11112014_11112014182002_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Sep-2014.","29-Oct-2014 12:19:02","2014-10-29 12:19:02","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30Sep14_B_10292014121901_.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 29, 2014 , titled ""Dr. Reddy's Q2 and H1 FY15 Financial Results""","29-Oct-2014 12:18:00","2014-10-29 12:18:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_10292014121801_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 28, 2014 , titled ""Dr. Reddy's announces the Launch of Sirolimus Tablets, 1 mg and 2 mg""","28-Oct-2014 18:08:00","2014-10-28 18:08:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease28102014_10282014180802_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 28, 2014, titled "" Dr. Reddy's announces the Launch of Sirolimus Tablets, 1 mg and 2 mg"".","28-Oct-2014 18:05:00","2014-10-28 18:05:00","-","-","https://nsearchives.nseindia.com/corporate/drReddi_10282014180501_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to a news item captioned ""Sun, Dr Reddy's, cadila named in US Congress price probe"". The Company has clarified that ""On October 2, 2014, Dr. Reddy s Laboratories Ltd. received notice from US Congress Committees on price escalation of its generic products of Divalproex Sodium ER and Pravastatin Sodium. The Company has strict internal policies of complying with all applicable statutes and regulatory requirements of markets in which it operates, globally. The Company is of the opinion that it has complied with all applicable product pricing norms. Also, Company's Divalproex Sodium ER marketing approval was received well after all market price increases were put in place by competitors. Company does not now market Pravastatin Sodium. Company is responding to the US Congress letter well within time. As it stands today, Company does not see the notice material to its operations or consolidated results"".","09-Oct-2014 17:03:00","2014-10-09 17:03:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited  has submitted to the Exchange, vide letter dated October 8, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","08-Oct-2014 18:56:00","2014-10-08 18:56:00","-","-","https://nsearchives.nseindia.com/corporate/FormD08102014_08102014185640.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange, vide letter dated October 1, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","01-Oct-2014 14:52:00","2014-10-01 14:52:00","-","-","https://nsearchives.nseindia.com/corporate/FormD01102014_01102014145218.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange, vide letter dated September 29, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","29-Sep-2014 19:50:00","2014-09-29 19:50:00","-","-","https://nsearchives.nseindia.com/corporate/FormD29092014_29092014195046.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange, vide letter dated September 17, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","17-Sep-2014 18:12:00","2014-09-17 18:12:00","-","-","https://nsearchives.nseindia.com/corporate/FormD_09172014181201_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 30,800 equity shares of Rs.5/- each of the Company, fully paid up, on September 4, 2014, to Employees on exercise of their Stock Options as per the following details. (a) 20,153 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 10,647 equity shares of Rs. 5/- each underlying 10,647 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","04-Sep-2014 17:52:00","2014-09-04 17:52:00","-","-","https://nsearchives.nseindia.com/corporate/ESOPAllotmentSep42014_09042014175202_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Dr. Reddy's Laboratories Limited has submitted to the Exchange outcome of Annual General Meeting & Clause 35A of the Listing Agreement-Voting results","01-Aug-2014 18:16:00","2014-08-01 18:16:00","-","-","https://nsearchives.nseindia.com/corporate/Outcomeof30thAGMandClause35AoftheListingAgreementVotingResults_08012014181601_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 30, 2014 titled ""Dr. Reddy's Q1 FY15 Financial Results"".","30-Jul-2014 14:04:00","2014-07-30 14:04:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_07302014140401_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the exchange the standalone financial results along with the Limited Review Report for the period ended 30-Jun-2014.","30-Jul-2014 14:03:02","2014-07-30 14:03:02","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30June14_S.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange, vide letter dated July 22, 2014 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","25-Jul-2014 15:00:00","2014-07-25 15:00:00","-","-","https://nsearchives.nseindia.com/corporate/drreddys_25072014_25072014145807.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company on July 14, 2014, has granted 500 stock options, exercisable at par value of Rs.5/- under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and 1,000 stock options, exercisable at par value of Rs.5/- under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"" to the employees of the Company.","15-Jul-2014 12:04:00","2014-07-15 12:04:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_150720143_07152014120401_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated June 27, 2014 titled ""Dr. Reddy's announces the Launch of Duloxetine Delayed-Release Capsules USP"".","27-Jun-2014 10:08:00","2014-06-27 10:08:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_27062014_06272014100801_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated June 27, 2014, titled""Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F"".","27-Jun-2014 09:16:00","2014-06-27 09:16:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_06272014091602_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated June 25, 2014, titled ""Dr. Reddy's announces the Launch of Paricalcitol Capsules"".","25-Jun-2014 11:28:00","2014-06-25 11:28:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_06252014112802_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 56,031 equity shares of Rs.5/- each of the Company, fully paid up, on June 23, 2014, to Employees on exercise of their Stock Options as per the following details. (a) 50,803 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 5,228 equity shares of Rs. 5/- each underlying 5,228 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","24-Jun-2014 11:40:00","2014-06-24 11:40:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06242014114002_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company vide a circular resolution passed on June 15, 2014 has granted 95,428 stock options, exercisable at par value of Rs.5/- under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and 4,700 stock options, exercisable at par value of Rs.5/- under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"" to the employees of the Company.  The grant of above stock options is in line with SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, as amended and as per the terms of the Stock Option Schemes.","16-Jun-2014 11:36:00","2014-06-16 11:36:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_06162014113602_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that the Register of Members & share transfer books of the Company will remain close from July 15, 2014 to July 18, 2014 (both days inclusive) for the purpose of Payment of dividend & Annual General Meeting scheduled to be held on July 31, 2014.","03-Jun-2014 19:52:00","2014-06-03 19:52:00","-","-","https://nsearchives.nseindia.com/corporate/BookclosurenoticetoBSENSE_06032014195201_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy's Laboratories Limited has informed the Exchange regarding allotment of Equity Shares on exercise of ESOP.","03-Jun-2014 11:36:00","2014-06-03 11:36:00","-","-","https://nsearchives.nseindia.com/corporate/BSENSEAnnouncement_06032014113602_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange vide its letter dated May 26, 2014 regarding Grant of Stock Options.","26-May-2014 13:08:00","2014-05-26 13:08:00","-","-","https://nsearchives.nseindia.com/corporate/GrantofStockOptions_05262014130801_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Year  ended 31-MAR-2014 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2014 as follows: Net Sales of Rs. 949572 lacs for year ending on 31-MAR-2014 against Rs. 807434 lacs for the year ending on 31-MAR-2013. Net Profit / (Loss) of Rs. 193284 lacs for the year ending on 31-MAR-2014 against Rs. 126547 lacs for the year ending on 31-MAR-2013. ","13-May-2014 14:43:00","2014-05-13 14:43:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter  ended 31-MAR-2014 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2014 as follows: Net Sales of Rs. 253227 lacs for the quarter ending on 31-MAR-2014 against Rs. 216090 lacs for the quarter ending on 31-MAR-2013. Net Profit / (Loss) of of Rs. 47143 lacs for the quarter ending on 31-MAR-2014 against Rs. 37815 lacs for the quarter ending on 31-MAR-2013.","13-May-2014 14:43:00","2014-05-13 14:43:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated May 13, 2014 titled ""Senior level changes at Dr. Reddy's"".","13-May-2014 14:04:00","2014-05-13 14:04:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_13052014_05132014140402_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press Release dated May 13, 2014 titled ""Dr. Reddy's Q4 & FY14 Financial Results"".","13-May-2014 13:56:00","2014-05-13 13:56:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_Pr_05132014135602_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 13, 2014 have recommended a final dividend of Rs.18/- (360%) per equity share of Rs.5/- face value, for the financial year 2013-14..","13-May-2014 13:48:00","2014-05-13 13:48:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Date of payment of dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that the dividend on equity shares, if declared by the shareholders at the ensuing Annual Genera! Meeting, will be credited / despatched on or after August 07, 2014.","13-May-2014 13:48:00","2014-05-13 13:48:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of Audited Consolidated Financial Results of the Company and its subsidiaries for the quarter and year ended March 31, 2014 prepared in compliance with IFRS as issued by International Accounting Standards Board (IASB).","13-May-2014 13:44:00","2014-05-13 13:44:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_13052014_05132014134401_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the exchange the standalone financial results for the period ended 31-mar-2014.","13-May-2014 13:39:02","2014-05-13 13:39:02","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31mar2014_S_05132014133901_.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 23, 2014, titled, ""Dr. Reddy's announces the Launch of Fenofibrate Capsules, USP 43 mg and 130 mg"".","23-Apr-2014 10:44:00","2014-04-23 10:44:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_23042014_04232014104403_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release April 16, 2014, titled, ""Dr. Reddy's announces the Launch of Eszopiclone Tablets C-IV.""","16-Apr-2014 10:24:00","2014-04-16 10:24:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_16042014_04162014102401_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Publish Audited Results","Dr. Reddy's Laboratories Limited has informed the Exchange that the Company will announce and publish the audited annual financial results of the Company for the year ended March 31, 2014 instead of unaudited/audited quarterly financial results for the quarter ended March 31, 2014. the above referred audited annual financial results of the Company for the year ended March 31, 2014 would be announced within 60 days from the end of the relevant financial year. ","08-Apr-2014 18:52:00","2014-04-08 18:52:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated March 27, 2014, titled ""Dr. Reddy's announces the Launch of Amlodipine Besylate and Atorvastatin Calcium Tablets"".","27-Mar-2014 10:16:00","2014-03-27 10:16:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_27032014_03272014101602_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","The Exchange had sought clarification from Dr. Reddy's Laboratories Limited with respect to a news item captioned ""Lawsuit filed against DRL in US"". The Company has clarified that ""Dr. Reddy's Laboratories Ltd. is one of a number of companies that have filed applications with the USFDA requesting permission to sell generic versions of Cephalon's Treanda(R) (Bendamustine HCI) Injection for treatment of leukemia. The Company's ANDA includes paragraph IV certifications reflecting the fact that it seeks approval to market the products prior to expiration of certain patents owned by Cephalon. On December 20, 2013, Cephalon filed suit in the US District Court for the District of Delaware, alleging that the Company's actions infringe its patents. This is in the ordinary course of business of the pharmaceutical industry"".","20-Mar-2014 15:08:00","2014-03-20 15:08:00","-","-","https://nsearchives.nseindia.com/corporate/Clarification_DrReddy_03202014150802_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding press release dated March 05, 2014 titled,""Dr. Reddy's announces the Launch of Moxifloxacin Hydrochloride Tablets.""","05-Mar-2014 10:48:00","2014-03-05 10:48:00","-","-","https://nsearchives.nseindia.com/corporate/launchofmoxifloaxcin_03052014104802_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Press Release dated February 25, 2014 titled ""Dr. Reddy's announces the Launch of Sumatriptan Injection USP, Autoinjector System"".","25-Feb-2014 19:32:00","2014-02-25 19:32:00","-","-","https://nsearchives.nseindia.com/corporate/launchofsumatriptan_02252014193201_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Redemption","Members of the Exchange are hereby informed that the trading in the Non-convertible Debentures (Symbol DRREDDY, Series N1) of Dr. Reddy's Laboratories Limited shall be suspended w.e.f. February 20, 2014 (i.e. closing hours of trading on February 19, 2014) on account of Redemption.","19-Feb-2014 16:36:00","2014-02-19 16:36:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Record Date","Dr. Reddy's Laboratories Limited has informed the Exchange that the Company has fixed Record Date as February 21, 2014 for the purpose of ascertaining the debenture holder's entitlement to receive the third and final year's interest, at the rate of 9.25% per annum, on Non-convertible Debentures (NCDs) of the Company due for payment on March 24, 2014. The said interest on NCDs will be credited/paid on March 24, 2014.","11-Feb-2014 17:16:00","2014-02-11 17:16:00","-","-","https://nsearchives.nseindia.com/corporate/RecordDateforRedemptionInterest_02112014171602_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 11, 2014, titled, ""Dr. Reddy's Q3 & 9 Months FY14 Financial Results"".","11-Feb-2014 13:52:00","2014-02-11 13:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_11022014_02112014135202_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the exchange the standalone financial results for the period ended 31-DEC-2013.","11-Feb-2014 13:47:02","2014-02-11 13:47:02","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31DEC2013_s_02112014134702_.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter  ended 31-DEC-2013 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2013 as follows: Net Sales of Rs. 254711 lacs for the quarter ending on 31-DEC-2013 against Rs. 269182 lacs and Rs. 213725 lacs for the quarters ending on 30-SEP-2013 and 31-DEC-2012 respectively. Net Profit / (Loss) of Rs. 62317 lacs for the quarter ending on 31-DEC-2013 against Rs. 77338 lacs and Rs. 34664 lacs for the quarters ending on 30-SEP-2013 and 31-DEC-2012 respectively.","11-Feb-2014 13:47:00","2014-02-11 13:47:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Clarification","Dr. Reddy's Laboratories Limited has submitted to the Exchange the clarification on media release in Financial Express titled ""Dr Reddy's inks deal with US co for cancer vaccine""","20-Jan-2014 12:20:00","2014-01-20 12:20:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_01202014122002_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that pursuant to Company's Employees Stock Option Scheme, 2002, the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 9,133 equity shares of Rs.5/- each of the Company, fully paid up, on January 17, 2014, to Employees on exercise of their Stock Options.","20-Jan-2014 11:44:00","2014-01-20 11:44:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the exchange the standalone financial results for the period ended 30-Sep-2013.","31-Oct-2013 14:19:02","2013-10-31 14:19:02","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30SEP2013_S.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated October 31, 2013 titled ""Dr. Reddy's Q2 & H1 FY14 Financial Results"".","31-Oct-2013 14:12:00","2013-10-31 14:12:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_31102013_10312013141201_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Press release dated September 17, 2013 titled ""Dr. Reddy's announces the approval of Azacitidine for Injection"".","17-Sep-2013 11:56:00","2013-09-17 11:56:00","-","-","https://nsearchives.nseindia.com/corporate/130917112148_0001_09172013115601_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation committee of the Board of Directors of the Company has allotted 31,216 equity shares of Rs.5/- each of the Company, fully paid up, on September 03, 2013, to Employees on exercise of their Stock Options as per the following details: (a) 27,903 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 3,313 equity shares of Rs.5/- each underlying 3,313 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","04-Sep-2013 11:24:00","2013-09-04 11:24:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press Release dated August 22, 2013, titled ""Dr. Reddy's announces the Launch of Divalproex Sodium Extended - Release Tablets, USP""","22-Aug-2013 19:04:00","2013-08-22 19:04:00","-","-","https://nsearchives.nseindia.com/corporate/DRReddy_PR_22082013_08222013185202_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has submitted to the Exchange a copy of Press release dated August 12, 2013 titled ""Dr. Reddy's appoints Dr. Sripada Chandrasekhar as President and Global Head of Human Resources"".","12-Aug-2013 14:08:00","2013-08-12 14:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_08122013140802_4.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of Voting Pattern - Clause 35A","Dr. Reddy's Laboratories Limited has informed the Exchange the disclosure of Voting pattern for Annual General Meeting held on July 31, 2013 as per clause 35A of listing agreement along with outcome of the Annual General Meeting.","31-Jul-2013 18:08:00","2013-07-31 18:08:00","-","-","https://nsearchives.nseindia.com/corporate/Clause35AOutcomeofAGM_07312013180802_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 30, 2013 titled ""Dr. Reddy's Q1 FY14 Financial Results"".","30-Jul-2013 15:40:00","2013-07-30 15:40:00","-","-","https://nsearchives.nseindia.com/corporate/drreddys2591_001_07302013154001_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended June 30,2013.","30-Jul-2013 14:44:25","2013-07-30 14:44:25","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30JUN2013_S_Q1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 27, 2013 titled ""Dr. Reddy s announces the Launch of Donepezil Hydrochloride Tablets, 23 mg"".","29-Jul-2013 10:00:00","2013-07-29 10:00:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_27072013_07292013100003_4.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 12, 2013 titled ""Dr. Reddy's announces the Launch of Decitabine for Injection"".","12-Jul-2013 10:12:00","2013-07-12 10:12:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_12072013_07122013101201_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 10, 2013, titled ""Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F"".","10-Jul-2013 10:00:00","2013-07-10 10:00:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_10072013_07102013100001_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","First State Investments Management (UK) Limited has submitted to the Exchange, vide letter dated June 07, 2013 a copy of disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","02-Jul-2013 13:56:00","2013-07-02 13:56:00","-","-","https://nsearchives.nseindia.com/corporate/drreddyslaboratories_firststateinvestments_29062013.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding Press Release dated June 26, 2013 titled ""Dr. Reddy's announces the Launch of Lamotrigine Extended-Release Tablets"".","26-Jun-2013 11:44:00","2013-06-26 11:44:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease26062013_06262013114402_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange vide letter dated June 22, 2013 regarding allotment of Equity shares on exercise of ESOP.","24-Jun-2013 08:52:00","2013-06-24 08:52:00","-","-","https://nsearchives.nseindia.com/corporate/dreddy_allotment_24062013_06242013085202_3.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange vide letter dated June 10, 2013 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of) Insider Trading Regulations, 1992. ","18-Jun-2013 18:12:00","2013-06-18 18:12:00","-","-","https://nsearchives.nseindia.com/corporate/drreddyslaboratoriesltd_18062013.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS/ESPS","Dr. Reddy's Laboratories Limited has informed the Exchange vide letter date June 4, 2013 regarding allotment of Equity shares on excercise of ESOP.","04-Jun-2013 14:12:00","2013-06-04 14:12:00","-","-","https://nsearchives.nseindia.com/corporate/AllotmentOfSharesOnExerciseOfStockOptions03062013_06042013141202_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated June 03, 2013, titled ""Fujifilm and Dr. Reddy's call off joint venture for generic drugs in Japan"".","03-Jun-2013 11:40:00","2013-06-03 11:40:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_03062013_06032013114002_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy's Laboratories Limited has informed the Exchange that the Company has fixed Book Closure from July 16, 2013 to July 19, 2013 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determing the sharehoders who would be entitled for the payment of dividend if declared at the forthcoming Annual General Meeting, scheduled to be held on July 31, 2013. ","20-May-2013 14:40:00","2013-05-20 14:40:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Discl. under SEBI Insider Trading and Takeover Regulation","Life Insurance Corporation of India has submitted to the Exchange a copy of disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 and under SEBI (Prohibition of Insider Trading) Regulations, 1992.","16-May-2013 15:44:00","2013-05-16 15:44:00","-","-","https://nsearchives.nseindia.com/corporate/Drrreddy.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy's Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 13, 2013 has granted 261,650 stock options, exercisable at par value of Rs. 5/- under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and 45,040 stock options, exercisable at par value of Rs. 5/- under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"" to the employees of the Company. The grant of above stock options is in line with SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, as amended and as per the terms of the Stock Option Schemes.","15-May-2013 19:24:00","2013-05-15 19:24:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press Release dated May 14, 2013 titled ""Dr. Reddy's Q4 & FY13 Financial Results "".","14-May-2013 14:36:00","2013-05-14 14:36:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_14052013_05142013143602_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy's Laboratories Limited  has submitted to the Exchange a copy of Audited Consolidated Financial Results of the Company  for the quarter and year ended March 31, 2013 prepared in compliance with IFRS as issued by International Accounting Standards Board (IASB).","14-May-2013 14:08:00","2013-05-14 14:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_CONSOLIDATEDIFRS_14052013_05142013140801_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Date of payment of dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that the dividend on equity shares, if declared by the shareholders at the ensuing Annual Genera! Meeting, will be credited / despatched on or after August 07, 2013.","14-May-2013 14:08:00","2013-05-14 14:08:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Year ended, 31-MAR-2013 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2013 as follows: Net Sales of Rs. 807434 lacs for year ending on 31-MAR-2013 against Rs. 660378 lacs for the year ending on 31-MAR-2012. Net Profit / (Loss) of Rs. 126547 lacs for the year ending on 31-MAR-2013 against Rs. 91236 lacs for the year ending on 31-MAR-2012.","14-May-2013 14:04:00","2013-05-14 14:04:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 14, 2013 have recommended a final dividend of Rs.15/- (300%) per equity share of Rs.5/- face value, for the financial year 2012-13. ","14-May-2013 14:04:00","2013-05-14 14:04:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 31-MAR-2013 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2013 as follows: Net Sales of Rs. 216090 lacs for the quarter ending on 31-MAR-2013 against Rs. 174871 lacs for the quarter ending on 31-MAR-2012. Net Profit / (Loss) of of Rs. 37815 lacs for the quarter ending on 31-MAR-2013 against Rs. 21179 lacs for the quarter ending on 31-MAR-2012.","14-May-2013 14:02:00","2013-05-14 14:02:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2013.","14-May-2013 13:48:17","2013-05-14 13:48:17","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31MAR2013_S_Q4A.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press Release dated April 09, 2013 titled ""Dr. Reddy s announces the relocation of their North America headquarters and establishment of a R&D Center in Princeton, NJ, USA"".","09-Apr-2013 18:16:00","2013-04-09 18:16:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease09042013_04092013181601_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press Release dated April 04, 2013, titled ""Dr. Reddy's Announces the Launch of Zoledronic Acid Injection"".","04-Apr-2013 10:36:00","2013-04-04 10:36:00","-","-","https://nsearchives.nseindia.com/corporate/DREREDDY_pr_04042013_04042013103602_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press Release dated April 01, 2013 titled ""Dr. Reddy's appoints GV Prasad as Chairman and Satish Reddy as Vice-Chairman of the Company"".","01-Apr-2013 16:28:00","2013-04-01 16:28:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease01042013_04012013162801_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press Release dated March 29, 2013 titled ""Dr. Reddy's announces the launch of Zenatane (Isotretinoin Capsules USP)"".","01-Apr-2013 08:20:00","2013-04-01 08:20:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_PR_30032013_04012013082001_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange vide ite letter dated March 22, 2013 regarding a press release titled, ""Dr. Reddy's and Nordion Inc. (formerly MDS Inc.) settle claims"".","22-Mar-2013 20:08:00","2013-03-22 20:08:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease22032013_03222013200802_2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press Release dated March 15, 2013, titled ""Dr. K. Anji Reddy is no more"".","18-Mar-2013 08:32:00","2013-03-18 08:32:00","-","-","https://nsearchives.nseindia.com/corporate/Pressrelease15032013_03182013083201_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a Press release dated March 05, 2013 titled ""Dr. Reddy's Announces the Launch of Zoledronic Acid Injection"".","05-Mar-2013 10:32:00","2013-03-05 10:32:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease05032013_03052013102802_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 28, 2013 titled ""Dr. Reddy's holds 98.6% of the shares in OctoPlus after the Post Closing Acceptance Period"" .","28-Feb-2013 10:04:00","2013-02-28 10:04:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease28022013_02282013100401_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","First State Investment Management (UK) Limited has submitted to the Exchange vide letter dated February 19, 2013 a copy of disclosure under Regulation 29(1) and 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","21-Feb-2013 13:00:00","2013-02-21 13:00:00","-","-","https://nsearchives.nseindia.com/corporate/DRRDY_First_Reg29.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Record Date","Dr. Reddy's Laboratories Limited has informed the Exchange that the Board of Directors has fixed February 22, 2013 as record date for the purpose of ascertaining the debenture holder's entitlement to receive the second year's interest, at the rate of 9.25% per annum, on Non-convertible Debentures (NCDs) of the Company due for payment on March 24, 2013. The said interest on NCDs will be credited/paid on March 24, 2013.","18-Feb-2013 12:20:00","2013-02-18 12:20:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 14, 2013, titled ""Dr. Reddy's Q3 & 9 months FY13 Financial Results"".","14-Feb-2013 14:04:00","2013-02-14 14:04:00","-","-","https://nsearchives.nseindia.com/corporate/DRRDDY_PR_14022013_02142013140401_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2012.","14-Feb-2013 13:55:06","2013-02-14 13:55:06","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31DEC2012_S_Q3.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 31-DEC-2012 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2012 as follows: Net Sales of Rs. 212460 lacs for the quarter ending on 31-DEC-2012 against Rs. 209011 lacs and Rs. 156680 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively. Net Profit / (Loss) of Rs. 34664 lacs for the quarter ending on 31-DEC-2012 against Rs. 36303 lacs and Rs. 10803 lacs for the quarters ending on 30-SEP-2012 and 31-DEC-2011 respectively.","14-Feb-2013 13:55:00","2013-02-14 13:55:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated February 12, 2013, titled ""Dr. Reddy's declares Offer for OctoPlus unconditional"".","12-Feb-2013 09:20:00","2013-02-12 09:20:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_12022013_02122013092001_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","First State Investment Management (UK) Limited has submitted to the Exchange vide its letter dated January 29, 2013 a copy of disclosure under Regulation 29(1) and 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.","06-Feb-2013 17:36:00","2013-02-06 17:36:00","-","-","https://nsearchives.nseindia.com/corporate/Firststatementinvestment_dr_02062013173602_1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 25, 2013 about the Launch of Desloratadine ODT (Orally Disintegrating Tablets)","25-Jan-2013 10:40:00","2013-01-25 10:40:00","-","-","https://nsearchives.nseindia.com/corporate/PressRelease_01252013104002_3.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Life Insurance Corporation of India has submitted to the Exchange vide letter dated January 12, 2013 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 along with a copy of disclosure under regulation 13(3) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","14-Jan-2013 11:55:00","2013-01-14 11:55:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_LICDISC_14012013.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 2,480 equity shares of Rs. 5/- each of the Company, fully paid up, on January 07, 2013, to  Employees on exercise of their Stock Options as per the following details : (a) 1,930 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (b) 550 equity shares of Rs.5/- each underlying 550 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","08-Jan-2013 15:26:00","2013-01-08 15:26:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated January 03, 2013, titled ""Dr. Reddy's announces the Launch of Finasteride Tablets"".","03-Jan-2013 10:10:00","2013-01-03 10:10:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_03012013.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange vide its letter dated December 24, 2012 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","26-Dec-2012 16:55:00","2012-12-26 16:55:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_REG13_26122012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated December 14, 2012, titled ""Dr. Reddy's launches the recommended Public Cash Offer for all the issued and outstanding ordinary shares of OctoPlus N.V."".","14-Dec-2012 08:50:00","2012-12-14 08:50:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_pr_14122012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated November 27, 2012, titled ""Dr. Reddy's announces the appointment of new Chief Financial Officer (CFO) and Head for North America Business"".","27-Nov-2012 15:55:00","2012-11-27 15:55:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_27112012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated November 19, 2012, titled ""Dr. Reddy's announces the Launch of SILDENAFIL TABLETS"".","19-Nov-2012 09:31:00","2012-11-19 09:31:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddys_pr_19112012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated November 16, 2012, titled ""Dr. Reddy's Laboratories to request AFM approval for Offer Memorandum in connection with its Offer for OctoPlus N.V."".","16-Nov-2012 09:23:00","2012-11-16 09:23:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_pr_16112012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated October 30, 2012, titled ""Dr. Reddy's Q2 & H1 FY13 Financial Results"".","30-Oct-2012 13:45:00","2012-10-30 13:45:00","-","-","https://nsearchives.nseindia.com/corporate/dreaddy_pr_30102012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter and half year ended September 30, 2012 prepared in compliance with IFRS as issued by International Accounting Standards Board (IASB).","30-Oct-2012 13:42:00","2012-10-30 13:42:00","-","-","https://nsearchives.nseindia.com/corporate/drready_irfs_30102012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 30-SEP-2012 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2012 as follows: Net Sales of Rs. 204129 lacs for the quarter ending on 30-SEP-2012 against Rs. 174755 lacs and Rs. 161256 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively. Net Profit / (Loss) of Rs. 36303 lacs for the quarter ending on 30-SEP-2012 against Rs. 17766 lacs and Rs. 13850 lacs for the quarters ending on 30-JUN-2012 and 30-SEP-2011 respectively.","30-Oct-2012 13:36:00","2012-10-30 13:36:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone Financial Results along with the Limited Review Report for the period ended September 30,2012.","30-Oct-2012 13:33:54","2012-10-30 13:33:54","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30SEP2012_S_Q2.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding the press release dated October 22, 2012, titled ""Dr. Reddy's Laboratories Limited intends to make a recommended public offer for OctoPlus N.V."".","22-Oct-2012 08:51:00","2012-10-22 08:51:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_22102012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy'S Laboratories Limited has submitted to the Exchange vide letter dated October 11, 2012 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","12-Oct-2012 16:48:00","2012-10-12 16:48:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_reg_12102012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated October 08, 2012, titled ""Dr. Reddy's Custom Pharmaceutical Services (CPS) business expands its manufacturing operations in Mirfield, UK"".","08-Oct-2012 16:37:00","2012-10-08 16:37:00","-","-","https://nsearchives.nseindia.com/corporate/DRReddys_pr_08102012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated September 27, 2012, titled ""Dr. Reddy's Announces the Launch of Montelukast Sodium Oral Granules"".","27-Sep-2012 12:35:00","2012-09-27 12:35:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY01_pr_27092012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 20, 2012, titled ""Dr.Reddy's announces the Launch of Amoxicillin Tablets, Capsules, and Oral Suspension"".","20-Sep-2012 13:09:00","2012-09-20 13:09:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_PR_20092012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy's Laboratories Limited has submitted to the Exchange vide its letter dated September 13, 2012 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","17-Sep-2012 09:13:00","2012-09-17 09:13:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_REG13_14092012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated September 11, 2012, titled ""Dr.Reddy's Announces the Launch of Metoprolol Succinate ER (Extended-Release) Tablets"".","12-Sep-2012 07:56:00","2012-09-12 07:56:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_Pr_12092012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 1992.","08-Sep-2012 16:58:00","2012-09-08 16:58:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddyLab_reg_08092012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 26,082 equity shares of Rs. 5/- each of the Company, fully paid up, on September 01, 2012, to Non-Executive Directors / Employees on exercise of their Stock Options as per the following details. (a) 12,470 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 13,612 equity shares of Rs.5/- each underlying 13,612 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","03-Sep-2012 12:08:00","2012-09-03 12:08:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 07, 2012, titled ""Dr. Reddy's announces the launch of Montelukast Sodium tablets and Montelukast Sodium chewable tablets"".","07-Aug-2012 18:05:00","2012-08-07 18:05:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_pr_07082012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 27, 2012, titled ""USFDA lifts import alert from Dr. Reddy's Chemical Manufacturing Facility at Cuernavaca, Mexico"".","30-Jul-2012 08:57:00","2012-07-30 08:57:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_30072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","G. V. Sanjana Reddy has submitted to the Exchange vide letter dated July 25, 2012 a copy of Disclosure in terms of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (the""SEBI Takeover Regulations"").","26-Jul-2012 10:21:00","2012-07-26 10:21:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_sanjana_26072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","K Satish Reddy has submitted to the Exchange vide letter dated July 25, 2012 a copy of Disclosure in terms of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (the""SEBI Takeover Regulations"").","26-Jul-2012 10:18:00","2012-07-26 10:18:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_ksatish_26072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. K. Anji Reddy has submitted to the Exchange vide letter dated July 25, 2012 a copy of Disclosure in terms of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (the""SEBI Takeover Regulations"").","26-Jul-2012 10:16:00","2012-07-26 10:16:00","-","-","https://nsearchives.nseindia.com/corporate/ddreddy_anji_26072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","G. V. Prasad has submitted to the Exchange vide letter dated July 25, 2012 a copy of Disclosure in terms of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (the""SEBI Takeover Regulations"").","26-Jul-2012 10:13:00","2012-07-26 10:13:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_prasad_26072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","G. Anuradha has submitted to the Exchange vide letter dated July 25, 2012 a copy of Disclosure in terms of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (the""SEBI Takeover Regulations"").","26-Jul-2012 10:07:00","2012-07-26 10:07:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_anuradha_26072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","APS Trust has submitted to the Exchange vide letter dated July 25, 2012 a copy of Disclosure in terms of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.","26-Jul-2012 09:59:00","2012-07-26 09:59:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_aps_26072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Annual General Meeting","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding the Outcome of Annual General Meeting held on July 20, 2012.","20-Jul-2012 20:01:00","2012-07-20 20:01:00","-","-","https://nsearchives.nseindia.com/corporate/Drreddy_AGM_20072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Unaudited Consolidated Financial Results of the Company for the quarter ended June 30, 2012 prepared in compliance with International Financial Reporting Standards (IFRS) as issued by International Accounting Standards Board (IASB).","19-Jul-2012 15:03:00","2012-07-19 15:03:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_consolidated_19072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 19, 2012, titled ""Dr. Reddy's Q1 FY13 Financial Results"".","19-Jul-2012 14:59:00","2012-07-19 14:59:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_pr_19072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2012 with Limited Review Report.","19-Jul-2012 14:52:04","2012-07-19 14:52:04","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30JUN2012_S_Q1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 18, 2012, titled ""Dr. Reddy's announces the Launch of Atorvastatin Calcium Tablets"".","18-Jul-2012 14:13:00","2012-07-18 14:13:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy02_pr_18072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 18, 2012, titled ""Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F"".","18-Jul-2012 11:03:00","2012-07-18 11:03:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_PR_18072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 02, 2012, titled ""Dr. Reddy's announces the launch of Ibandronate Sodium tablets"".","02-Jul-2012 11:10:00","2012-07-02 11:10:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddys01_pr_02072012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 67,095 equity shares of Rs. 5/- each of the Company, fully paid up, on June 23, 2012, to various employees on exercise of their Stock Options as per the following details. (a) 60,526 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 6,569 equity shares of Rs.5/- each underlying 6,569 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","25-Jun-2012 12:23:00","2012-06-25 12:23:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy'S Laboratories Limited has submitted to the Exchange vide its letter dated June 07, 2012 a copy of disclosure pursuant to Regulation 13(4), 13(4A) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992.","08-Jun-2012 13:26:00","2012-06-08 13:26:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_Reg13_08062012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated June 07, 2012, titled ""Dr. Reddy's announces the Launch of Ropinirole Hydrochloride XR (Extended-Release) Tablets.""","07-Jun-2012 09:56:00","2012-06-07 09:56:00","-","-","https://nsearchives.nseindia.com/corporate/drrreddy_pr_07062012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM / Book Closure","Dr. Reddy'S Laboratories Limited has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 03, 2012 to July 06, 2012 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 20, 2012.","06-Jun-2012 15:23:00","2012-06-06 15:23:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated June 06, 2012, titled ""Dr. Reddy's Laboratories Ltd. and Merck Serono announce collaboration to develop and commercialize Biosimilars"".","06-Jun-2012 11:10:00","2012-06-06 11:10:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_pr_06062012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 180,472 equity shares of Rs. 5/- each of the Company, fully paid up, on June 01, 2012, to Non-Executive Directors / Employees on exercise of their Stock Options as per the following details. (a) 153,657 equity shares of Rs. 5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 26,815 equity shares of Rs.5/- each underlying 26,815 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","05-Jun-2012 15:54:00","2012-06-05 15:54:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated May 21, 2012 titled ""Dr. Reddy's announces the Launch of Over-the-Counter Lansoprazole Delayed-Release Capsules"".","21-May-2012 08:39:00","2012-05-21 08:39:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_21052012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated May 18, 2012, titled ""Dr. Reddy's announces the Launch of Clopidogrel Tablets, USP"".","18-May-2012 10:04:00","2012-05-18 10:04:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_18052012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 10, 2012 has granted 336,570 stock options, exercisable at par value of Rs.5/- under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and 58,840 stock options, exercisable at par value of Rs.5/- under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"" to the employees of the Company.","12-May-2012 11:39:00","2012-05-12 11:39:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Audited Consolidated Financial Results of the Company  for the quarter and year ended March 31, 2012 prepared in compliance with IFRS as issued by International Accounting Standards Board (IASB).","11-May-2012 14:50:00","2012-05-11 14:50:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_ConsolidatedIfrs_11052012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated May 11, 2012, titled ""Dr. Reddy's revenues cross $2 billion milestone in FY12"".","11-May-2012 14:33:00","2012-05-11 14:33:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_11052012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company have recommended a final dividend of Rs.13.75 (275%) per equity share of Rs.5/- face value, for the financial year 2011-12. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited/ dispatched on or after July 27, 2012.","11-May-2012 14:28:00","2012-05-11 14:28:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Year ended, 31-MAR-2012 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2012 as follows: Net Sales of Rs. 660378 lacs for year ending on 31-MAR-2012 against Rs. 521804 lacs for the year ending on 31-MAR-2011. Net Profit / (Loss) of Rs. 91236 lacs for the year ending on 31-MAR-2012 against Rs. 89331 lacs for the year ending on 31-MAR-2011.","11-May-2012 14:24:00","2012-05-11 14:24:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2012.","11-May-2012 14:16:26","2012-05-11 14:16:26","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31MAR2012_S_Q4A.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated April 24, 2012, titled ""Dr. Reddy's announces the launch of Olanzapine tablets"".","24-Apr-2012 21:17:00","2012-04-24 21:17:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_pr_24042012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated March 28, 2012, titled ""Dr. Reddy's announces the launch of Quetiapine Fumarate Tablets.""","28-Mar-2012 10:03:00","2012-03-28 10:03:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_28032012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated March 03, 2012 titled ""Dr. Reddy's announces the Launch of Ziprasidone Hydrochloride Capsules"".","03-Mar-2012 11:24:00","2012-03-03 11:24:00","-","-","https://nsearchives.nseindia.com/corporate/drredy_pr_03032012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that pursuant to Dr. Reddy'S Employees Stock Option Scheme, 2002, the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 16,295 equity shares of Rs 5/- each of the Company, fully paid up, on February 16, 2012, to Employees on exercise of their Stock Options.","20-Feb-2012 14:20:00","2012-02-20 14:20:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of the abstract of the terms of re-appointment Mr. Satish Reddy, as Whole Time Director designated as Managing Director and Chief Operating Officer (COO) of the Company for a period of 5 (five) years effective from October 01, 2012 to September 30, 2017 and the relevant Memorandum of Interest.","15-Feb-2012 18:07:00","2012-02-15 18:07:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_updts_15022012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Record Date","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors has fixed February 24, 2012 as record date for the purpose of ascertaing the debenture holders' entitlement to receive the 1st year's interest, at the rate of 9.25% per annum, On Non-convertible Debentures (NCDs) of the Company due for payment on March 24, 2012. The said interest on NCDs will be credited/ paid on March 24, 2012.","06-Feb-2012 11:06:00","2012-02-06 11:06:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reappointment","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on February 03, 2012 based on the recommendation of the Nomination, Governance and Compensation Committee, has approved the re-appointment of Mr. Satish Reddy as Whole-time Director designated as Managing Director and Chief Operating Officer for the a period of 5 years, subject to the shareholders' approval.","03-Feb-2012 15:00:00","2012-02-03 15:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated February 03, 2012 titled ""Dr. Reddy's Q3 FY12 Financial Results Highest ever quarterly sales and profit"".","03-Feb-2012 14:37:00","2012-02-03 14:37:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_pr_03022012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Un audited Consolidated Financial Results of the Company and its subsidiaries for the quarter and nine months ended December 31, 2011 prepared in compliance with IFRS as issued by International Accounting Standards Board (IASB).","03-Feb-2012 14:14:00","2012-02-03 14:14:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_consolidated_03022012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 31-DEC-2011 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2011 as follows: Net Sales of Rs. 156680 lacs for quarter ending on 31-DEC-2011 against Rs. 136479 lacs for the quarter ending on 31-DEC-2010. Net Profit / (Loss) of Rs. 10803 lacs for the quarter ending on 31-DEC-2011 against Rs. 26277 lacs for the quarter ending on 31-DEC-2010.","03-Feb-2012 14:10:00","2012-02-03 14:10:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone and Consolidated Financial Results along with Limited Review Report for the period ended December 31,2011.","03-Feb-2012 14:08:03","2012-02-03 14:08:03","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31DEC2011_B_Q3.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated January 27, 2012, titled ""Dr. Reddy's Clarifies media reports.""","27-Jan-2012 13:55:00","2012-01-27 13:55:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_27012012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","23-Jan-2012 20:12:00","2012-01-23 20:12:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_DISCL_23012012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","23-Jan-2012 19:47:00","2012-01-23 19:47:00","-","-","https://nsearchives.nseindia.com/corporate/REDDY_DISC_23012012.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under Insider Trading Regulation","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Disclosure under Regulation 13(4), 13(4A) and 13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","22-Nov-2011 14:45:00","2011-11-22 14:45:00","-","-","https://nsearchives.nseindia.com/corporate/DREDDY_reg_22112011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure under SEBI Takeover Regulations","Dr. Reddy'S Laboratories Limited has Submitted to the Exchange a copy of Disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 along with Regulation 13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992.","18-Nov-2011 15:05:00","2011-11-18 15:05:00","-","-","https://nsearchives.nseindia.com/corporate/DRREADY_REG_18112011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 17,565 equity shares of Rs.5/- each of the Company, fully paid up, on November 12, 2011, to Non- Executive Director / Employees on exercise of their Stock Options as per the following details : (1) 15,165 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (2) 2,400 equity shares of Rs.5/- each underlying 2,400 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","14-Nov-2011 11:09:00","2011-11-14 11:09:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated October 25, 2011, titled, ""Teva and Dr. Reddy's announce launch of generic Zyprexa in the United States"".","25-Oct-2011 18:18:00","2011-10-25 18:18:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy02_pr_25102011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy'S Laboratories Limited has informed the Exchange that based on the recommendation of the Nomination, Governance and Compensation Committee, the Board of Directors of the Company at its meeting held on October 25, 2011, proposed for an amendment in the Dr. Reddy's Employees' Stock Option Scheme, 2002 subject to the shareholders' approval.","25-Oct-2011 15:57:00","2011-10-25 15:57:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated October 25, 2011 titled, ""Dr.Reddy's Q2 FY12 Financial Results"".","25-Oct-2011 14:19:00","2011-10-25 14:19:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_pr_25102011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 30-SEP-2011 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2011 as follows: Net Sales of Rs. 161256 lacs for quarter ending on 30-SEP-2011 against Rs. 127832 lacs for the quarter ending on 30-SEP-2010. Net Profit / (Loss) of Rs. 13850 lacs for the quarter ending on 30-SEP-2011 against Rs. 22020 lacs for the quarter ending on 30-SEP-2010.","25-Oct-2011 14:17:00","2011-10-25 14:17:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2011.","25-Oct-2011 14:11:43","2011-10-25 14:11:43","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30SEP2011_S_Q2H.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated September 26, 2011, titled "" Dr. Reddy's and JB Chemicals & Pharmaceuticals (JBCPL) terminate Rx business deal in Russia and other CIS "".","26-Sep-2011 15:27:00","2011-09-26 15:27:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_26092011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated September 22, 2011 titled, "" Dr. Reddy's announces the Launch of Rivastigmine Tartrate Capsules "".","22-Sep-2011 18:10:00","2011-09-22 18:10:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddys_PR_22092011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 50,654 equity shares of Rs.5/- each of the Company, fully paid up, on September 08, 2011, to Non- Executive Directors / Employees on exercise of their Stock Options as per the following details : (1) 44,008 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (2) 6,646 equity shares of Rs.5/- each underlying 6,646 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","08-Sep-2011 19:53:00","2011-09-08 19:53:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated September 02, 2011, titled ""Dr. Reddy's announces start of Phase II study with the CETP inhibitor, DRL-17822 in dyslipidemia patients "".","02-Sep-2011 11:49:00","2011-09-02 11:49:00","-","-","https://nsearchives.nseindia.com/corporate/Drreddy_PR01_02092011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange vide its letter dated August 31, 2011, regarding a press release dated August 30, 2011, titled "" Dr. Reddy's announces settlement of Lipitor (atorvastatin) ANDA litigation with Pfizer "".","02-Sep-2011 11:27:00","2011-09-02 11:27:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_02092011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated August 30, 2011, titled ""Dr. Reddy's announces the launch of Over-the-Counter Fexofenadine HCI and Pseudoephedrine HCI extended release tablets"".","30-Aug-2011 18:31:00","2011-08-30 18:31:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_pr_30082011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment of Director","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on August 22, 2011 has appointed Mr. Sridar Iyengar as an Additional Director on the Board of Directors of the Company with effect from August 22, 2011.","22-Aug-2011 18:47:00","2011-08-22 18:47:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 28, 2011, titled ""FUJIFILM and Dr. Reddy's to establish an exclusive joint venture for developing, manufacturing and promoting generic drugs in Japan"".","28-Jul-2011 11:32:00","2011-07-28 11:32:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDYLTD_pr_28072011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 27, 2011, titled ""Dr. Reddy's announces the launch of Gemcitabine for Injection"".","28-Jul-2011 08:14:00","2011-07-28 08:14:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_28072011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 22, 2011, titled ""Dr Reddy's acquires prescription business of JB Chemicals & Pharmaceuticals in Russia & other CIS markets"".","22-Jul-2011 19:05:00","2011-07-22 19:05:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_22072011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Annual General Meeting","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding the Outcome of the Annual General Meeting of the members of the Company held on July 21, 2011.","21-Jul-2011 16:12:00","2011-07-21 16:12:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_agmoutcome_21072011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 21, 2011, titled ""Dr Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F"".","21-Jul-2011 15:03:00","2011-07-21 15:03:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_21072011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 20, 2011, titled ""Dr Reddy's Q1 FY12 Financial Results"".","20-Jul-2011 14:45:00","2011-07-20 14:45:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_20072011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter ended June 30, 2011 prepared in compliance with IFRS as issued by International Accounting Standards Board (IASB).","20-Jul-2011 14:43:00","2011-07-20 14:43:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_consolidated_20072011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 30-JUN-2011 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2011 as follows: Net Sales of Rs. 167571 lacs for quarter ending on 30-JUN-2011 against Rs. 125622 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 45405 lacs for the quarter ending on 30-JUN-2011 against Rs. 24448 lacs for the quarter ending on 30-JUN-2010.","20-Jul-2011 14:40:00","2011-07-20 14:40:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended June 30,2011.","20-Jul-2011 14:34:20","2011-07-20 14:34:20","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30JUN2011_S_Q1.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated July 13, 2011, titled ""Dr. Reddy's announces the USFDA Approval of Fondaparinux Sodium Injection.""","13-Jul-2011 10:03:00","2011-07-13 10:03:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDY_PR1_13072011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated July 07, 2011, titled ""Dr. Reddy's announces the launch of Amlodipine Besylate and Benazepril Hydrochloride capsules."" ","07-Jul-2011 10:42:00","2011-07-07 10:42:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_07072011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 84,014 equity shares of Rs 5/- each of the Company, fully paid up, on June 22, 2011, to Employees on exercise of their Stock Options as per the following details.(a) 74,026 equity shares of Rs 5/- each pursuant to Dr. Reddy's Employee Stock Option Scheme, 2002.(b)9,988 equity shares of Rs 5/- each underlying 9,988 ADRs pursuant to Dr. Reddy's Employee ADR Stock Option Scheme, 2007.","22-Jun-2011 18:27:00","2011-06-22 18:27:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated June 22, 2011, titled ""Dr. Reddy's announces the launch of Levofloxacin tablets"". ","22-Jun-2011 10:51:00","2011-06-22 10:51:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_22062011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated June 14, 2011, titled ""Dr. Reddy's Chemical Manufacturing Facility at Cuernavaca, Mexico Receives Warning Letter from USFDA"".","15-Jun-2011 08:41:00","2011-06-15 08:41:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_15062011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM / Book Closure","Dr. Reddy'S Laboratories Limited has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 05, 2011 to July 09, 2011 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 21, 2011.","14-Jun-2011 10:34:00","2011-06-14 10:34:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company on June 07, 2011 has approved the grant of 1,000 Stock Options, exercisable at par value of Rs.5/- to the employees of the Company under ""Dr. Reddy's Employees Stock Option Scheme, 2002.""","08-Jun-2011 12:53:00","2011-06-08 12:53:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated June 06, 2011, titled ""Dr. Reddy's announces three generic product launches in the US Market"".","06-Jun-2011 17:16:00","2011-06-06 17:16:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_06062011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 139,086 equity shares of Rs.5/- each of the Company, fully paid up, on June 02, 2011, to Non-Executive Directors/Employees on exercise of their Stock Options as per the following details : (1) 115,189 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (2) 23,897 equity shares of Rs.5/- each underlying 23,897 ADRs pursuant to Dr.Reddy's Employees ADR Stock Option Scheme, 2007.","03-Jun-2011 09:20:00","2011-06-03 09:20:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOPs/ESOS","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company in their meeting held on May 13, 2011, approved the grant of 9,600 stock options, exercisable at par value of Rs.5/- to the Independent Directors of the Company under ""Dr.Reddy's Employees Stock Option Scheme, 2002"" and also approved the grant of 7,200 stock options, exercisable at par value of Rs.5/- to the Independent Directors of the Company under ""Dr.Reddy's Employees ADR Stock Option Scheme, 2007"". Further the Nomination, Governance & Compensation Committee of the Board of Directors of the Company in their meeting held on May 12, 2011 approved the grant of 251,920 stock options, exercisable at par value of Rs.5/- to the employees of the Company under ""Dr.Reddy's Employees Stock Option Scheme 2002"" and also approved the grant of 48,860 stock options, exercisable at par value of Rs.5/- to the employees of the Company under ""Dr.Reddy's Employees ADR Stock Option Scheme, 2007"".","16-May-2011 17:35:00","2011-05-16 17:35:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Address Change","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Address of the Registered Office of the Company has been changed as under: 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500034, Andhra Pradesh, India.","13-May-2011 18:52:00","2011-05-13 18:52:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a revised press release dated May 13, 2011, titled ""Dr. Reddy's Q4 FY11 & FY11 Financial Results"".","13-May-2011 18:20:00","2011-05-13 18:20:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_revisedpr_13052011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on May 13, 2011, have recommended a final dividend of Rs.11.25 (225%) per equity share of Rs.5/- face value, for the financial year 2010-11. The dividend on equity shares, if declared by the shareholders at the ensuing Annual General Meeting, will be credited / despatched on or after July 28, 2011.","13-May-2011 14:42:00","2011-05-13 14:42:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated May 13, 2011, titled ""Dr. Reddy's Q4 FY11 & FY11 Financial Results"".","13-May-2011 14:36:00","2011-05-13 14:36:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_pr_13052011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Year ended, 31-MAR-2011 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 521804 lacs for year ending on 31-MAR-2011 against Rs. 440113 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 89331 lacs for the year ending on 31-MAR-2011 against Rs. 84608 lacs for the year ending on 31-MAR-2010.","13-May-2011 14:35:00","2011-05-13 14:35:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2011.","13-May-2011 14:31:55","2011-05-13 14:31:55","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31MAR2011_B_Q4A.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated May 10, 2011, titled ""Dr Reddy's launches pegfilgrastim in India under the brand name 'Peg-grafeel (TM)"".","10-May-2011 16:15:00","2011-05-10 16:15:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_10052011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated April 14, 2011, titled ""Dr Reddy's announces the launch of Over-the-Counter Fexofenadine HCI tablets"".","15-Apr-2011 08:49:00","2011-04-15 08:49:00","-","-","https://nsearchives.nseindia.com/corporate/drready_pr_15042011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated April 11, 2011, titled ""Dr Reddy's expands its R&D centre in Cambridge, United Kingdom"".","11-Apr-2011 17:56:00","2011-04-11 17:56:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY123_PR_11042011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Publish Audited Results","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Company will announce and publish the audited annual financial results of the Company for the year ended March 31, 2011 instead of unaudited/ audited quarterly financial results for the quarter ended March 31, 2011. In this respect, the audited annual financial results of the Company for the year ended March 31, 2011 would be announced within 60 days from the end of the relevant financial year.","08-Apr-2011 11:32:00","2011-04-08 11:32:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy'S Laboratories Limited has informed the Exchange that with reference to the issuance of 1,015,516,392 Unsecured, Redeemable, Non-Convertible Bonus Debentures of Rs.5/- each (bonus debentures) issued by the Company pursuant to the Scheme of Arrangement sanctioned by the Hon'ble High Court of Andhra Pradesh at Hyderabad vide Order dated July 19, 2010 (the Scheme), Dr Reddys Laboratories Ltd has informed the Exchange that the Liquidity Facility required to be provided to the Debenture holders in terms of Clause 6.2 of the said Scheme of Arrangement shall be provided by DSP Merrill Lynch Capital Ltd and is scheduled to open on April 07, 2011. Detailed terms and conditions of the above referred Liquidity Facility are available in the Letter of Offer, available on the website of DSP Merrill Lynch Capital Ltd i.e. www.dspml.com","07-Apr-2011 09:19:00","2011-04-07 09:19:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated April 01, 2011, titled ""Promius (TM) Pharma and Valeant form collaboration to market cloderm cream in the United States"".","01-Apr-2011 17:41:00","2011-04-01 17:41:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_01042011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated March 30, 2011, titled ""Dr. Reddy's announces completion of the acquisition of US penicillin facility and products from GlaxoSmithKline"".","30-Mar-2011 11:00:00","2011-03-30 11:00:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_pr_30032011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated March 28, 2011, titled ""Dr. Reddy's launches Levocetirizine tablets in US"".","28-Mar-2011 11:11:00","2011-03-28 11:11:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_28032011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Management Committee of the Board of Directors of the Company at its meeting held on March 24, 2011, has approved the allotment of 1,015,516,392 Unsecured Redeemable Non-Convertible Debentures of Rs. 5/- each carrying a coupon of 9.25% per annum, (""Bonus Debentures"") amounting to an aggregate value of Rs. 5,077,581,960/- from the General Reserve by way of distribution as bonus, to the Members, based on their equity holding on the Record Date i.e. March 18, 2011, in the ratio of 6 (six) Bonus Debentures of Rs. 5/- each for every equity share of Rs. 5/- each held.","24-Mar-2011 10:56:00","2011-03-24 10:56:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_Allot_24032011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 18,985 equity shares of Rs. 5/- each of the Company, fully paid up, on March 11, 2011, to Employees on exercise of their Stock Options.","11-Mar-2011 16:20:00","2011-03-11 16:20:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Record Date","Dr. Reddy'S Laboratories Limited has informed the Exchange that March 18, 2011 has been fixed as ""Record Date"" for determining the shareholders of the Company who will be entitled to receive 6(six) fully paid unsecured redeemable non-convertible bonus debentures of Rs.5/- each for every existing fully paid equity share of Rs.5/- each of the Company (bonus debentures) pursuant to the Scheme of Arrangement sanctioned by the Hon'ble High Court of Judicature, Andhra Pradesh at Hyderabad on July 19, 2010 which has come into effect on February 01, 2011.The Board of Directors has also fixed 9.25% as the coupon rate on these debentures, payable annually. These debentures would be redeemable, at par, at the end of 36 months from the date of allotment. ","09-Mar-2011 12:18:00","2011-03-09 12:18:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy'S Laboratories Limited has submitted to the exchange a copy of the abstract of the terms of re-appointment of Dr.K.Anji Reddy, Whole Time Director designated as Chairman of the Company for a further period of 5(five) years effective from July 13, 2011 to July 12, 2016 and of Mr. G. V. Prasad, Whole Time Director designated as Vice-Chairman and Chief Executive Officer (CEO) of the Company for a further period of 5 (five) years effective from January 30, 2011 to January 29, 2016.","15-Feb-2011 15:08:00","2011-02-15 15:08:00","-","-","https://nsearchives.nseindia.com/corporate/DRRed_Updates_15022011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated January 31, 2011, titled ""Dr. Reddy's provides update on the fexofenadine-pseudoephedrine 24 hour litigation"".","31-Jan-2011 10:24:00","2011-01-31 10:24:00","-","-","https://nsearchives.nseindia.com/corporate/drready_pr_31012011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter ended December 31, 2010 prepared in compliance with IFRS as issued by International Accounting Standards Board.","25-Jan-2011 14:32:00","2011-01-25 14:32:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_ifrsRESULT_25012011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated January 25, 2011, titled ""Dr. Reddy's Q3 FY11 Financial Results"".","25-Jan-2011 14:13:00","2011-01-25 14:13:00","-","-","https://nsearchives.nseindia.com/corporate/DrReddy_pr_25012011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 31-DEC-2010 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 136479 lacs for quarter ending on 31-DEC-2010 against Rs. 103136 lacs for the quarter ending on 31-DEC-2009. Net Profit / (Loss) of Rs. 26277 lacs for the quarter ending on 31-DEC-2010 against Rs. 16842 lacs for the quarter ending on 31-DEC-2009.","25-Jan-2011 14:07:00","2011-01-25 14:07:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended December 31,2010.","25-Jan-2011 14:05:23","2011-01-25 14:05:23","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_31DEC2010_B_Q3.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated January 20, 2011, titled ""Dr. Reddy's announces the launch of Pantoprazole Sodium delayed-released tablets"".","20-Jan-2011 16:52:00","2011-01-20 16:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_20012011.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 6,440 equity shares of Rs.5/- each of the Company, fully paid up, on January 08, 2011, to Employees on exercise of their Stock Options as per the following details : (1) 5,300 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (2) 1,140 equity shares of Rs.5/- each underlying 1,140 ADRs pursuant to Dr.Reddy's Employees ADR Stock Option Scheme, 2007.","10-Jan-2011 14:34:00","2011-01-10 14:34:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated December 21, 2010, titled ""Dr. Reddy's enters into an agreement with R-Pharm of Russia collaboration in the areas of high-technology and knowledge sharing"".","22-Dec-2010 08:52:00","2010-12-22 08:52:00","-","-","https://nsearchives.nseindia.com/corporate/DrREDDYS_PR_22122010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding the press release dated November 23, 2010, titled ""GlaxoSmithKline and Dr. Reddy's agree to the sale of US Penicillin Facility and Products"".","24-Nov-2010 08:40:00","2010-11-24 08:40:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_24112010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding the press release dated November 20, 2010, titled ""Dr. Reddy's announces the Launch of Zafirlukast Tablets"".","22-Nov-2010 08:48:00","2010-11-22 08:48:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_22112010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Nomination, Governance & Compensation Committee of the Board of Directors of the Company has allotted 25,732 equity shares of Rs.5/- each of the Company, fully paid up, on October 30, 2010, to Director/Employees on exercise of their Stock Options as per the following details : (1) 22,472 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (2) 3,260 equity shares of Rs.5/- each underlying 3,260 ADRs pursuant to Dr.Reddy's Employees ADR Stock Option Scheme, 2007.","01-Nov-2010 12:23:00","2010-11-01 12:23:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding the press release dated October 25, 2010, titled ""Dr. Reddy's expands portfolio in Russia & CIS through in-licensing deals"".","25-Oct-2010 15:52:00","2010-10-25 15:52:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_25102010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter ended September 30, 2010 prepared in compliance with IFRS as issued by International Accounting Standards Board.","23-Oct-2010 13:25:00","2010-10-23 13:25:00","-","-","https://nsearchives.nseindia.com/corporate/DRReddy_IFRS_23102010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding the press release dated October 23, 2010, titled ""Dr. Reddy's Q2 FY11 Financial Results"".","23-Oct-2010 13:23:00","2010-10-23 13:23:00","-","-","https://nsearchives.nseindia.com/corporate/Drready_PR_23102010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Financial Result Updates","Dr. Reddy's Laboratories Limited has submitted to the Exchange the Standalone Financial Results for the period ended September 30,2010.","23-Oct-2010 13:18:38","2010-10-23 13:18:38","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_30SEP2010_S_Q2H.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 30-SEP-2010 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 127832 lacs for quarter ending on 30-SEP-2010 against Rs. 107322 lacs for the quarter ending on 30-SEP-2009. Net Profit / (Loss) of Rs. 22020 lacs for the quarter ending on 30-SEP-2010 against Rs. 19706 lacs for the quarter ending on 30-SEP-2009.","23-Oct-2010 13:13:00","2010-10-23 13:13:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a Press Release dated October 16, 2010 titled ""Dr. Reddy's announces the approval of Lansoprazole delayed-release capsules"".","18-Oct-2010 09:15:00","2010-10-18 09:15:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_pr_18102010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange vide its letter dated September 23, 2010 regarding a Press Release dated September 22, 2010 titled ""Dr. Reddy's Laboratories Limited announces filing of Annual Report on Form 20-F"".","27-Sep-2010 11:29:00","2010-09-27 11:29:00","-","-","https://nsearchives.nseindia.com/corporate/drrreddy_pr_27092010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy's Laboratories Limited has informed the Exchange that the Governance & Compensation Committee of the Board of Directors of the Company has allotted 57,312 equity shares of Rs. 5/- each of the Company, fully paid up, on August 30, 2010, to Employees on exercise of their Stock Options as per the following details : (1) 53,304 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (2) 4,008 equity shares of Rs.5/- each underlying 4,008 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","31-Aug-2010 13:00:00","2010-08-31 13:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy'S Laboratories Limited has informed the Exchange with reference to earlier announcement regarding shareholder approval to the Scheme of Arrangement for issue of bonus debentures at a court convened meeting (the Scheme provides for issue of Unsecured, Redeemable, Non-convertible fully paid-up Bonus Debentures from the General Reserves, upto an amount of Rs. 520 crores in the ratio of six Bonus Debenture of Rs. 5 each for every share of Rs. 5 held by the shareholders) that the Hon'ble High Court of Andhra Pradesh at Hyderabad, vide its Order dated July 19, 2010 has approved the Scheme of Arrangement for issue of bonus debentures. A certified copy of the said Order has been obtained on August 11, 2010 by the Company and filed with the Registrar of Companies, Andhra Pradesh. The Company is in the process of seeking relevant regulatory approvals, including the approval of the Reserve Bank of India (RBI) which is a precondition to effectiveness of the Scheme. The Record Date will be fixed after all requisite approvals are received and the scheme has become effective in accordance with its terms.","12-Aug-2010 10:28:00","2010-08-12 10:28:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a Press Release dated August 09, 2010 titled ""Dr. Reddy's launches darbepoetin alfa in India under the brand name 'Cresp'"".","09-Aug-2010 17:02:00","2010-08-09 17:02:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_PR_09082010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Annual General Meeting","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding the outcome of Annual General Meeting held on July 23, 2010.","23-Jul-2010 17:26:00","2010-07-23 17:26:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_outcome_23072010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Company Secretary","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on July 22, 2010 approved the appointment of Mr. Sandeep Poddar as Company Secretary and Compliance Officer in place of Mr. V S Suresh.","22-Jul-2010 14:40:00","2010-07-22 14:40:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a Press Release dated July 22, 2010 titled ""Dr. Reddy's Q1 FY11 Financial Results Revenue at Rs.16.8 billion ($363 million) EBITDA at Rs.3.4 billion ($74 million) Profit after Tax at Rs.2.1 billion($45 million)"".","22-Jul-2010 14:27:00","2010-07-22 14:27:00","-","-","https://nsearchives.nseindia.com/corporate/DRredy_PR_22072010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Result Updates - IFRS","Dr. Reddy'S Laboratories Limited has submitted to the Exchange a copy of Unaudited Consolidated Financial Results of the Company and its subsidiaries for the quarter ended June 30, 2010 prepared in compliance with IFRS as issued by International Accounting Standards Board. A copy of the same shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","22-Jul-2010 14:25:00","2010-07-22 14:25:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_res_22072010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 30-JUN-2010 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 125622 lacs for quarter ending on 30-JUN-2010 against Rs. 114417 lacs for the quarter ending on 30-JUN-2009. Net Profit / (Loss) of Rs. 24448 lacs for the quarter ending on 30-JUN-2010 against Rs. 22744 lacs for the quarter ending on 30-JUN-2009.","22-Jul-2010 14:16:00","2010-07-22 14:16:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a Press Release dated June 29, 2010 titled ""Dr. Reddy's announces the launch of Anastrozole 1mg tablets"".","29-Jun-2010 18:02:00","2010-06-29 18:02:00","-","-","https://nsearchives.nseindia.com/corporate/drreddy_pr_29062010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Date of payment of dividend","Dr. Reddy'S Laboratories Limited has informed the Exchange that the dividend, which may be declared at the Annual General Meeting scheduled to be held on July 23, 2010, shall be paid to the shareholders on or after July 30, 2010.","29-Jun-2010 14:54:00","2010-06-29 14:54:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Governance & Compensation Committee of the Board of Directors of the Company has allotted the following equity shares of Rs.5/- each of the Company, fully paid up, on June 28, 2010, to Directors / Employees on exercise of their Stock Options : (1) 134,825 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002; (2) 35,643 equity shares of Rs.5/- each underlying 35,643 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","29-Jun-2010 13:21:00","2010-06-29 13:21:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated June 12, 2010, titled ""Dr. Reddy's provides update on the fexofenadine-pseudoephedrine 24 hour Preliminary Injunction hearing"".","14-Jun-2010 08:42:00","2010-06-14 08:42:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY_pr_14062010.ZIP"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy'S Laboratories Limited has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 6, 2010 to July 10, 2010 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 23, 2010.","10-Jun-2010 12:44:00","2010-06-10 12:44:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Securities","Dr. Reddy'S Laboratories Limited has informed the Exchange that pursuant to Dr Reddy's Employees Stock Option Scheme, 2002, the Governance & Compensation Committee of the Board of Directors of the Company has allotted 128,410 equity shares of Rs.5/- each of the Company, fully paid up, on June 1, 2010, to Directors / Employees on exercise of their Stock Options.","02-Jun-2010 16:37:00","2010-06-02 16:37:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Court Convened Meeting","Dr. Reddy'S Laboratories Limited has informed the Exchange that that at the Court Convened Meeting held on May 28, 2010 pursuant to the Order of the Hon'ble High Court at Judicature of Andhra Pradesh at Hyderabad dated April 21, 2010 passed in C.A. No. 286 of 2010, the shareholders of the Company have approved the proposed Scheme of Arrangement of the Company for issuance of bonus debentures with requisite majority.","28-May-2010 17:04:00","2010-05-28 17:04:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated May 21, 2010, titled ""Dr. Reddy's announces the Launch of Tacrolimus Capsules, the generic version of Prograf"".","21-May-2010 16:25:00","2010-05-21 16:25:00","-","-","https://nsearchives.nseindia.com/corporate/Drreddy_PR_21052010.ZIP"
"DRREDDY","Dr. Reddy's Laboratories Limited","Scheme of Arrangement","Dr. Reddy'S Laboratories Limited has informed the Exchange that pursuant to an order dated April 21, 2010, passed by the Hon'ble High Court of Andhra Pradesh in the Company Application (Dr. Reddy's Laboratories Limited), a meeting of the members of Dr. Reddy's Laboratories Limited, the Applicant abovenamed, is being convened for the purpose of considering and, if thought fit, approving, with or without modification, the proposed scheme of arrangement between Dr. Reddy's Laboratories Limited and its members for the issue of unsecured, redeemable, non-convertible, fully paid up bonus debentures of Dr. Reddy's Laboratories Limited from its general reserve, under sections 391 to 394 of the Companies Act, 1956 (hereinafter referred to as the ""Scheme"").","17-May-2010 18:57:00","2010-05-17 18:57:00","-","-","https://nsearchives.nseindia.com/corporate/DRReady_Notice_17052010.zip"
"DRREDDY","Dr. Reddy's Laboratories Limited","Stock Options/ ESOP","Dr. Reddy'S Laboratories Limited has informed the Exchange that ""The Board of Directors of the Company in their meeting held on May 06, 2010, approved the grant of 9,600 stock options, exercisable at par value of Rs.5/- to the Independent Directors of the Company under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and also approved the grant of 7,200 stock options, exercisable at par value of Rs.5/- to the Independent Directors of the Company under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"". Further the Compensation Committee of the Board of Directors of the Company in their meeting held on May 06, 2010 approved the grant of 275,070 stock options, exercisable at par value of Rs.5/- to the employees of the Company under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and also approved the grant of 51,460 stock options, exercisable at par value of Rs.5/- to the employees of the Company under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"".","10-May-2010 13:31:00","2010-05-10 13:31:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated May 06, 2010 titled ""Dr. Reddy's FY10 Financial Results, Revenues at Rs. 70.3 billion ($1.56 billion) EBITDA adjusted at Rs. 15.8 billion ($352 million) Profits after tax adjusted at Rs. 9.2 billion ($205 million)"", alongwith consolidated unaudited financial results as per IFRS for the year ended March 31, 2010.","06-May-2010 14:37:00","2010-05-06 14:37:00","-","-","https://nsearchives.nseindia.com/corporate/DRREDDY01_PR_06052010.ZIP"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy'S Laboratories Limited has informed the Exchange that the Board of Directors at its meeting held on May 06, 2010 have recommended a final dividend of Rs.11.25 (225%)  per equity share of Rs.5/- face value, subject to the approval of shareholders at the ensuing Annual General Meeting.","06-May-2010 13:59:00","2010-05-06 13:59:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Year ended, 31-MAR-2010 (Consolidated)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 685164 lacs for year ending on 31-MAR-2010 against Rs. 679037 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 35147 lacs for the year ending on 31-MAR-2010 against Rs. (91724) lacs for the year ending on 31-MAR-2009.","06-May-2010 13:55:00","2010-05-06 13:55:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Year ended, 31-MAR-2010 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2010 as follows: Net Sales of Rs. 440113 lacs for year ending on 31-MAR-2010 against Rs. 399963 lacs for the year ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 84608 lacs for the year ending on 31-MAR-2010 against Rs. 56089 lacs for the year ending on 31-MAR-2009.","06-May-2010 13:53:00","2010-05-06 13:53:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 31-MAR-2010 (Standalone)","Dr. Reddy's Laboratories Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 115237 lacs for quarter ending on 31-MAR-2010 against Rs. 104583 lacs for the quarter ending on 31-MAR-2009. Net Profit / (Loss) of Rs. 25316 lacs for the quarter ending on 31-MAR-2010 against Rs. 15617 lacs for the quarter ending on 31-MAR-2009.","06-May-2010 13:52:00","2010-05-06 13:52:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Limited has informed the Exchange regarding a press release dated April 26, 2010, titled ""Dr.Reddy's announces the Launch of Amlodipine Benazepril in US market"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRREDDY_pr_26042010.ZIP target=NEW> For more details click here.</a>","26-Apr-2010 14:33:00","2010-04-26 14:33:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 15, 2010, titled ""Dr. Reddy's introduces 'Dose Counter Inhalers' for the first time in India"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_Pr_15042010.zip target=NEW> For more details click here.</a>","15-Apr-2010 18:45:00","2010-04-15 18:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Publish Audited Results","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company will announce and publish the audited annual financial results of the Company for the year ended March 31, 2010 instead of unaudited/ audited quarterly financial results for the quarter ended March 31, 2010.","06-Apr-2010 17:04:00","2010-04-06 17:04:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Bonus Debentures","Dr. Reddy's Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on March 31, 2010, considered and approved the proposal for issuance of bonus debentures to shareholders of the Company from its General Reserves built from undistributed profits in terms of a scheme of arrangement under Sections 391-394 and other relevant provisions of the Companies Act, 1956 (""Scheme"").The proposed Scheme provides that subject to necessary approvals, the Company would issue, upon effectiveness of the Scheme, unsecured, non-convertible, redeemable, fully paid up bonus debentures of the face value of Rs. 5/- each (""Bonus Debentures"") to its shareholders on the record date to be determined by the board of directors, in the ratio of 6 Bonus Debentures for every 1 equity share of Rs. 5/- each held by a member of the Company. The draft Scheme was also approved by the Board of Directors at the meeting. The Bonus Debentures would carry a coupon rate to be determined by the board of directors, payable annually and would be redeemable at par at the end of thirty six months from the date of allotment. The Bonus Debentures are proposed to be rated and listed. The issue and allotment of debentures will account for an amount not exceeding Rs. 520 Crores. The above proposal is subject to the satisfaction of various conditions, including obtaining necessary approvals from the shareholders and regulatory authorities including those of the stock exchanges under the Listing Agreement, Reserve Bank of India and sanction of the scheme of arrangement by the High Court of Andhra Pradesh. Further, the Company has submitted to the Exchange a copy of Press Release dated March 31, 2010 titled ""Dr. Reddy's board approves bonus debentures issue"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_pr_31032010.zip target=NEW> For more details click here.</a>","31-Mar-2010 19:21:00","2010-03-31 19:21:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated March 17, 2010, titled ""Dr. Reddy's Custom Pharmaceutical Services (CPS) business commissions mPEG alcohol manufacturing facility and officially brands its Activated mPEG Products as PEGtech"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/reddy_pr_17032010.zip target=NEW> For more details click here.</a>","17-Mar-2010 17:07:00","2010-03-17 17:07:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""The Governance & Compensation Committee of the Board of Directors of the Company has allotted the following equity shares of Rs.5/- each of the Company, fully paid up on February 26, 2010, to Employees on exercise of their Stock Options. (a) 19,850 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 500 equity shares of Rs.5/- each underlying 500 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007"".","26-Feb-2010 11:28:00","2010-02-26 11:28:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated February 03, 2010, titled ""Sanjeev Verma appointed as new Head of Corporate Communications and Branding"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_pr_03022010.zip target=NEW> For more details click here.</a>","03-Feb-2010 13:44:00","2010-02-03 13:44:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated January 20, 2010, titled ""Dr.Reddy's Q3 FY10 Financial Results- Revenues at Rs. 17,296 million, EBITDA at Rs. 3,666 million, Profits after Tax adjusted for impairment at Rs. 2,307 million"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_20012010.zip target=NEW> For more details click here.</a>","20-Jan-2010 14:16:00","2010-01-20 14:16:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 31-DEC-2009 (Consolidated)","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 170355 lacs for quarter ending on 31-DEC-2009 against Rs. 180499 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. (23307) lacs for the quarter ending on 31-DEC-2009 against Rs. 15916 lacs for the quarter ending on 31-DEC-2008.","20-Jan-2010 14:11:00","2010-01-20 14:11:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 31-DEC-2009 (Standalone)","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2009 as follows: Net Sales of Rs. 103136 lacs for quarter ending on 31-DEC-2009 against Rs. 95212 lacs for the quarter ending on 31-DEC-2008. Net Profit / (Loss) of Rs. 16842 lacs for the quarter ending on 31-DEC-2009 against Rs. 10367 lacs for the quarter ending on 31-DEC-2008.","20-Jan-2010 14:09:00","2010-01-20 14:09:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated January 04, 2010, titled ""Dr.Reddy's and Rheoscience announce headline results from First Phase III clinical trial of Balaglitazone (DRF 2593)"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_pr_04012010.zip target=NEW> For more details click here.</a>","04-Jan-2010 18:24:00","2010-01-04 18:24:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""The Governance & Compensation Committee of the Board of Directors of the Company has allotted the following equity shares of Rs.5/- each of the Company, fully paid up on December 08, 2009, to Employees on exercise of their Stock Options. (a) 21,884 equity shares of Rs.5/- each pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 1,450 equity shares of Rs.5/- each underlying 1,450 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007"".","09-Dec-2009 09:39:00","2009-12-09 09:39:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at their meeting held on October 23, 2009 has appointed Dr. Ashok S Ganguly as an Additional Director on the Board of Directors of the Company with effect from October 23, 2009.","26-Oct-2009 14:42:00","2009-10-26 14:42:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 23, 2009, titled ""Dr. Reddy's Q2 FY10 Results, Revenues at Rs.18,368 million, up by 14% EBITDA at Rs.3,797 million, up by 51%, PAT at Rs.2,173 million, up by 106%"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DReddy_PR_23102009.zip target=NEW> For more details click here.</a>","23-Oct-2009 14:05:00","2009-10-23 14:05:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Half Year ended, 30-SEP-2009 (Consolidated)","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 357921 lacs for half year ending on 30-SEP-2009 against Rs. 305720 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 47874 lacs for the half year ending on 30-SEP-2009 against Rs. 17860 lacs for the half year ending on 30-SEP-2008.","23-Oct-2009 13:45:00","2009-10-23 13:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Half Year ended, 30-SEP-2009 (Standalone)","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2009 as follows: Net Sales of Rs. 221739 lacs for half year ending on 30-SEP-2009 against Rs. 200168 lacs for the half year ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 42450 lacs for the half year ending on 30-SEP-2009 against Rs. 30105 lacs for the half year ending on 30-SEP-2008.","23-Oct-2009 13:44:00","2009-10-23 13:44:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 30-SEP-2009 (Consolidated)","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 180043 lacs for quarter ending on 30-SEP-2009 against Rs. 157594 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 23985 lacs for the quarter ending on 30-SEP-2009 against Rs. 8664 lacs for the quarter ending on 30-SEP-2008.","23-Oct-2009 13:43:00","2009-10-23 13:43:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results Update, Quarter ended, 30-SEP-2009 (Standalone)","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 107322 lacs for quarter ending on 30-SEP-2009 against Rs. 92243 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 19706 lacs for the quarter ending on 30-SEP-2009 against Rs. 9101 lacs for the quarter ending on 30-SEP-2008.","23-Oct-2009 13:42:00","2009-10-23 13:42:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 20, 2009, titled ""Dr. Reddy's joins American Chemicals Society Green Chemistry Instituteﾮ Pharmaceutical Roundtable"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DREDDY_PR_20102009.zip target=NEW> For more details click here.</a>","20-Oct-2009 13:49:00","2009-10-20 13:49:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 06, 2009, titled ""Dr. Reddy's launches Strea(TM) C10 and Strea(TM) A15 in India"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_pr_06102009.zip target=NEW> For more details click here.</a>","06-Oct-2009 16:32:00","2009-10-06 16:32:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""The Governance & Compensation Committee of the Board of Directors of the Company has allotted the following equity shares of Rs.5/- each of the Company on October 5, 2009, to Employees on exercise of their Stock Options. (a) 41,140 equity shares of Rs.5/- each of the Company pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 15,282 equity shares of Rs.5/- each underlying 15,282 ADRs of the Company pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007"".","05-Oct-2009 15:02:00","2009-10-05 15:02:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares/ others","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Governance & Compensation Committee of the Board of Directors of the Company has allotted the following equity shares of Rs.5/- each of the Company on September 3, 2009, to Director/Employees on exercise of their Stock Options. (a) 69,519 equity shares of Rs.5/- each of the Company pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002. (b) 8,490 equity shares of Rs.5/- each underlying 8,490 ADRs. of the Company pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.","03-Sep-2009 12:31:00","2009-09-03 12:31:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Proceedings of AGM","Dr. Reddy's Laboratories Ltd. has submitted to the Exchange a copy of the minutes of the proceedings of the Annual General Meeting of the company held on July 22, 2009. A copy of the same shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_AGMProc_26082009.zip target=NEW> For more details click here.</a>","26-Aug-2009 11:49:00","2009-08-26 11:49:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated August 13, 2009, titled ""Dr. Reddy's launches Strea(TM) Professional in India"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy01_pr_13082009.zip target=NEW> For more details click here.</a>","13-Aug-2009 11:28:00","2009-08-13 11:28:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated August 05, 2009, titled ""Dr. Reddy's launches FINRID (TM) in India"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRREDDY_PR_05082009.zip target=NEW> For more details click here.</a>","05-Aug-2009 11:25:00","2009-08-05 11:25:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 30, 2009, titled ""Dr. Reddy's launches Execare (TM) in India"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_Pr_30072009.zip target=NEW> For more details click here.</a>","30-Jul-2009 14:54:00","2009-07-30 14:54:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of AGM","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding the outcome of Annual General Meeting held on July 22, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_AGM_22072009.zip target=NEW> For more details click here.</a>","22-Jul-2009 19:09:00","2009-07-22 19:09:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 21, 2009, titled ""Dr. Reddy's Q1 FY10 Results, Revenues at Rs.18,189 million, up by 21% EBITDA at Rs.4,364 million, up by 90%, PAT at Rs.2,445 million, up by 120%"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRREDDY_pr_21072009.zip target=NEW> For more details click here.</a>","21-Jul-2009 16:37:00","2009-07-21 16:37:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 30-JUN-2009","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 114417 lacs for quarter ending on 30-JUN-2009 against Rs. 107925 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 22744 lacs for the quarter ending on 30-JUN-2009 against Rs. 21005 lacs for the quarter ending on 30-JUN-2008.","21-Jul-2009 16:14:00","2009-07-21 16:14:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-JUN-2009","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 177878 lacs for quarter ending on 30-JUN-2009 against Rs. 148126 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 23889 lacs for the quarter ending on 30-JUN-2009 against Rs. 9197 lacs for the quarter ending on 30-JUN-2008.","21-Jul-2009 16:11:00","2009-07-21 16:11:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 07, 2009, titled ""Dr. Reddy's Laboratories Limited announces filing of Annual Report on From 20-F"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRREDDY_PR_070720009.zip target=NEW> For more details click here.</a>","07-Jul-2009 11:44:00","2009-07-07 11:44:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated June 23, 2009, titled ""Dr. Reddy's launches Bispec(TM) in India"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_pr_23062009.zip target=NEW> For more details click here.</a>","23-Jun-2009 16:47:00","2009-06-23 16:47:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that : ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Governance & Compensation Committee of the Board of Directors of the Company has allotted 150,058 equity shares of Rs. 5 each of the Company on June 17, 2009, to Directors/ Employees who have exercised their Stock Options. Further, pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007, the Governance & Compensation Committee of the Board of Directors of the Company has allotted 48,435 equity shares of Rs. 5 each underlying 48,435 ADRs of the Company on June 17, 2009, to a Director/ Employees of the Company who have exercised their Stock Options.""","18-Jun-2009 13:04:00","2009-06-18 13:04:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated June 15, 2009, titled ""Dr. Reddy's announces strategic alliance with GSK for Emerging Markets"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRReddy_PR_15062009.zip target=NEW> For more details click here.</a>","15-Jun-2009 18:17:00","2009-06-15 18:17:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 7, 2009 to July 11, 2009 (both days inclusive) for the purpose of Annual General Meeting of the shareholders of the Company and for determining the shareholders who would be entitled for the payment of dividend, if declared at the forthcoming Annual General Meeting, scheduled to be held on July 22, 2009.","11-Jun-2009 14:35:00","2009-06-11 14:35:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated June 09, 2009, titled ""Dr. Reddy's announces ANDA approval of Omeprazole Mg OTC"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_PR_09062009.zip target=NEW> For more details click here.</a>","09-Jun-2009 18:29:00","2009-06-09 18:29:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 21, 2009, titled ""Dr. Reddy's receives approval for Three INDs and announces reorganization of its Drug Discovery Operations"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreaddy_pr_21052009.ZIP target=NEW> For more details click here.</a>","21-May-2009 15:54:00","2009-05-21 15:54:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Stock Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""The Board of Directors of the Company on May 18, 2009, approved the grant of 9,000 stock options, exercisable at par value of Rs.5/- to the Independent Directors of the Company under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and also approved the grant of 9,000 stock options, exercisable at par value of Rs.5/- to the Independent Directors of the Company under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"". Further the Compensation Committee of the Board of Directors of the Company on May 18, 2009 approved the grant of 350,840 stock options, exercisable at par value of Rs.5/- to the employees of the Company under ""Dr. Reddy's Employees Stock Option Scheme, 2002"" and also approved the grant of 65,600 stock options, exercisable at par value of Rs.5/- to the employees of the Company under ""Dr. Reddy's Employees ADR Stock Option Scheme, 2007"".","20-May-2009 15:18:00","2009-05-20 15:18:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 31-MAR-2009","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 104583 lacs for quarter ending on 31-MAR-2009 against Rs. 98887 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 15617 lacs for the quarter ending on 31-MAR-2009 against Rs. 16226 lacs for the quarter ending on 31-MAR-2008.","18-May-2009 16:03:00","2009-05-18 16:03:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Year ended, 31-MAR-2009","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 399963 lacs for year ending on 31-MAR-2009 against Rs. 333066 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 56089 lacs for the year ending on 31-MAR-2009 against Rs. 47522 lacs for the year ending on 31-MAR-2008.","18-May-2009 16:02:00","2009-05-18 16:02:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 18, 2009, titled ""Dr. Reddy's FY09 Revenues at Rs.69,441 million; EBITDA at Rs.14,505 million"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRReddy_pr_18052009.zip target=NEW> For more details click here.</a>","18-May-2009 16:01:00","2009-05-18 16:01:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Final Dividend","Dr. Reddy's Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on May 18, 2009 have recommended a final dividend of 125% i.e. Rs. 6.25 per equity share of  Rs. 5/- face value, subject to the approval of shareholders  at the ensuing Annual General Meeting.","18-May-2009 16:01:00","2009-05-18 16:01:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Year ended, 31-MAR-2009","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2009 as follows: Net Sales of Rs. 679037 lacs for year ending on 31-MAR-2009 against Rs. 491417 lacs for the year ending on 31-MAR-2008. Net Profit / (Loss) of Rs. (91724) lacs for the year ending on 31-MAR-2009 against Rs. 43813 lacs for the year ending on 31-MAR-2008.","18-May-2009 15:55:00","2009-05-18 15:55:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 28, 2009, titled ""Dr. Reddy's launches Nexret (TM)"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_pr_28042009.zip target=NEW> For more details click here.</a>","28-Apr-2009 15:09:00","2009-04-28 15:09:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 22, 2009, titled ""Dr. Reddy's launches Redispar (TM) in India"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_22042009.zip target=NEW> For more details click here.</a>","22-Apr-2009 16:07:00","2009-04-22 16:07:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Publish Audited Results","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company will announce and publish the Audited Annual Results of the Company for the year ended March 31, 2009 instead of Unaudited Quarterly Results for the Quarter ended March 31, 2009.","06-Apr-2009 12:04:00","2009-04-06 12:04:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated March 19, 2009, titled ""Dr. Reddy's Laboratories realigns Global Generics geography portfolio"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_19032009.ZIP target=NEW> For more details click here.</a>","19-Mar-2009 17:44:00","2009-03-19 17:44:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated March 18, 2009, titled ""Dr. Reddy's crosses $150 million revenue milestone in Russia & CIS region"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_18032009.ZIP target=NEW> For more details click here.</a>","18-Mar-2009 17:43:00","2009-03-18 17:43:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated March 12, 2009, titled ""Dr. Reddy's receives favorable summary judgment ruling in the Omeprazole Mg OTC litigation"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_13032009.zip target=NEW> For more details click here.</a>","13-Mar-2009 18:37:00","2009-03-13 18:37:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy's Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option scheme, 2002 the Compensation Committee of the Board of Directors of the Company has allotted 29,888 equity shares of Rs.5 each of the Company on March 09, 2009 to employees who have exercised their Stock Options. Further, pursuant to Dr. Reddy's Employees ADR Stock Option scheme, 2007, the Compensation Committee of the Board of Directors of the Company has allotted 9,752 ADR's of Rs.5 each of the Company on March 09, 2009 to US employees of the Company who have exercised their ADR Stock Options.","09-Mar-2009 11:57:00","2009-03-09 11:57:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Limited Review Report","Dr. Reddy's Laboratories Ltd. has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended December  31,2008.A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRREDDY_LR_25022009.zip target=NEW> For more details click here.</a>","25-Feb-2009 12:53:00","2009-02-25 12:53:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Regulation 8A of SEBI (Susbs Acq of shares & Takeovers)","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""We have been informed by the promoters/promoter group of the company that pledge on 4,10,000 equity shares of the company held by them, have been released. Accordingly, the percentage of pledged shares has come down from 6.19% to 5.94% of the outstanding share capital of the company as on Febuary 16, 2009."" The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","16-Feb-2009 16:44:00","2009-02-16 16:44:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Regulation 8A of SEBI (Susbs Acq of shares & Takeovers)","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the company has been informed by the promoters / promoter group of the Company that they have pledged 10,419,829 equity shares of the Company held by them. This represents 6.19% of the company's outstanding shares as on date. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_Pledge_06022009.zip target=NEW> For more details click here.</a>","06-Feb-2009 19:24:00","2009-02-06 19:24:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated February 05, 2009, titled ""Dr. Reddy's announces five ANDA approvals and Generic product launches in the US Market"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_pr_05022009.zip target=NEW> For more details click here.</a>","05-Feb-2009 17:13:00","2009-02-05 17:13:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Resignation","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that Prof. Krishna G. Palepu, non-executive Director on the Board of Directors of the Company has resigned from his position with effect from January 20, 2009. The Board has accepted his resignation with immediate effect and appreciated his contribution to the Company.","20-Jan-2009 16:32:00","2009-01-20 16:32:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated January 20, 2009, titled ""Dr. Reddy's Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 million"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_pr_20012009.zip target=NEW> For more details click here.</a>","20-Jan-2009 16:31:00","2009-01-20 16:31:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Quarter ended, 31-DEC-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 180499 lacs for quarter ending on 31-DEC-2008 against Rs. 119915 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 15916 lacs for the quarter ending on 31-DEC-2008 against Rs. 6226 lacs for the quarter ending on 31-DEC-2007.","20-Jan-2009 16:31:00","2009-01-20 16:31:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 31-DEC-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 95212 lacs for quarter ending on 31-DEC-2008 against Rs. 76370 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 10367 lacs for the quarter ending on 31-DEC-2008 against Rs. 4229 lacs for the quarter ending on 31-DEC-2007.","20-Jan-2009 16:29:00","2009-01-20 16:29:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated January 02, 2009, titled ""Dr Reddyﾒs announces the appointment of new Chief Financial Officer (CFO)"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_PR_02012009.zip target=NEW> For more details click here.</a>","02-Jan-2009 11:11:00","2009-01-02 11:11:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated December 23, 2008, titled ""Dr. Reddy's Laboratories announce settlement of Clarinex (R) (Desloratadine) ANDA patent litigation with Schering Corporation and Sepracor Inc."". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRREDDY_PR_23122008.zip target=NEW> For more details click here.</a>","23-Dec-2008 18:42:00","2008-12-23 18:42:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOP","Dr. Reddy's Laboratories Ltd. has informed the Exchange that ""Pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007, the Compensation Committee of the Board of Directors of the Company has allotted 7,000 ADRs of Rs.5 each of the Company on December 17, 2008, to US Employee of the Company who has exercised his ADR Stock Options.""","18-Dec-2008 10:43:00","2008-12-18 10:43:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares/ others","Dr. Reddy's Laboratories Ltd. has informed the Exchange that ""Pursuant to Dr. Reddy's employees stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has approved the grant of 20,000 stock options at fair market value on December 02, 2008 to an employee of the Company. Pursuant to Dr. Reddy's Employees Stock option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 21,109 equity shares of Rs.5 each of the Company on December 02, 2008, to Employees who have exercised their Stock option. Pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007, the Compensation Committee of the Board of directors of the Company has allotted 300 ADR of Rs. 5 each of the Company on December 02, 2008, to US Employee of the Company who has exercised her ADR Stock Option"".","04-Dec-2008 11:38:00","2008-12-04 11:38:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated November 24, 2008, titled ""Dr. Reddy's launches authorized generic version of Imitrex Tablets"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_PR_24112008.zip target=NEW> For more details click here.</a>","24-Nov-2008 19:31:00","2008-11-24 19:31:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Scheme of Amalgamation","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on October 23, 2008 have, subject to such approvals as are required, approved a Scheme of Amalgamation by which Perlecan Pharma Private Limited, a subsidiary of the Company will be amalgamated with Dr Reddy's Laboratories Limited, effective January 01, 2006.","23-Oct-2008 14:04:00","2008-10-23 14:04:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 23, 2008, titled ""Dr. Reddy's Q2 FY09 Revenue at Rs. 16,151 million, EBITDA at Rs. 2,746 million, PAT at Rs. 1,212 million"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/dRREDDY_pr_23102008.zip target=NEW> For more details click here.</a>","23-Oct-2008 13:58:00","2008-10-23 13:58:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Half Yearly ended, 30-SEP-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 200168 lacs for half year ending on 30-SEP-2008 against Rs. 157810 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 30105 lacs for the half year ending on 30-SEP-2008 against Rs. 27069 lacs for the half year ending on 30-SEP-2007.","23-Oct-2008 13:55:00","2008-10-23 13:55:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 30-SEP-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 92243 lacs for quarter ending on 30-SEP-2008 against Rs. 85040 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 9101 lacs for the quarter ending on 30-SEP-2008 against Rs. 12500 lacs for the quarter ending on 30-SEP-2007.","23-Oct-2008 13:54:00","2008-10-23 13:54:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Half Yearly ended, 30-SEP-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the half year ended on 30-SEP-2008 as follows: Net Sales of Rs. 305720 lacs for half year ending on 30-SEP-2008 against Rs. 244844 lacs for the half year ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 17860 lacs for the half year ending on 30-SEP-2008 against Rs. 29741 lacs for the half year ending on 30-SEP-2007.","23-Oct-2008 13:54:00","2008-10-23 13:54:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-SEP-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 157594 lacs for quarter ending on 30-SEP-2008 against Rs. 125570 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 8664 lacs for the quarter ending on 30-SEP-2008 against Rs. 11047 lacs for the quarter ending on 30-SEP-2007.","23-Oct-2008 13:53:00","2008-10-23 13:53:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 14, 2008, titled ""Dr. Reddy's wholly-owned subsidiary Promius Pharma launches EPICERAM (R) skin barrier emulsion "". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Dr.Reddy_PR_14102008.zip target=NEW> For more details click here.</a>","14-Oct-2008 15:21:00","2008-10-14 15:21:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disclosure of shareholding","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""Pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 1992 and further to the intimation received from Mr. Anupam Puri, Independent Director on the Board of the Company, we hereby intimate you that Ms. Rajika Puri, wife of Mr. Anupam Puri, has made a sale of 4000 ADRs of the Company on September 26, 2008"".","01-Oct-2008 12:59:00","2008-10-01 12:59:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 25, 2008, titled ""Dr Reddy's enters the respiratory inhalers market in India with the launch of 'Combihale' and 'Redihaler' Forays into inhalation asthama market"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).   <a href=/content/corporate/DRREDDY_PR_25092008.zip target=NEW> For more details click here.</a>","25-Sep-2008 15:45:00","2008-09-25 15:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees  ADR Stock Option Scheme, 2007, the Compensation Committee of the Board of Directors of the Company has allotted 21,800 ADRs of Rs.5 each of the Company on September 23, 2008, to US Employees of the Company who have exercised their ADR Stock Options.","23-Sep-2008 11:42:00","2008-09-23 11:42:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 18, 2008,  titled "" Dr. Reddy's formally announces its US Specialty Business, Promius Pharma, LLC"". A copy of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_18092008.zip target=NEW> For more details click here.</a>","18-Sep-2008 16:21:00","2008-09-18 16:21:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 04, 2008, titled ""Dr Reddy's announces partnership with Cosmederm Technologies for Indian distribution of proprietary skin care products"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).  <a href=/content/corporate/drreddy_PR_04092008.zip target=NEW> For more details click here.</a>","04-Sep-2008 15:44:00","2008-09-04 15:44:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 65,575 equity shares of Rs.5 each of the Company on August 27, 2008, to Directors / Employees who have exercised their Stock Options"".","27-Aug-2008 15:12:00","2008-08-27 15:12:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Updates","Dr. Reddy'S Laboratories Ltd. had informed the Exchange regarding outcome of the Annual General Meeting of the Company held on July 22, 2008. The Company has now informed the Exchange with reference to Item 8 of the outcome of the Annual General Meeting of the Company that, the proposed issue of 84,06,782 share warrants resulting into equity shares of Rs.5/- each at a later date of preferential basis in terms of Section 81 (1A) of the Companies Act, 1856 to Dr. Reddy's Holdings Private Limited, as approved at the Annual General Meeting of the Company held on July 22, 2008 stands cancelled / withdrawn as the issue / allotment has not taken place in terms of Chapter XIII-Clause 13.1.2.3(a) and Clause 13.4.1 of SEBI (Disclosure& Investor Protection) Guidelines, 2000. Pursuant to this, the Company has withdraw its application made to the stock exchanges earlier, for in-principle approval sought in respect of the above shares.","08-Aug-2008 09:30:00","2008-08-08 09:30:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 30, 2008, titled ""Dr. Reddy's Laboratories Limited invests in Perlecan Pharma Private Limited by acquiring shares of Joint Venture Partners"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/REDDY_PR_30072008.zip target=NEW> For more details click here.</a>","30-Jul-2008 20:07:00","2008-07-30 20:07:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of AGM","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding the outcome of Annual General Meeting of the Company held on July 22, 2008.The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRReddy_OutcomeofAGm_22072008.zip target=NEW> For more details click here.</a>","22-Jul-2008 15:46:00","2008-07-22 15:46:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-JUN-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 148126 lacs for quarter ending on 30-JUN-2008 against Rs. 118809 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 9197 lacs for the quarter ending on 30-JUN-2008 against Rs. 18723 lacs for the quarter ending on 30-JUN-2007.","21-Jul-2008 14:00:00","2008-07-21 14:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 30-JUN-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 107925 lacs for quarter ending on 30-JUN-2008 against Rs. 72770 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 21005 lacs for the quarter ending on 30-JUN-2008 against Rs. 14569 lacs for the quarter ending on 30-JUN-2007.","21-Jul-2008 13:57:00","2008-07-21 13:57:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 21, 2008, titled ""Dr. Reddy'S Q1 FY09 Revenue at Rs.15,038 million; EBITDA at Rs.2,710 million, PAT at Rs. 1,346 million"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_pr_21072008.zip target=NEW> For more details click here.</a>","21-Jul-2008 13:51:00","2008-07-21 13:51:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 18, 2008, titled ""Dr. Reddy'S Annual Report on Form 20-F for the year ended March 31, 2008 available on the Company's website"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRReddys_Pr_18072008.zip target=NEW> For more details click here.</a>","18-Jul-2008 12:28:00","2008-07-18 12:28:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 08, 2008, titled ""Dr Reddy's  signs global distribution agreement with Albemarle Corporation for Ibuprofen API"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_08072008.zip target=NEW> For more details click here.</a>","08-Jul-2008 17:41:00","2008-07-08 17:41:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Payment of Dividend","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the dividend, which may be declared at the Annual General Meeting scheduled to be held on July 22, 2008, shall be paid to the shareholders on or after July 29, 2008.","07-Jul-2008 12:02:00","2008-07-07 12:02:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees  ADR Stock Option Scheme, 2007, the Compensation Committee of the Board of Directors of the Company has allotted 15,970 ADRs of Rs.5 each of the Company on July 02, 2008, to US Employees of the Company who have exercised their ADR Stock Options.","02-Jul-2008 16:56:00","2008-07-02 16:56:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 93,297 equity shares of Rs.5 each of the Company on June 17, 2008, to Directors/Employees who have exercised their Stock Options.","17-Jun-2008 17:07:00","2008-06-17 17:07:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Book Closure","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the register of members and share transfer books of the Company would remain closed from July 08, 2008 to July 12, 2008 (both days inclusive) for the purpose of payment of Dividend for the year 2007-08. The said payment of dividend is subject to the approval of Shareholders of the Company at the ensuing Annual General Meeting (AGM) scheduled to be held on July 22, 2008.","16-Jun-2008 14:59:00","2008-06-16 14:59:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 29, 2008, titled ""Dr Reddy's launches 'Atocor - R' - combination of Atorvastatin and Ramipril in India"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_29052008.zip target=NEW> For more details click here.</a>","29-May-2008 14:20:00","2008-05-29 14:20:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 22, 2008, titled ""Dr Reddy's launches 'Omez Insta' - Immediate Release Omeprazole in sachets"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddys_PR_22052008.zip target=NEW> For more details click here.</a>","22-May-2008 16:19:00","2008-05-22 16:19:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 31-MAR-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 98887 lacs for quarter ending on 31-MAR-2008 against Rs. 105933 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 16226 lacs for the quarter ending on 31-MAR-2008 against Rs. 26890 lacs for the quarter ending on 31-MAR-2007.","20-May-2008 15:47:00","2008-05-20 15:47:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Year ended, 31-MAR-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 333066 lacs for year ending on 31-MAR-2008 against Rs. 375010 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 47522 lacs for the year ending on 31-MAR-2008 against Rs. 117686 lacs for the year ending on 31-MAR-2007.","20-May-2008 15:45:00","2008-05-20 15:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of Board Meeting","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on May 20, 2008: 1) Mr. P.N. Devarjan ceased to be the Director of the Company effective as on date. 2) The Compensation committee approved the grant of 407,220 stock options at par value to the employees of the Company. 3) The Board of Directors approved grant of 18,000 stock options at par value to the Independent Directors of the Company. 4) The Board of Directors based on the recommendation of the Compensation Committee proposed for an amendment in the existing schemes of stock options subjects to the shareholders approval. 5) The Board of Directors approved the appointment of Mr. V. S. Suresh as Company Secretary in place of Mr. V. Viswanath, who moved Director, Finance in BFROW Business Operations.","20-May-2008 15:29:00","2008-05-20 15:29:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 20, 2008, titled ""Dr. Reddy's FY08 Revenue at Rs.50,006 million; EBITDA at Rs.9,736 million"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Dr.Reddy_PR_20052008.zip target=NEW> For more details click here.</a>","20-May-2008 14:20:00","2008-05-20 14:20:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Final Dividend","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at its meeting held on May 20, 2008 have recommended a final dividend of 75% i.e. Rs. 3.75 per share of the face value of Rs. 5 subject to the shareholders approval.","20-May-2008 14:20:00","2008-05-20 14:20:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Year ended, 31-MAR-2008","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 491417 lacs for year ending on 31-MAR-2008 against Rs. 643463 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 43813 lacs for the year ending on 31-MAR-2008 against Rs. 96589 lacs for the year ending on 31-MAR-2007.","20-May-2008 14:18:00","2008-05-20 14:18:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares/ others","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 2,870 equity shares of Rs.5 each of the Company on May 03, 2008, to an Employees who has exercised his Stock Options. Further, Pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007, the Compensation Committee of the Board of Directors of the Company has allotted 17,604 ADRs of Rs.5 each of the Company on May 03, 2008, to US Employees of the Company who have exercised their ADR Stock Options.","05-May-2008 17:58:00","2008-05-05 17:58:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 01, 2008, titled ""Dr. Reddy's announces the completion of two acquisitions"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRREDDY_PR_02052008.zip target=NEW> For more details click here.</a>","02-May-2008 08:36:00","2008-05-02 08:36:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding a press release dated April 30, 2008, titled ""Dr. Reddy's Acquires BASF's Pharmaceutical Contract Manufacturing Business and related facility at Shreveport in the US"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_Pr_30042008.zip target=NEW> For more details click here.</a>","30-Apr-2008 08:55:00","2008-04-30 08:55:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""Pursuant to Dr. Reddy's Employees Stock Options Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 10,866 equity Shares of Rs. 5 each of the Company on April 21, 2008, to Employees who have exercised their Stock Options.""","22-Apr-2008 10:11:00","2008-04-22 10:11:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Publish Audited Results","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""The Company will announce and publish the audited annual results of the Company for the year ended March 31, 2008 instead of unaudited quarterly results for the quarter ended March 31, 2008"".","08-Apr-2008 16:45:00","2008-04-08 16:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 03, 2008,  titled ""Dr. Reddy's acquires Jet Generici Srl. Acquisition to establish Generics business in Italy"". A copy of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_03042008.zip target=NEW> For more details click here.</a>","03-Apr-2008 14:40:00","2008-04-03 14:40:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 01, 2008,  titled ""Dr. Reddy's signs definitive agreement to acquire Dowpharma Small Molecules business associated with Dow's Mirfield and Cambridge, UK Sites"". A copy of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_01042008.zip target=NEW> For more details click here.</a>","01-Apr-2008 09:53:00","2008-04-01 09:53:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated March 10, 2008,  titled ""Dr. Reddy's Enters into Drug Discovery Collaboration with 7TM Pharma on Selected Drug Targets"". A copy of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRreddy_PR_10032008.zip target=NEW> For more details click here.</a>","10-Mar-2008 15:19:00","2008-03-10 15:19:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy's Laboratories Ltd. has informed the Exchange that ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 37,094 equity shares of Rs.5 each of the Company on February  21, 2008, to Employees who have exercised their Stock Options"".","22-Feb-2008 11:03:00","2008-02-22 11:03:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding a press release dated February 08, 2008, titled ""Dr. Reddy's Announces collaboration with SkyePharma for New Product utilizing two of SkyePharma's proprietary drug delivery systems"". A copy of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_08022008.zip target=NEW> For more details click here.</a>","08-Feb-2008 12:52:00","2008-02-08 12:52:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated January 25, 2008, titled ""Dr. Reddy's Q3 FY08 Revenue at Rs 12,320 million; EBITDA at Rs 2,037 million"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRreddy_PR_25012008.zip target=NEW> For more details click here.</a>","25-Jan-2008 16:31:00","2008-01-25 16:31:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Preferential issue","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that  ""The Board of Directors of the Company has considered and approved raise of further equity by way of preferential issue of share warrants up to 5% of the existing equity of the Company exercisable into equal number of equity Shares of Rs.5 each to the promoters/ Promoter Group as per ""Guidelines on Preferential Issues"" under Chapter XIII of the SEBI (DIP) Guidelines, 2000, subject to the shareholders approval.""","25-Jan-2008 16:18:00","2008-01-25 16:18:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Quarter ended, 31-DEC-2007","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 119915 lacs for quarter ending on 31-DEC-2007 against Rs. 147837 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 6255 lacs for the quarter ending on 31-DEC-2007 against Rs. 10563 lacs for the quarter ending on 31-DEC-2006.","25-Jan-2008 15:59:00","2008-01-25 15:59:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 31-DEC-2007","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 76370 lacs for quarter ending on 31-DEC-2007 against Rs. 115339 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 4229 lacs for the quarter ending on 31-DEC-2007 against Rs. 50349 lacs for the quarter ending on 31-DEC-2006.","25-Jan-2008 15:58:00","2008-01-25 15:58:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated January 21, 2008, titled ""Dr. Reddy's announces settlement of Exelon(R) (rivastigmine tartrate) ANDA litigation with Novartis"". A copy of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_21012008.zip target=NEW> For more details click here.</a>","21-Jan-2008 12:53:00","2008-01-21 12:53:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated January 16, 2008, titled ""Dr. Reddy's launches Supanac(R) - (Diclofenac potassium)"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_16012008.zip target=NEW> For more details click here.</a>","16-Jan-2008 17:37:00","2008-01-16 17:37:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy's Laboratories Ltd. has informed the Exchange that ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 3,510 equity shares of Rs.5 each of the Company on January 04, 2008, to Employees who have exercised their Stock Options"".","04-Jan-2008 12:40:00","2008-01-04 12:40:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Resignation","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""Mr. Girish Tekchandani, Asst. Company Secretary has resigned and relieved from our Company with effect from December 7, 2007"".","11-Dec-2007 20:38:00","2007-12-11 20:38:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated November 26, 2007 titled ""Sygnis AG and DR.Reddy's Sign Exclusive Supply Collaboration for AX200 in Stroke"". The details of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR2_26112007.zip target=NEW> For more details click here.</a>","26-Nov-2007 15:57:00","2007-11-26 15:57:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated November 26, 2007, titled ""Argenta Discovery and Dr Reddy's progress pre-clinical anti-inflammatory candidate to treat chronic respiratory disease"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_26112007.zip target=NEW> For more details click here.</a>","26-Nov-2007 15:34:00","2007-11-26 15:34:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 24, 2007, titled ""Dr. Reddy's Q2 FY08 revenue at Rs 12,670 million; Net Income at Rs 2,672 million"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)<a href=/content/corporate/drreddy_PR_241007.zip target=NEW> For more details click here.</a>","24-Oct-2007 16:52:00","2007-10-24 16:52:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-SEP-2007","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 125570 lacs for quarter ending on 30-SEP-2007 against Rs. 194396 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 11060 lacs for the quarter ending on 30-SEP-2007 against Rs. 29250 lacs for the quarter ending on 30-SEP-2006.","24-Oct-2007 16:49:00","2007-10-24 16:49:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 30-SEP-2007","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 85040 lacs for quarter ending on 30-SEP-2007 against Rs. 83645 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 12500 lacs for the quarter ending on 30-SEP-2007 against Rs. 27266 lacs for the quarter ending on 30-SEP-2006.","24-Oct-2007 16:45:00","2007-10-24 16:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 30-SEP-2007","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2007 as follows: Net Sales of Rs. 85040 lacs for quarter ending on 30-SEP-2007 against Rs. 83645 lacs for the quarter ending on 30-SEP-2006. Net Profit / (Loss) of Rs. 12500 lacs for the quarter ending on 30-SEP-2007 against Rs. 27266 lacs for the quarter ending on 30-SEP-2006.","24-Oct-2007 16:44:00","2007-10-24 16:44:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that : ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 34,700 equity shares of Rs. 5 each of the Company on October 5, 2007, to Directors/Employees who have exercised their Stock Options.""","08-Oct-2007 15:37:00","2007-10-08 15:37:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 28, 2007, titled ""Dr. Reddy's Annual Report on Form 20-F for year ended March 31, 2007 available on the Company's Website"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR2_28092007.zip target=NEW> For more details click here.</a>","28-Sep-2007 16:42:00","2007-09-28 16:42:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 28, 2007, titled ""Dr. Reddy's commences operations in Philippines"". The details of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_28092007.zip target=NEW> For more details click here.</a>","28-Sep-2007 15:48:00","2007-09-28 15:48:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 13, 2007, titled ""Dr. Reddy's receives USFDA approval for Ranitidine (Zantac TM) Tablets, 150mg (OTC)"". The details of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_12092007.zip target=NEW> For more details click here.</a>","13-Sep-2007 10:45:00","2007-09-13 10:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 05, 2007, titled ""Dr. Reddy's enters the Dermatology topical anti-fungal market with the launch of 'Ebernet TM'-(Eberconazole)"". The details of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_05092007.zip target=NEW> For more details click here.</a>","05-Sep-2007 12:13:00","2007-09-05 12:13:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated August 01, 2007, titled ""Rheoscience and Dr. Reddy's commence the first Phase III trial of Balaglitazone (DRF 2593)"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddys_PR1_01082007.zip target=NEW> For more details click here.</a>","01-Aug-2007 15:50:00","2007-08-01 15:50:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of AGM","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the members of the Company passed the resolutions unanimously at the Annual General Meeting of the Company held on July 24, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/drreddy_agm_250707.zip target=NEW> For more details click here.</a>","25-Jul-2007 16:28:00","2007-07-25 16:28:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 23, 2007, titled ""Dr. Reddy's Q1 FY08 revenue at Rs 12,018 million; Net income at Rs 1,825 million"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR2_23072007.zip target=NEW> For more details click here.</a>","23-Jul-2007 17:42:00","2007-07-23 17:42:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Consolidated Results Update, Quarter ended, 30-JUN-2007","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 118809 lacs for quarter ending on 30-JUN-2007 against Rs. 133676 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 18723 lacs for the quarter ending on 30-JUN-2007 against Rs. 12892 lacs for the quarter ending on 30-JUN-2006.","23-Jul-2007 16:09:00","2007-07-23 16:09:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Standalone Results Update, Quarter ended, 30-JUN-2007","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 72770 lacs for quarter ending on 30-JUN-2007 against Rs. 70093 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 14569 lacs for the quarter ending on 30-JUN-2007 against Rs. 13181 lacs for the quarter ending on 30-JUN-2006.","23-Jul-2007 15:55:00","2007-07-23 15:55:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 10, 2007, titled ""Dr. Reddy's launches Glimy MP1 and Glimy MP2"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_10072007.zip target=NEW> For more details click here.</a>","10-Jul-2007 16:56:00","2007-07-10 16:56:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Notice of AGM","Dr. Reddy'S Laboratories Ltd. has submitted to the Exchange a copy of the notice of the Annual General Meeting of the Company to be held on July 24, 2007. A copy of the same shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Dr.Reddy_100707.zip target=NEW> For more details click here.</a>","10-Jul-2007 15:04:00","2007-07-10 15:04:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that: ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has allotted 47,590 equity shares of Rs.5 each of the Company on July 10, 2007, to Employees who have exercised their Stock Options"".","10-Jul-2007 12:42:00","2007-07-10 12:42:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM/Others","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the dividend, which may be declared at the Annual General Meeting scheduled to be held on July 24, 2007, shall be paid to the shareholders on or after July 30, 2007.","10-Jul-2007 11:53:00","2007-07-10 11:53:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of Equity Shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that: ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has allotted 137,672 equity shares of Rs.5 each of the Company on June 21, 2007, to Directors/Employees who have exercised their Stock Options"".","26-Jun-2007 18:14:00","2007-06-26 18:14:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Book Closure","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that: ""The register of members and transfer register of the Company would remain closed from July 10 to July 14, 2007 (both days inclusive) for the purpose of payment of Dividend for the year 2006-07"".","18-Jun-2007 17:12:00","2007-06-18 17:12:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated June 15, 2007, titled ""Dr. Reddy's commences operations in Nigeria"". The details of the press release shall be available on the NSE website   (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR_15062007.zip target=NEW> For more details click here.</a>","15-Jun-2007 15:50:00","2007-06-15 15:50:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated June 08, 2007, titled ""Dr. Reddy's enters the Dermatology topical steroid market with the launch of 'UltravexTM' - (Halobetasol)"". A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_08062007.zip target=NEW> For more details click here.</a>","08-Jun-2007 14:14:00","2007-06-08 14:14:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that: ""The Board of Directors have appointed Ms.Kalpana Morparia as an Additional Director on the Board of the Company by way of a circular resolution dated June 05, 2007"".","05-Jun-2007 13:30:00","2007-06-05 13:30:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 18, 2007 , titled ""Dr. Reddy's FY07 revenue at Rs.65,095 million (US$ 1.5 billion) Net Income at Rs. 9,327 million (US$ 216 million"""". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddyPR180507.zip target=NEW> For more details click here.</a>","18-May-2007 15:46:00","2007-05-18 15:46:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Appointment/Others","Dr. Reddy'S Laboratories Ltd. has informed the Exchange with respect to the Board Meeting held on May 18, 2007 that: ""(1) The Board of Directors has appointed Dr. J P Moreau as Additional Director on the Board of the Company. (2) The Compensation Committee has granted 466,460 stock options including 87,500 ADR linked stock options to the employees of the Company. The shares covered by such options are 466,460. The options have been granted at a price of Rs.5 per option. The options may be exercised in a phased manner after a vesting period of 12 months but before completion of five years from the date of vesting"".","18-May-2007 15:19:00","2007-05-18 15:19:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors at its meeting held on May 18, 2007 have recommended a final dividend of 75% i.e. Rs. 3.75 per share of face value of Rs.5 on the enhanced share capital due to bonus issue in August 2006.","18-May-2007 14:59:00","2007-05-18 14:59:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 30, 2007, titled ""Dr. Reddy's announces new R&D Chief"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR30042007.zip target=NEW> For more details click here.</a>","30-Apr-2007 20:16:00","2007-04-30 20:16:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 30, 2007, titled ""Dr Reddy's launches Reditux(TM)- Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DRreddy_PR_30042007.zip target=NEW> For more details click here.</a>","30-Apr-2007 17:57:00","2007-04-30 17:57:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release, dated April 25, 2007, titled ""Dr. Reddy's announces the launch of Zolpidem Tartrate tablets"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR250407.zip target=NEW> For more details click here.</a>","25-Apr-2007 09:59:00","2007-04-25 09:59:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release, dated April 24, 2007, titled ""Dr. Reddy's employees awarded PG certificates from BITS Pilani."" The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/DrReddy_PR240407.zip target=NEW> For more details click here.</a>","24-Apr-2007 17:09:00","2007-04-24 17:09:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release, dated April 17, 2007, titled ""Dr. Reddy's is the first Participant in United States Pharmacopoeia's New Pharmaceutical Ingredient Verification Programme"". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_17042007.zip target=NEW> For more details click here.</a>","17-Apr-2007 14:16:00","2007-04-17 14:16:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that: ""The Company has granted 126,418 stock options at par value of Rs.5 per option, to the US Employees of the Company at the meeting of the Compensation Committee of the Board of Directors of the Company held on April 5, 2007. The shares covered by such options are 126,418. The vesting period of these options is in a phased manner over a period of four years. The options may be exercised within a period of five years from the date of vesting"".","05-Apr-2007 16:12:00","2007-04-05 16:12:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Publish Audited Results","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that: ""The Company will announce and publish the audited annual results of the Company for the year ended March 31, 2007 instead of unaudited quarterly results for the quarter ended March 31, 2007"".","05-Apr-2007 16:00:00","2007-04-05 16:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that: ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has allotted 11,836 equity shares of Rs.5 each of the Company on March 20, 2007, to Employees who have exercised their Stock Options"".","21-Mar-2007 10:47:00","2007-03-21 10:47:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has allotted 70,782 equity shares of Rs.5 each of the Company on February 16, 2007, to a Director and Employees who have exercised their Stock Options"".","16-Feb-2007 10:46:00","2007-02-16 10:46:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release, dated January 22, 2007, titled ""Dr. Reddy's Q3 FY07 revenue at Rs. 15,434 million; Net income at Rs. 1,879 million;."" The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddys_press_220107.zip target=NEW> For more details click here.</a>","22-Jan-2007 16:46:00","2007-01-22 16:46:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated December 27, 2006, titled ""Dr. Reddy's announces Final Approval of Ondansetron Tablets with 180-days of marketing exclusivity"". The copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/dr.reddy_PR_271206.zip target=NEW> For more details click here.</a>","27-Dec-2006 12:52:00","2006-12-27 12:52:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""Pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has allotted 13,958 equity shares of Rs.5 each of the Company on December 19,2006, to a Director and Employees who have exercised their Stock Options.""","20-Dec-2006 14:12:00","2006-12-20 14:12:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that: ""The Company has granted 10,800 stock options at par value of Rs.5 per option, to the employees of the Company at the meeting of the Compensation Committee held on December 7, 2006. The shares covered by such options are 10,800. The vesting period of these options is in phased manner over a period of four years. The options may be exercised within a period of five years from the date of vesting"".","07-Dec-2006 17:54:00","2006-12-07 17:54:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated November 29, 2006, titled ""Dr. Reddy's announces issuance of additional American Depositary Shares"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddys_PR_30112006.zip target=NEW> For more details click here.</a>","30-Nov-2006 09:35:00","2006-11-30 09:35:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated November 29,2006, titled ""Dr. Reddy's and Torrent Pharma Sign Agreement for Exclusive Commercialization of Listril and Listril Plus in Russia"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_29112006.zip target=NEW> For more details click here.</a>","29-Nov-2006 14:07:00","2006-11-29 14:07:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated November 16,2006, titled ""Dr. Reddy's announces pricing of American Depositary Shares"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_17112006.zip target=NEW> For more details click here.</a>","17-Nov-2006 10:25:00","2006-11-17 10:25:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated November 13, 2006, titled ""Dr. Reddy's Files F-3 Registration Statement with the U.S. Securities And Exchange Commission"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_14112006.zip target=NEW> For more details click here.</a>","14-Nov-2006 09:45:00","2006-11-14 09:45:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 27,2006, titled ""Dr. Reddy's Q2 FY07 revenue at Rs 20,039 million; Net income at Rs 2,798 million"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_27102006.zip target=NEW> For more details click here.</a>","27-Oct-2006 18:35:00","2006-10-27 18:35:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 10, 2006, titled ""Dr. Reddy's Announces Settlement of Imitrexﾮ Litigation with Glaxosmithkline"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_PR_10102006.zip target=NEW> For more details click here.</a>","10-Oct-2006 10:25:00","2006-10-10 10:25:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 27, 2006, titled ""Dr. Reddy's and Clintec International Announce Co-development of Anti-Cancer Compound DRF 1042"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_270906.zip target=NEW> For more details click here.</a>","27-Sep-2006 15:53:00","2006-09-27 15:53:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 26, 2006, titled ""Dr. Reddy's inaugurates its first Finished Dosages Facility in Visakhapatnam"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Drreddy_260906.zip target=NEW> For more details click here.</a>","26-Sep-2006 15:35:00","2006-09-26 15:35:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has allotted 20,862 equity shares of Rs.5 each of the Company on August 16,2006, to a Director and Employees who have exercised their Stock Options.","17-Aug-2006 00:00:00","2006-08-17 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Record Date","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that August 29,2006 has been fixed as the Record date for the purpose of issue of Bonus Shares. A certified copy of the resolution pertaining to Bonus issue passed by the Shareholders at the AGM held on July 28,2006 shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","28-Jul-2006 00:00:00","2006-07-28 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of AGM","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the members of the Company passed the following resolutions unanimously at the AGM of the Company held on July 28, 2006 :- 1) Approval of payment of dividend of Rs.5 on each equity share of Rs.5. 2) Retirement of Mr. P N Devarajan by rotation and his re-appointment. 3) Retirement of Dr. V Mohan by rotation and not filling up the vacancy caused. 4) Re-appointment of BSR & Co. as statutory auditors till the conclusion of AGM to be held in the year 2007. 5) Re-appointment of Dr. K Anji Reddy as Executive Chairman. 6) Re-appointment of Mr. G V Prasad as Vice Chairman and Chief Executive Officer. 7) Revision in terms of appointment of Mr. Satish Reddy as Managing Director and Chief Operating Officer. 8) Remuneration to Directors other than the Managing / Whole Time Director(s). 9) Increase in the authorized share capital from Rs.50.00 crores to Rs.100 crores. 10) Capitalization of the reserves by issuing bonus shares to the shareholders in the ratio of 1:1. 11) Further issue of shares.","28-Jul-2006 00:00:00","2006-07-28 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 27,2006, titled ""Dr. Reddy's Q1 FY07 revenue at Rs 14,049 million; Net Income at Rs 1,398 million"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","27-Jul-2006 00:00:00","2006-07-27 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Date of Payment of Dividend","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the dividend, which may be declared at the the AGM scheduled to be held on July 28, 2006, shall be paid to the shareholders on or after August 02, 2006.","12-Jul-2006 00:00:00","2006-07-12 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","AGM","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the AGM of the Company will be held on July 28,2006.","04-Jul-2006 00:00:00","2006-07-04 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated July 03,2006, titled ""Dr. Reddy's launches 'Alfoo' for rapid relief from signs & symptoms of BPH "". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","03-Jul-2006 00:00:00","2006-07-03 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that Mr. Satish Reddy, Managing Director & COO has acquired 5000 shares of the total paid up capital of Dr. Reddy'S Laboratories Ltd on June 23, 2006. The mode acquisition is through Market Purchase and the total shareholding Mr. Satish Reddy after the said acquisition is 604,389 shares aggregating to 0.79% of the total paid up capital of Dr. Reddy'S Laboratories Ltd.","03-Jul-2006 00:00:00","2006-07-03 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has allotted 34,687 equity shares of Rs.5 each of the Company on July 01, 2006, to the Directors/Employees who have exercised their Stock Options.","03-Jul-2006 00:00:00","2006-07-03 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release, dated June 28, 2006, titled ""Top Management Moves at Dr Reddy's"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","28-Jun-2006 00:00:00","2006-06-28 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release, dated, June 23, 2006, titled ""Dr. Reddy's launches authorized generic versions of Proscarﾮ and Zocorﾮ"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","26-Jun-2006 00:00:00","2006-06-26 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Miscellaneous","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that ""In February 2006, Dr. Reddy's entered into an agreement with Merck & Co., which allows Dr. Reddy's to distribute and sell generic versions of Proscarﾮ (Finasteride 5 mg) and Zocorﾮ (Simvastain), upon the expiry of Merck's patents covered by these products, provided there's an 180 day exclusivity after the patents expiration for either product.  Following Teva Pharmaceutical being awarded 180-day marketing exclusivity for Finsteride 5mg. Dr. Reddy's has launched the authorized generic version of Proscarﾮ in the US yesterday post the patent expiry. The Company is under confidentiality not to disclose the terms of the agreement.""","21-Jun-2006 00:00:00","2006-06-21 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company at their meeting held on May 31, 2006 has recommended a dividend of 100% for the Financial Year ending March 31, 2006.","09-Jun-2006 00:00:00","2006-06-09 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Book Closure","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the register of members of the Company would remain closed from July 11,2006 to July 14,2006 (both days inclusive) for the purpose of payment of Dividend for the year 2005-06.","08-Jun-2006 00:00:00","2006-06-08 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has granted 199,880 stock options to the employees of the Company at an exercise price of Rs.5, which is the par value of the shares of the Company. The shares covered by such options are 199,880. The vesting period of these options is 25% options each year over a period of four years. The options may be exercised within a period of five years from the date of vesting. Further, Company has granted 8,250 stock options to the impendent Directors of the Company at an exercise price of Rs.5, which is the par value of the shares of the Company. The shares covered by such options are 8,250. The vesting period of these options is one year. The options may be exercised within a period of five years from the date of vesting.","01-Jun-2006 00:00:00","2006-06-01 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Bonus","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the BODs of the company in its meeting held on May 31,2006 have recommended issue of bonus equity shares to the shareholders at the ratio of 1:1(one equity share for each equity share held) for all existing shares including American Depository shares on the record date to be fixed by the board.","31-May-2006 00:00:00","2006-05-31 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 31, 2006, titled ""Dr. Reddy's FY06 revenue at Rs.24,267 million; Net Income at Rs.1,629 million"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","31-May-2006 00:00:00","2006-05-31 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc under Reg Subs Acq &Takeover & SEBI Insider Trading Reg","Fidelity International has informed the Exchange that funds under the management of FMR Corp and its direct and indirect subsidiaries and Fidelity International Limited and its direct and indirect subsidiaries have acquired 246,511 shares aggregating to 0.32% of the total paid up capital of Dr. Reddys Laboratories Limited on May 18, 2006. The mode of acquisition is through Open Market and the shareholding of funds under the management of FMR Corp and its direct and indirect subsidiaries and Fidelity International Limited and its direct and indirect subsidiaries after the said acquisition is 3,893,491 shares aggregating to 5.08% of the total paid up capital of Dr. Reddys Laboratories Ltd.. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","22-May-2006 00:00:00","2006-05-22 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated May 15, 2006, titled ""Dr. Reddy's launches 'Doxobid'- a new oral bronchodilator for asthma & COPD"". A copy of the press realse shall be available on NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","16-May-2006 00:00:00","2006-05-16 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has alloted 7,683 equity shares of Rs.5 each of the Company on May 11, 2006, to the  employees who have exercised their Stock Options.","12-May-2006 00:00:00","2006-05-12 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc under Reg Subs Acq &Takeover & SEBI Insider Trading Reg","Funds under the management of FMR Corp and its direct and indirect subsidiaries and Fidelity International Limited and its direct and indirect subsidiaries has informed the Exchange that they have sold 254,184 shares aggregating to 0.33% of the total paid up capital of Dr. Reddys Laboratories Limited on April 19, 2006. The mode of sale is through Open Market and the shareholding of Funds under the management of FMR Corp and its direct and indirect subsidiaries and Fidelity International Limited and its direct and indirect subsidiaries after the said sale is 3,676,806 shares aggregating to 4.80% of the total paid up capital of Dr. Reddys Laboratories Ltd..","24-Apr-2006 00:00:00","2006-04-24 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc under Reg Subs Acq &Takeover & SEBI Insider Trading Reg","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that HSBC Global Investment Fund has acquired 100,000 shares aggregating to 0.13% of the share capital of Dr. Reddy's Laboratories Ltd. on April 10, 2006. The mode of acquisition is through Market Purchase and the shareholding of HSBC Global Investment Fund after the said acquisition is 5,518,325 shares (including ADRs) aggregating to 7.195% of the total share capital of Dr. Reddy's Laboratories Ltd.","19-Apr-2006 00:00:00","2006-04-19 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release, dated, April 13, 2006, titled, ""Dr. Reddy's receives USFDA approval for fexofenadine hydrochloride."" The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","13-Apr-2006 00:00:00","2006-04-13 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has alloted 75,000 equity shares of Rs.5 each of the Company on March 31, 2006, to an employee who has exercised his Stock Options.","03-Apr-2006 00:00:00","2006-04-03 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated April 3, 2006, titled ""Dr. Reddy's launches 'Z&D' - Zinc therapy for effective management of diarrhea"". A copy of the press realse shall be available on NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","03-Apr-2006 00:00:00","2006-04-03 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr.Reddy's Employees Stock Option Scheme,2002, the compensation committee of the company has allotted 12,573 equity shares of Rs.5 each of the company on March 24, 2006, to the employees who have exercised their Options.","27-Mar-2006 00:00:00","2006-03-27 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Miscellaneous","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that a minor fire broke out in a section of the Active Pharmaceutical Ingredients (API) manufacturing facility of the Company at Pydibheemavaram (near Vizag) on March 21, 2006. All immediate remedial actions were undertaken and the fire was brought under control. Other than the affected section of the facility where the fire broke out, all other sections of the facilities including all production blocks remained unaffected. No injury has been reported. The API manufacturing facility at Pydibheemavaram is one of Dr Reddy's seven API manufacturing facilities in India. ","21-Mar-2006 00:00:00","2006-03-21 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc under Reg Subs Acq &Takeover & SEBI Insider Trading Reg","Fidelity International has informed the Exchange that Funds under the management of FMR Corp and its direct and indirect subsidiaries and Fidelity International Limited and its direct and indirect subsidiaries has acquired 410,000 shares aggregating to 0.54% of the total paid up capital of Dr. Reddys Laboratories Limited on March 13, 2006. The mode of acquisition is through Open Market and the shareholding of Funds under the management of FMR Corp and its direct and indirect subsidiaries and Fidelity International Limited and its direct and indirect subsidiaries after the said acquisition is 4,050,660 shares aggregating to 5.28% of the total paid up capital of Dr. Reddys Laboratories Ltd.. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","16-Mar-2006 00:00:00","2006-03-16 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Section 192A of Companies Act, 1956 read with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001. The Company dispatched the draft resolution alongwith the explanatory statement for authorizing the Board of Directors of the Company for borrowings and investments in excess of the limits prescribed under Section 293 and 372A of the Companies Act, 1956, creation of charges on the Company's properties and issue of securities for raising the funds on February 02, 2006 under Certificate of posting. The last date of receiving the response from the shareholders was not later than the close of working hours on March 04, 2006. The Company appointed Mr. B Satya Reddy, Practicing Company Secretary as scrutinizer for conducting the postal ballot process in a fair and transparent manner. The scrutinizer has submitted his report to the Chairman of the Company after completion of the scrutiny. According to the postal ballot results, following resolutions have been passed. (1) Borrowings powers of the Board beyond limits under Section 293 (1) (d). (2) Creation of charges under Section 293 (1) (a). (3) Investments beyond the limits prescribed under Section 372A. (4) Issue of securities under Section 81 (1A).","08-Mar-2006 00:00:00","2006-03-08 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release, dated, March 04, 2006, titled, ""Dr. Reddy's completes the acquisition of betapharm."" The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","06-Mar-2006 00:00:00","2006-03-06 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release, dated, February 16, 2006, titled, ""Dr. Reddy's signs definitive agreement with 3i for the strategic acquisition of betapharm."" The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).","16-Feb-2006 00:00:00","2006-02-16 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Allotment of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has allotted 68,048 equity shares of Rs.5 each of the Company on February 13, 2006, to the employees who have exercised their Stock Options.","14-Feb-2006 00:00:00","2006-02-14 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that Life Insurance Corporation of India has sold 1,667,144 shares aggregating to 2.18% of the share capital of Dr. Reddy'S Laboratories Ltd. on January 30, 2006. The mode of sale is Market Sale and the shareholding of Life Insurance Corporation of India after the said sale is 5,186,496 shares aggregating to 6.77% of the share capital of Dr. Reddy'S Laboratories Ltd.","14-Feb-2006 00:00:00","2006-02-14 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Section 192A of the Companies Act, 1956 the company is seeking approval of the shareholders by means of a postal ballot for the following resolutions : (1) Ordinary Resolution under Section 293(1)(d) of the Companies Act, 1956 for enhancing the borrowing limits of the Board. (2) Ordinary Resolution under Section 293(1)(a) of the Companies Act, 1956 for creation for mortgage / charges. (3) Special Resolution under Section 372A of the Companies Act, 1956 for giving loans / corporate guarantees / making investments in excess of limits prescribed under said Section. (4) Special resolution under Section 81(1A) for Issue of Securities. The Company has appointed Mr. B Satya Reddy, a practicing Company Secretary, as Scrutinizer for conducting the postal ballot process in a fair and transparent manner. The duly completed Postal Ballot Form should reach the scrutinizer on or before March 04, 2006. The results of the postal ballot will be announced through a press release. The details of the postal ballot notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","10-Feb-2006 00:00:00","2006-02-10 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Section 192A of Companies Act, 1956 read with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001, the Company has dispatched the draft resolution alongwith the explanatory statement for authorizing the Board of Directors of the Company for borrowings and investments in excess of the limits prescribed under Section 293 and 372A of the Companies Act, 1956, creation of charges on the Company's properties and issue of securities for raising the funds. The last date of receiving the response from the shareholders is not later than the close of working hours on March 04, 2006. The Company has appointed Mr. B. Satya Reddy, Practicing Company Secretary as scrutinizer for conducting the postal ballot process in a fair and transparent manner. The Scrutinizer shall submit his report to the Chairman after completion of the scrutiny and the results of the postal ballot will be announced through press release.","06-Feb-2006 00:00:00","2006-02-06 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated February 02, 2006, titled ""DR.REDDY'S AND ARGENTA DISCOVERY ANNOUNCE R&D COLLABORATION - Collaboration to develop and commercialize a novel approach to Chronic Obstructive Pulmonary Disease"".The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","02-Feb-2006 00:00:00","2006-02-02 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","News Verification","News Verification : The media had reports that Dr. Reddy's Laboratories Ltd. has signed deal with Merck to market Zocor, Proscar in U.S. The Exchange, in order to verify the accuracy or otherwise of the information reported in the media and to inform the market place so that the interest of the investors is safeguarded, had written to the officials of the company. Dr. Reddy's Laboratories Ltd. has vide its letter inter-alia stated, ""We would like to inform you that Dr. Reddy's has entered into an agreement with Merck which will allow Dr. Reddy's to distribute and sell generic versions of Proscar and Zocor, upon the expiry of Merck's patents covered by these products, provided there is an 180 day exclusivity after the patents expiration for either product.""","01-Feb-2006 00:00:00","2006-02-01 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated January 24, 2006, titled ""Dr. Reddy's reports Q3 FY06 revenue of Rs.5,902 million; YoY growth of 25%; Net income at Rs.628 million"".The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","24-Jan-2006 00:00:00","2006-01-24 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Change in Directors","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Board of Directors of the Company in its meeting held on January 24, 2006 approved re-appointment of Dr. K Anji Reddy as Executive Chairman and Mr. G V Prasad as Executive Vice Chairman and Chief Executive Officer of the Company for a period of 5 years w.e.f. July 13, 2006 and January 30, 2006 respectively. The Board also approved revision in the terms of appointment of Mr. Satish Reddy, Managing Director and Chief Operating Officer w.e.f. February 01, 2006.","24-Jan-2006 00:00:00","2006-01-24 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc under Reg Subs Acq &Takeover & SEBI Insider Trading Reg","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that HSBC Global Investment Funds - A/C, HSBC Global Investment Funds (Mauritius) Limited alongwith PAC HSBC Halbis Partners (Hong Kong) Limited has acquired 78,700 ADRs of Dr. Reddy'S Laboratories Limited on January 03, 2006. The mode of acquisition is Market Purchase and the shareholding of HSBC Global Investment Funds - A/C, HSBC Global Investment Funds (Mauritius) Limited alongwith PAC HSBC Halbis Partners (Hong Kong) Limited after the said acquisition is 3,889,468 shares (including ADRs) aggregating to 5.08% of the total paid up capital of Dr. Reddy'S Laboratories Limited.","10-Jan-2006 00:00:00","2006-01-10 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Disc under Reg Subs Acq &Takeover & SEBI Insider Trading Reg","HSBC Halbis Partners (Hong Kong) Limited has informed the Exchange that HSBC Global Investment Funds - A/C, HSBC Global Investment Funds (Mauritius) Limited alongwith PAC HSBC Halbis Partners (Hong Kong) Limited has acquired 78,700 ADRs of Dr. Reddy'S Laboratories Limited on January 03, 2006. The mode of acquisition is Market Purchase and the shareholding of HSBC Global Investment Funds - A/C, HSBC Global Investment Funds (Mauritius) Limited alongwith PAC HSBC Halbis Partners (Hong Kong) Limited after the said acquisition is 3,889,468 shares aggregating to 5.08% of the total paid up capital of Dr. Reddy'S Laboratories Limited.","09-Jan-2006 00:00:00","2006-01-09 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reg 7 of SEBI (Susbs Acq of shares & Takeovers)","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that JP Morgan Fleming Asset Management (Europe) Flagship Indian Inv Mauritius Limited, JF India Fund, JP Morgan Fleming India Investment Company (Mauritius) Limited, The Master Trust Bank of Japan, Ltd a/c JF India Equity Mother Fund, Kuwait Investment Authority and Flamingo has acquired 200,000 shares aggregating to 0.26% of the total paid up capital of Dr. Reddy'S Laboratories Ltd. on November 11, 2005. The mode of acquisition is through Open Market and the shareholding of JP Morgan Fleming Asset Management (Europe) Flagship Indian Inv Mauritius Limited, JF India Fund, JP Morgan Fleming India Investment Company (Mauritius) Limited, The Master Trust Bank of Japan, Ltd a/c JF India Equity Mother Fund, Kuwait Investment Authority and Flamingo after the said acquisition is 3,895,806 shares aggregating to 5.09% of the total paid up capital of Dr. Reddy's Laboratories Ltd.","23-Nov-2005 00:00:00","2005-11-23 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated November 15, 2005, titled 'Dr. Reddy's announces the launch of 'Save the Foot' initiative to reduce Diabetic Foot Amputations."" The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","16-Nov-2005 00:00:00","2005-11-16 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reg 7 of SEBI (Susbs Acq of shares & Takeovers)","JF Asset Management Limited has informed the Exchange that JP Morgan Fleming Asset Management (Europe) Flagship Indian Inv Mauritius Limited, JF India Fund, JP Morgan Fleming India Investment Company (Mauritius) Limited, The Master Trust Bank of Japan, Ltd a/c JF India Equity Mother Fund, Kuwait Investment Authority and Flamingo has acquired 200,000 shares aggregating to 0.26% of the total paid up capital of Dr. Reddy'S Laboratories Ltd. on November 11, 2005. The mode of acquisition is through Open Market and the shareholding of JP Morgan Fleming Asset Management (Europe) Flagship Indian Inv Mauritius Limited, JF India Fund, JP Morgan Fleming India Investment Company (Mauritius) Limited, The Master Trust Bank of Japan, Ltd a/c JF India Equity Mother Fund, Kuwait Investment Authority and Flamingo after the said acquisition is 3,895,806 shares aggregating to 5.09% of the total paid up capital of Dr. Reddy's Laboratories Ltd.","16-Nov-2005 00:00:00","2005-11-16 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding the press release issued by the company dated November 08, 2005, titled, ""Dr. Reddy's signs definitive agreement to acquire Roche's API business at its Mexico facility"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","08-Nov-2005 00:00:00","2005-11-08 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated October 17, 2005, titled 'Dr. Reddy's launches 'Viboliv' - (Metadoxine) to enter the hepatoprotectives market'.  The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","17-Oct-2005 00:00:00","2005-10-17 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a press release dated September 29, 2005, titled 'Dr. Reddy's announces India's first major Drug Co-Development and Commercialization deal; Co-development and commercialization of Balaglitazone (DRF 2593) with Rheoscience.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","29-Sep-2005 00:00:00","2005-09-29 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Ltd. has informed the Exchange regarding a press release dated September 28, 2005, titled 'Dr. Reddy's announces the formation of Perlecan Pharma; Perlecan Pharma raises USD 52.5 million as initial equity capital; Perlecan Pharma: India's First Integrated Drug Development Company.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","28-Sep-2005 00:00:00","2005-09-28 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Results of Postal Ballot","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that pursuant to Section 192A of Companies Act, 1956 read with the Companies (Passing of Resolution by Postal Ballot) Rules, 2001, the Company dispatched the draft resolution alongwith the explanatory statement for disposal of the Company's formulations manufacturing facility situated at Goa and the postal ballot forms to the shareholders of the Company on August 1, 2005 under certificate of posting. The last date for receiving the postal ballot mandate by the scrutinizer was not later than the close of working hours on August 31, 2005. Mr. B Satya Reddy, Practicing Company Secretary was appointed as scrutinizer for conducting the postal ballot process in a fair and transparent manner.  The Scrutinizer has submitted his report to the Chairman of the Company after completion of the scrutiny. According to the postal ballot results, the resolution under Section 293(1)(a) of the Companies Act, 1956 for disposal of the Companies formulations manufacturing facility situated at Goa has been passed.","02-Sep-2005 00:00:00","2005-09-02 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Stock Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has granted 8,300 stock options to the employees of the Company at an exercise price of Rs.5, which is the par value of the shares of the Company. The shares covered by such options are 8,300. The vesting period of these options is 25% options each year over a period of four years. The options may be exercised within a period of five years from the date of vesting.","01-Sep-2005 00:00:00","2005-09-01 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has issued a press release dated, August 25, 2005, titled, ""Dr. Reddy's launches 'Shadowz' a unique high SPF protection sunscreen"". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","25-Aug-2005 00:00:00","2005-08-25 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Postal Ballot","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that as per Section 192A of the Companies Act, 1956 read with the Companies (Passing of the Resolution by Postal ballot) Rules, 2001, the company is seeking consent of the shareholders by means of a postal ballot to transfer, sell and / or dispose off the formulations factory of the Company at Plot No. A-3 to A-6, Phase 1-A, Verna Industrial Estate, Goa. The Company has appointed Mr. B Satya Reddy, a practicing Company Secretary, as Scrutinizer for conducting the postal ballot process in a fair and transparent manner. The duly completed Postal Ballot Form should reach the scrutinizer on or before August 31, 2005. The results of the postal ballot will be announced through press release. The details of the postal ballot notice shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","09-Aug-2005 00:00:00","2005-08-09 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has partnered up with Narsee Monjee Institute of Management Studies (NMIMS), Mumbai, a premier B-school in India to offer a unique MBA (Pharma Management) program to its employees. The details of the press release issued by the Company regarding the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","08-Aug-2005 00:00:00","2005-08-08 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Outcome of AGM","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the members of the company approved the following proposals at the AGM of the Company held on July 27, 2005: 1) Adoption of annual accounts of the Company for the Financial Year 2004-05. 2) Approval to payment of dividend of Rs.5 on each equity share of Rs.5. 3) Retirement of Dr. Krishna G Palepu and Mr. Ravi Bhoothalingam by rotation and their re-appointment. 4) Re-appointment of BSR & Co. as statutory auditors till the conclusion of AGM to be held in the year 2006. 5) Approval to the amendment in the Employee Stock Option Scheme of the Company to provide for grant of more options at Par Value (Rs.5). 6) Approval to the new ADR linked Employee Stock Option Scheme of the Company.","29-Jul-2005 00:00:00","2005-07-29 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release/Others","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has issued a press release dated July 26, 2005, with respect to its unaudited financial results for the quarter ended June 30, 2005. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements). The Company has further informed that the Board has approved the disposal of the formulations manufacturing facility of the Company situated at Goa. The Company would take the necessary approval of the Shareholders in this regard by way of postal ballot.","26-Jul-2005 00:00:00","2005-07-26 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a Press Release dated July 15, 2005 titled ""Dr. Reddy's organizes an International Symposium on Gastro Intestinal Cancer"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","15-Jul-2005 00:00:00","2005-07-15 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has issued a Press Release dated July 14, 2005 titled ""Dr. Reddy's launches a novel immune booster for children; Product launched in collaboration with Symbiotics of New Zealand"". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","14-Jul-2005 00:00:00","2005-07-14 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Payment of Dividend","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the dividend, which may be declared at the AGM scheduled to be held on July 27, 2005, shall be paid to the shareholders on or after August 02, 2005.","01-Jul-2005 00:00:00","2005-07-01 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Notice of AGM","Dr. Reddy'S Laboratories Ltd. has submitted to the Exchange a copy of the notice of AGM of the Company scheduled to be held on July 27, 2005. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server /Common/CorporateAnnouncements).","28-Jun-2005 00:00:00","2005-06-28 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has issued a Press Release dated June 21, 2005 titled ""Dr. Daniel Rader joins Dr. Reddy's Laboratories Scientific Advisory Board "". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","21-Jun-2005 00:00:00","2005-06-21 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Stock Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has granted 12000 stock options to the employees of the Company  at an exercise price of Rs.5, which is the par value of the shares of the Company . The shares covered by such options are 12000. The vesting period of these options is 25% options each year over a period of four years. The options may be exercised within a period of five years from the date of vesting.","16-Jun-2005 00:00:00","2005-06-16 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange regarding a Press Release dated June 14, 2005 titled ""Dr. Reddy's wins WorldStar awards for anti -counterfeit and patient protection packaging, Only pharmaceutical company from India to win the awards"".The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements)  ","14-Jun-2005 00:00:00","2005-06-14 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Stock Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has granted following Stock options: 1) 178,560 stock options at an exercise price of Rs.5, which is the par value of the shares of the Company and 2) 32,500 stock options at an exercise price of Rs.725, which is the Fair Market Value of the shares of the Company as per Dr. Reddy's Employee Stock Option Scheme, 2002. The shares covered by such options are 211,060. The vesting period of these options is 25% options each year over a period of four years. The options may be exercised within a period of five years from the date of vesting.","30-May-2005 00:00:00","2005-05-30 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Reg.13-SEBI(Prohibition of Insider Trading Regulations)1992","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that Mr. G V Prasad, Executive Vice Chairman and Chief Executive Officer of the Company has sold 13,852 equity shares of the Company on May 20, 2005. The mode of sale is Market Sales and the shareholding of Mr. G V Prasad after the said sale is 6,78,920 equity shares aggregating to 0.89% of the share capital of Dr. Reddy's Laboratories Ltd..","26-May-2005 00:00:00","2005-05-26 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Book Closure","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the register of members of the company would remain closed from July 11,2005 to July 15,2005(both days inclusive) for the purpose of payment of dividend for the year 2004-05.","25-May-2005 00:00:00","2005-05-25 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Stock Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the company has granted 17,000 stock options to the independent directors of the company at an exercise price of Rs.5, which is the par value of the shares of the company. The company has further informed that the shares covered by such options are 17,000. The vesting period of these options is 25% options each year over a period of four years. The options may be exercised within a period of five years from the date of vesting.","09-May-2005 00:00:00","2005-05-09 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Dividend","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the BODs of the Company at its meeting held on May 06,2005 have recommended the final dividend of Rs.5 per share subject to approval of the shareholders.","06-May-2005 00:00:00","2005-05-06 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Miscellaneous","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has entered into an agreement to develop, manufacture and commercialize eleven generic pharmaceutical products for the Canadian marketplace. Under the terms of the agreement, Dr. Reddy's and the Pharmascience Group will share the costs and benefits associated with the commercialization of the products.","25-Apr-2005 00:00:00","2005-04-25 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has issued a press release dated April 15, 2005, titled 'DR. REDDY'S ANNOUNCES DISTRICT COURT RULING ON ZYPREXAﾮ '. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","15-Apr-2005 00:00:00","2005-04-15 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","ESOS","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has granted 1,000 stock options to an employee of the Company at an exercise price of Rs.5, which is the par value of the shares of the Company. The shares covered by such options are 1,000. The Company has further informed that the vesting period of these options is 25% options each year over a period of four years. The options may be exercised within a period of five years from the date of vesting.","07-Apr-2005 00:00:00","2005-04-07 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has issued a press release dated April 07, 2005, titled 'Dr. Reddy's launches India's first drug for treatment of diabetic foot ulcers'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","07-Apr-2005 00:00:00","2005-04-07 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has issued a press release dated March 28, 2005, titled 'Dr. Reddy's and ICICI Venture announce USD 56 million-partnership for the commercialization of ANDAs'. The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","28-Mar-2005 00:00:00","2005-03-28 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has issued a press release dated March 24, 2005, titled 'Dr. Reddy's launches new treatment modality for Osteoarthritis.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","24-Mar-2005 00:00:00","2005-03-24 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Stock Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the company has granted 12,000 stock options to an employee of the company at an exercise price of Rs.5, which is the par value of the shares of the Company. The shares covered by such options are 12,000. The vesting period of these options is 25% options each year over a period of four years. The options may be exercised within a period of five years from the date of vesting.","21-Feb-2005 00:00:00","2005-02-21 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Delisting of shares","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the applications for delisting of company's equity shares were filed with four stock exchanges  viz. the Hyderabad Stock Exchange Ltd. (Regional Stock Exchange), Madras Stock Exchange Ltd., the Calcutta Stock Exchange Association Ltd and the Stock Exchange Ahmedabad and all four stock Exchanges have approved the delisting  of the equity shares.The proposal was approved by the shareholders at the AGM of the company held on August 25,2003. The equity shares of the company are now listed on the following stock exchanges:1. The Stock Exchange, Mumbai 2. The National Stock of India 3. New York Stock Exchange (ADS listed).","10-Feb-2005 00:00:00","2005-02-10 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the company has issued a press release dated February 07, 2005 titled 'Dr. Reddy's initiates clinical trials of its cardiovascular drug in Ireland: RUS 3108 is a first-in-class compound.' The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","07-Feb-2005 00:00:00","2005-02-07 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Stock Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the company has granted following stock options to the employees of the Company at the meeting of the Compensation Committee:1)280,873 options at an exercise price of Rs.5,which is the par value of the shares of the Company.2)30,000 options at an exercise price of Rs.809,which is equivalent to the weighted average share price of the Company for previous 30 days. The shares covered by such options are 310,873.The vesting period of these options is in phased manner over a period of four years. The options may be exercised within a period of 5 years from the date of vesting.  ","27-Jan-2005 00:00:00","2005-01-27 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has on November 08, 2004 issued a press release titled 'Dr. Reddy's appoints Alan Sheppard as Head of Generics Business in Europe'. The details of the press release issued by the Company shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","08-Nov-2004 00:00:00","2004-11-08 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has on October 28, 2004 announced that the U. S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Citalopram hydrobromide tablets 10 mg, 20 mg and 40 mg. The details of the press release issued by the company regarding the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","29-Oct-2004 00:00:00","2004-10-29 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Grant of Stock Options","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the BOD in its meeting held on October 26, 2004, has granted 22900 stock options to certain employees of the Company. The shares covered by such options are 22900. The options have been granted at a price of Rs.747 per option, which is equivalent to weighted average share price of the Company for last 30 trading days on NSE. The options may be exercised in a phased manner after a vesting period of 12 months to 48 months but before completion of five years from the date of vesting.","27-Oct-2004 00:00:00","2004-10-27 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy'S Laboratories Ltd. has informed the Exchange that the Company has on October 27, 2004, issued a Press Release titled 'Novo Nordisk terminates further clinical development of Balaglitazone (DRF 2593) out-licensed by Dr. Reddy's'. The details of the press release issued by the Company shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","27-Oct-2004 00:00:00","2004-10-27 00:00:00","-","-","-"
"DRREDDY","Dr. Reddy's Laboratories Limited","Press Release","Dr. Reddy's Laboratories Ltd. has informed the Exchange that the Company has on October 01, 2004, announced that the Company had filed an Abbreviated New Drug Application (ANDA) with the United States Food and Drug Administration for Finasteride tablets 1 mg with a Paragraph IV certification on three of the four Orange Book patents listed for the drug, in June 2002. The details of the press release issued by the Company shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements).","01-Oct-2004 00:00:00","2004-10-01 00:00:00","-","-","-"